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Summary 
 
 
T helper 2 (Th2) cell responses typify the immune response to parasitic 
organisms, which frequently invade the intestine. Dendritic cells (DCs) are 
considered vital for the induction of Th2 responses as they present parasite-
derived antigens to naive T cells in draining lymph nodes. However, the identities 
of the DC populations responsible for priming Th2 cells in the intestine are still 
unclear. We developed an experimental immunization protocol to deliver 
Schistosoma mansoni eggs into the intestine. During live infection by the parasite, 
these eggs cause intestinal damage, granuloma formation, tissue fibrosis and 
strong type 2 immune responses.  
Many aspects of type 2 immunity are controlled by the transcription factor IRF4 
and we observed that intestinal Th2 responses against Schistosoma mansoni 
eggs did not develop in the draining lymph nodes in the absence of IRF4+ DCs. 
IRF4f/f CD11c-cre positive mice had fewer CD11b-expessing migrating DCs, and 
fewer parasite antigen-carrying DCs were present in the mesenteric lymph nodes 
(MLNs) draining the small intestine and colon. However, transfer of antigen-loaded 
IRF4-deficient DCs directly into the MLN revealed that these cells could induce 
antigen-specific Th2 responses, suggesting that IRF4 controlled the migration of 
CD11b-expessing DCs rather than their Th2 inducing capacity. 
Furthermore, immature DCs from the intestinal lamina propria, and semi-mature 
DCs from lymph were sufficient to prime antigen-specific Th2 responses against 
egg antigens when transferred into naive recipient mice. This induction was 
dependent on MHCII expression but not on the production of IL-4 by the 
transferred DCs, indicating that conventional intestinal DCs are fully capable of 
inducing Th2 responses against S. mansoni egg antigens upon transfer.  
Further analysis of migratory small intestinal and colonic lymph DCs revealed that 
distinct subsets of CD11b-expressing DCs were sufficient for the induction of Th2 
responses in the small intestine and colon. CD11b+CD103+ DCs transported 
parasite antigen from the small intestine, whereas CD11b+CD103- DCs performed 
this role in the colon. Of note, these same small intestinal and colonic DC subsets 
were also the populations that were most efficient at priming antigen-specific Th2 
responses in vivo.  
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Thus, we have not only identified that IRF4-dependent CD11b-expressing DCs are 
specialized to drive Th2 responses in the intestine but have also revealed that 
different DC subsets promote Th2 responses in the small intestine and colon. 
These findings not only advance our knowledge of intestinal Th2 responses 
against parasite antigens but also reveal a hitherto unappreciated functional 
heterogeneity among intestinal DCs, which could also be relevant for other tissue-
specific intestinal conditions like Crohn’s disease, ulcerative colitis and celiac 
disease. 
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Chapter 1: Introduction 
 
 
Parasite infections present a huge global health burden that cause chronic 
diseases and also have wide socioeconomical effects by infecting livestock. Over 
2.5 billion people, which is about a third of the world’s population, are infected by 
parasitic worms such as helminths, which mostly reside within the gastrointestinal 
tract (Hotez et al., 2008). Most parasite infections cause type 2 immune 
responses, which include innate responses that try to damage or expel the 
parasite, and adaptive responses that recruit effector cells, support expulsion and 
produce antibodies. However, many parasites have evolved to persist within the 
host for many years, and cause chronic morbidity. One example are 
schistosomes, which are parasitic worms that chronically infect more than 200 
million people worldwide and cause an estimated mortality of 280,000 per year 
(van der Werf et al., 2003). Most of the pathologic symptoms of schistosomiasis 
are caused by damaging effects of chronic type 2 immune responses against 
parasite eggs (Vennervald and Polman, 2009), and the aim of this project is to 
understand how these immune responses are initiated. In this work we focused on 
immune responses in the intestine, which is heavily damaged by Schistosoma 
mansoni eggs and is the major site of infection of most soil-transmitted helminths 
parasites. In order to understand the infection of S. mansoni and the immune 
responses that are caused by the eggs within the definitive human host, the 
immune system is first introduced. We hereby focus on the immune system of the 
gastrointestinal tract, as it directly relates to the experiments that follow. These 
experiments were all performed within the mouse but findings from both human 
and murine studies are introduced to relate to human pathology.  
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1.1 The intestinal immune system 
 
1.1.1 Intestinal anatomy and physiology 
 
The different regions of the intestine have distinct anatomical features, which have 
specialized to support their primary function of nutrient and water uptake. The 
intestine is constantly exposed to molecules from the outside world and harbours 
the largest number of immune cells in the body to tolerate and if necessary defend 
against these foreign antigens. It is anatomically divided into the small intestine 
and the colon. The small intestine starts after the stomach and consists of the 
duodenum, the jejunum and the ileum. It is arranged in multiple coils and can 
reach up to 7 meters of length in humans. The main function of the small intestine 
is the uptake of nutrients, which is performed by microvillous enterocytes, which 
line the epithelium, have a large surface area and are specialized for nutrient 
digestion and uptake. The surface area of the small intestine is further amplified by 
finger-like projections known as villi, which extend into the intestinal lumen. 
Epithelial cells, such as enterocytes, mucus-secreting goblet cells and Paneth 
cells are continuously renewed by multipotent stem cells, which reside in the 
crypts at the bottom of the villi, and are fully replaced every 4-5 days (Mowat and 
Agace, 2014). Apart from enterocytes and goblet cells, intraepithelial lymphocytes 
(IELs) are present within the epithelial layer of the villi, and help maintain epithelial 
integrity.  
 
Food allergies and celiac disease are restricted to the small intestine as these 
conditions represent immune responses that are directed against food antigens. In 
food allergy, pathologic type 2 immune responses are activated by food antigens 
and innate immune cells mount an acute reaction immediately after allergen 
exposure, which is amplified by T cells and allergen specific antibodies (Smythies 
et al., 2005; Johnston et al., 2014). Celiac disease, on the other hand, is a genetic 
autoimmune disorder where the ingestion of gluten leads to damage in the small 
intestine. Inflammatory gluten-specific T cells accumulate in the small intestine and 
induce epithelial damage and activate cytotoxic IELs, leading to the intestinal 
lesions and crypt hyperplasia (Hadis et al., 2011; Meresse et al., 2012). 
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Paneth cells reside at the bottom of the crypts and secrete antimicrobial peptides, 
which together with mucus, help to keep bacteria away from the epithelial cells 
(Fig. 1-1). It is estimated that the jejunum is colonized by 104 bacteria/g intestinal 
content and a more dense and diverse bacterial community is present in the ileum 
(up to 108 bacteria/g content) (Zoetendal et al., 2006). Underneath the epithelium 
lies the lamina propria, which consists of a loosely packed connective tissue 
containing blood and lymph capillaries, the nervous system and most of the cells 
that comprise the intestinal innate and adaptive immune system. Immune cells of 
the lamina propria are the focus of this work as they monitor antigens within the 
lamina propria, such as S. mansoni eggs that penetrate the intestinal tissue or 
invading microbial antigens and are therefore described in more detail in the 
following sections. 
 
Apart from the lamina propria, immune cells also reside in macroscopically visible 
Peyer’s patches and smaller solitary isolated lymphoid tissues (SILTs), which are 
important structures of the gut-associated lymphoid tissue in the small intestine 
(Jung et al., 2010). Within these structures, aggregates of T and B cells reside 
within large B cell lymphoid follicles and smaller T cell areas and respond to 
antigen presented by dendritic cells. Peyer’s patches and SILTs are specialized to 
recognize luminal antigen and defend against pathogens that try to invade the 
intestine. Luminal antigen is transported into these structures by specialized 
microfold cells (M cells) and presented to T cells that drive adaptive immune 
responses such as B cell activation and antibody production (Mabbott et al., 2013). 
One of the most important types of antibodies produced under homeostatic 
conditions in the intestine is Immunoglobulin A (IgA), which is secreted to target 
microbial antigens. By binding to bacteria, IgA facilitates bacterial entrapment 
within the lumen and the regulated uptake of luminal antigens by M cells and helps 
maintain intestinal homeostasis against the microbiota (Mantis et al., 2011).  
 
Adaptive immune responses against intestinal antigens are also initiated in the 
mesenteric lymph nodes, which are connected to the intestine by the lymphatic 
system. Here, migratory immune cells, like dendritic cells, present intestinal 
antigen to naive T cells and initiate the appropriate immune responses. As 
dendritic cells are specialized to prime T cells against foreign antigens, including 
those derived from parasites, the mechanisms by which they prime T cells and 
induce immune responses will be discussed in more detail later on. Carter and 
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Collins already observed in 1974 that separate lymph nodes drain different 
segments of the intestine and identified that the upper and central node of the four 
to five mesenteric lymph nodes in mice drain the small intestine (Carter and 
Collins, 1974). They also identified that different parts of the large intestine drained 
into different lymph nodes located within the body cavity. The caecum and 
ascending colon drain into the lower of the four to five mesenteric lymph nodes, 
the transverse colon is drained by the pancreatic lymph nodes and the descending 
colon and rectum are drained by the caudal lymph node. Thus, careful distinctions 
between the respective lymph nodes need to be made when studying adaptive 
small intestinal and colonic immune responses, which reflects on work presented 
in this thesis that investigates and compares small intestinal and colonic immune 
responses against S. mansoni egg antigens.  
 
The large intestine follows a similar anatomical structure as the small intestine and 
is encased by a muscle layer, which is responsible for intestinal peristalsis, the 
muscularis mucosae and submucosa, which are densely packed with nerve fibres 
and the serosa, which provides a thick fibrous covering and separates the intestine 
from the surrounding peritoneal cavity (Mowat and Agace, 2014). It extends from 
the small intestine to the anus and is divided into the caecum, the ascending, 
transverse and descending colon, and the rectum. Structurally it is a thick tube that 
is wider and shorter than the small intestine and reaches up to 1.5 meter in 
humans. In contrast to the small intestine, the colon has little or no intrinsic 
digestive function and its main roles are the reabsorption of water and the 
elimination of undigested material. As such, epithelial enterocytes have a smooth 
surface without microvilli, and villous structure are also missing from the colon. 
However, similar to the small intestine, crypts are present and stem cells develop 
into epithelial cells, such as enterocytes and goblet cells. Paneth cells, which 
secrete antimicrobial peptides in the small intestine, are not present in the colon 
but mucus-secreting goblet cells are much more frequent (Fig. 1-1). Two distinct 
layers of mucus exist in the colon, which help keep the large bacterial community 
of 1012 bacteria/g content, which mostly metabolize undigested material, at bay 
(Zoetendal et al., 2006). Impaired intestinal homeostasis leads to inflammatory 
bowel diseases where aberrant inflammatory responses are directed against these 
commensal bacteria and cause damage to the intestinal tissue. Crohn’s disease is 
hereby more prevalent in the distal small intestine whereas ulcerative colitis 
selectively affects the colon (Knights et al., 2013). 
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Instead of Peyer’s patches, caecal and colonic patches can be identified in the 
colon, which serve similar functions and are an important site for colonic T cell 
priming and IgA production against microbial antigens (Masahata et al., 2014). 
Similar to the small intestine, the colonic lamina propria harbours blood and lymph 
vessels, the nervous system and immune cells, which control and protect large 
intestinal homeostasis. The details of the innate and adaptive immune responses 
that exist in these tissues and maintain intestinal homeostasis or defend against 
foreign pathogens, such as parasites, are described in the section that follows.  
 
 
 
Figure 1-1. Anatomy of the small intestinal and colonic mucosa 
The intestine is separated from the lumen by a single layer of epithelial cells, which are constantly 
renewed by stem cells in the crypts. In the small intestine microvillous enterocytes take up and 
digest nutrients, intraepithelial lymphocytes (IELs) provide epithelial immune defences, goblet cells 
produce mucus and Paneth cells release antibacterial molecules that maintains the sterility of the 
crypts. The colon is separated from the microbiota by two layers of mucus and its epithelium is 
specialized for the reabsorption of water. The lamina propria underneath the epithelium harbours 
cells of the innate and adaptive immune system, such as dendritic cells (DCs), macrophages, T 
cells, innate lymphoid cells (ILCs), and IgA+ B cells and is connected to the draining lymph nodes 
by the lymphatics. 
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1.1.2 Innate immune cells in the intestine 
 
Macrophages and dendritic cells play an important role in maintaining homeostatic 
conditions in the intestine, whereas other innate immune cells such as mast cells, 
basophils, eosinophils and innate lymphoid cells (ILCs) are effector cells that 
rapidly respond to pathogens and protect the intestine against infections. In this 
section we will focus on the role of these cells during homeostasis and their 
involvement in the defence against pathogens, especially against parasites.  
 
Both macrophages and dendritic cells represent mononuclear phagocytes, which 
take up and present foreign antigens. Despite these and other similarities, like 
their expression of CD11c and MHCII, they develop from distinct progenitors and 
perform distinct functions during the immune response.  
Macrophages represent the most abundant leukocyte in the healthy intestinal 
lamina propria. They are located in close proximity to the epithelial cell layer and 
are constantly replenished by Ly6Chi blood monocytes. Ly6Chi monocytes have 
been shown to constantly enter the colonic lamina mucosa and mature into 
resident macrophages, through several intermediate stages, demonstrated by 
adoptive transfers of monocytes into CCR2-/- mice, which lack blood monocytes 
(Bain et al., 2013). Resident macrophages are highly phagocytic and maintain 
intestinal homeostasis by clearing apoptotic and senescent cells locally, which is 
consistent with their expression of scavenging receptors such as CD36. They are 
also required for the proliferation of epithelial progenitors in the intestinal crypts. 
This was demonstrated in Csf1op/op mice, which lack macrophages. In these mice, 
epithelial wound healing after dextran sulfate sodium (DSS) treatment was 
severely impaired and epithelial progenitors did no longer proliferate (Pull et al., 
2005). Intestinal macrophages also take up and destroy microorganisms but in 
contrast to macrophages elsewhere in the body do not trigger proinflammatory 
responses. They do not express the lipopolysaccharide (LPS) co-receptor CD14 or 
the IgA receptor CD89 and do not produce proinflammatory cytokines, such as 
Interleukin 1 (IL-1), IL-6, IL-10, IL-12 and Tumor-necrosis factor alpha (TNF-α), in 
response to an array of bacterial stimuli, such as LPS and flagellin, in vitro 
(Smythies et al., 2005). They do however produce large amounts of IL-10 and play 
an important part in intestinal tolerance by expanding and maintaining antigen-
specific regulatory T cells in the intestinal mucosa. This was for example 
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demonstrated in CX3CR1-deficient mice, which showed impaired IL-10 production 
in macrophages, and did not support the proliferation of regulatory T cells in the 
lamina propria (Hadis et al., 2011). This correlates with the observation that 
spontaneous colitis develops in mice in which the IL10-IL10R regulatory axis is 
disrupted and intestinal homeostasis against the microbiota, predominantly against 
Helicobacter hepaticus, is no longer maintained (Kullberg et al., 2001). Thus, 
intestinal macrophages help maintain tissue integrity and tolerance against 
bacterial stimuli (Fig. 1-2). They also phagocytose invading bacteria or soluble 
antigen and have been shown to pass antigen on to dendritic cells that are 
specialized to prime naive T cells in the draining lymph nodes (Mazzini et al., 
2014). Macrophages can also stimulate effector T cells in the lamina propria and 
thus potentiate immune responses against larger pathogens, such as parasites, 
which they cannot phagocytose. 
 
In contrast to macrophages, dendritic cells are specialized to acquire antigen 
locally and migrate to the draining lymph nodes to prime naive T cells, that home 
back to the intestine to respond. Because they are the central focus of this thesis 
and are described in detail in the following sections, only their primary functions 
are presented here. 
DCs develop under steady-state conditions from specific, bone marrow-derived 
precursors within peripheral tissues and lymphoid organs. They take up local 
protein antigen, process it and present distinct peptide fragments to naive T cells 
in the draining lymph nodes. Beyond inducing the proliferation of naive T cells that 
recognize the presented antigen, they also influence their differentiation into 
distinct T helper cells, thus shaping the immune response. Dendritic cells integrate 
environmental cues through a vast array of pattern recognition receptors and other 
danger-sensing elements and influence the strength and quality of the immune 
response by expressing costimulatory markers or secreting cytokines. As such, 
the upregulation of the costimulatory molecules CD40, CD80 and CD86 and the 
secretion of IL-12, drive the differentiation of proinflammatory Th1 cells (Bekiaris et 
al., 2014). Dendritic cells have also been shown to sample parasite antigen and 
are involved in the induction of Th2 responses. However, the molecular 
mechanisms are not well understood and it remains unclear if dendritic cells alone 
are sufficient to prime Th2 cells. We therefore aimed to clarify the role of intestinal 
DCs in the initiation of Th2 responses in this project. 
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Dendritic cells can furthermore imprint distinct migratory preferences onto 
lymphocytes and induce the expression of distinct surface molecules, such as the 
integrin α4β7 and the chemokine receptor CCR9, which enables these cells to 
home back to intestinal tissues (Iwata et al., 2004; Johansson-Lindbom and 
Agace, 2007). Furthermore, the idea is emerging that distinct subsets of DCs are 
specialized to drive specific types of immune responses, a question that is also 
addressed in regards to Th2 responses in this thesis. 
 
Innate effector cells within the intestine include tuft cells, mast cells, basophils, 
eosinophils and innate lymphoid cells (ILCs), all of which have been shown to play 
a role in type 2 immune responses. Epithelial tuft cells expand rapidly after 
parasite infection, drive goblet cell hyperplasia, secrete IL-25, which activates IL-
13 production by ILCs and promote parasite expulsion (Howitt et al., 2016; Gerbe 
et al., 2016). Mucosal mast cells become activated through pathogen specific 
antibodies such as IgE and release pre-formed mediators, such as histamine and 
proteases. These mediators induce mucus production and smooth muscle 
contraction, which helps expulse the pathogen. Mast cells can also increase 
vascular permeability and local blood flow and can induce the maturation of DCs 
and the recruitment of eosinophils and effector T cells (Urb and Sheppard, 2012). 
During infection eosinophils and basophils are quickly recruited from blood to the 
site of infection. Similar to mast cells, basophils are activated by IgE and release 
histamines. They can also secrete cytokines and express MHCII and some 
costimulatory molecules and can activate effector T cells within tissues. 
Eosinophils release cationic granule proteins and reactive oxygen species, which 
damage the pathogen. They also produce growth factors and cytokines that 
influence the surrounding tissue and stimulate other cells such as macrophages, 
mast cells and effector T cells. These innate effector cells are however not only 
recruited upon the infection of pathogens, such as parasites, but also during the 
pathologic type 2 immune responses of asthma and other allergies, and drive local 
inflammation (Stone et al., 2010).  
 
ILCs, a recently identified population of innate effector cells, have rapidly been 
recognized as key orchestrators of immune defences at mucosal surfaces (Fig. 1-
2) (Spits and Cupedo, 2012). Like other innate immune cells, ILCs lack 
recombined antigen receptors, are activated in the early phases of the immune 
response and do not generate memory immune responses. Upon activation they 
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secrete large amounts of cytokines and have been classified in three main 
subsets: ILC1s, which produce Th1 cytokines such as IFN-γ; ILC2s, which 
produce IL-5 and IL-13; and ILC3s, which produce IL17A and IL-22. In regards to 
type 2 immune responses, ILC2s have been shown to mediate resistance against 
parasites, such as the helminth Nippostrongylus brasiliensis. IL-25-/- mice, which 
lack ILC2s, displayed inefficient parasite expulsion and delayed cytokine 
production by Th2 cells. Upon administration of recombinant IL-25 in vivo ILC2s 
developed within 4 days and led to effective worm expulsion (Fallon et al., 2006). 
Similar to mast cells, basophils and eosinophils, ILC2s also play a role in type 2 
mediated pathology, such as virus-mediated exacerbation of allergic asthma and 
drive airway hyper-reactivity even in the absence of the adaptive immune system, 
as demonstrated in infected Rag2-/- mice (Chang et al., 2011).  
 
In conclusion, innate immune responses have evolved to rapidly respond to 
foreign invaders and are beneficial to defend against parasite infections. However, 
they are also involved in pathologic type 2 immune responses and drive the 
pathology of asthma and other allergies. 
 
1.1.3 Adaptive immune cells 
 
Adaptive immune cells (T and B cells) provide potent, antigen specific acute and 
memory immune responses that maintain intestinal homeostasis and protect 
against infections. They are present within the intestinal epithelium, the lamina 
propria and the mesenteric lymph nodes and are primed within the Peyer’s 
patches or the draining lymph nodes. In this section, their role in tissue 
homeostasis and pathogen defence, in particular against parasites, is discussed. 
 
Intraepithelial lymphocytes (IELs) are antigen-experienced T cells that are located 
within the epithelium and develop through thymic (natural) and peripheral 
(induced) differentiation. Natural IELs populate the gut early in life, whereas 
induced IELs develop from effector T cells that have responded to peripherally 
encountered antigens and gradually accumulate over time. Most IELs are CD8+, 
have cytotoxic activity and can express effector cytokines, such as IFN-γ, IL-2, IL-
4 and IL-17. They can kill infected epithelial cells and thus preserve the integrity of 
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the mucosal barrier but are not involved in the defence against multicellular 
organisms (Cheroutre et al., 2011).  
 
In contrast to IELs, CD4 T cells play a more diverse role in tissue homeostasis and 
the defence against microbial and multicellular organisms. They are primed in 
secondary lymphoid organs and display an effector memory phenotype. In the 
steady state the most abundant CD4 T helper cell subsets in the intestine are IFN-
γ and IL-2-producing Th1 cells, IL-17+ Th17 cells and IL-10-producing regulatory T 
(T reg) cells (Zhu and Paul, 2008). Whereas proinflammatory Th1 cells that protect 
the host against intracellular pathogens are present at equal numbers throughout 
the intestine, cytotoxic CD8 T cells and antibacterial Th17 cells are more abundant 
in the small intestine, suggesting that microbial defence is of primary importance in 
this tissue. Conversely, regulatory FoxP3+ Treg cells are present in higher 
numbers in the colon (Fig. 1-2). Tregs cells and the production of IL-10 is 
important in maintaining colonic homeostasis, which was demonstrated in mice 
where IL-10 was specifically deleted in FoxP3-expressing cells. These mice 
developed colonic disease and systemic sensitivity (Rubtsov et al., 2008). The 
mechanism by which IL-10 influences tissue homeostasis is by downregulating 
effector T cell responses. Colonization of germ-free mice, for example, resulted in 
activation and differentiation of colonic Tregs, which contributed to intestinal 
homeostasis. Administration of a blocking IL-10-receptor antibody during 
colonization however resulted in an increase in Th1 and Th17 cells and led to 
pathology (Geuking et al., 2011). Thus, IL-10-producing cells are crucial in 
regulating effector cell functions and maintaining intestinal homeostasis.  
 
During the infection of pathogens, such as parasites, CD4 T cells are primed 
against parasite antigens in secondary lymphoid tissues and differentiate into Th2 
cells. These Th2 cells mediate host defences against extracellular parasites but 
also play a role in pathologic conditions like asthma or other allergic diseases. Th2 
cells produce an array of cytokines among which are IL-4, IL-5, IL-10 and IL-13. 
IL-4 is required for the differentiation of Th2 cells and provides a positive feedback 
loop (Constant and Bottomly, 1997).  It also promotes IgE class switching in B 
cells, which can in turn activate basophils and mast cells to participate in host 
defence. IL-5 on the other hand is necessary to recruit eosinophils. Both 
mechanisms were investigated by antibody blocking experiments in nematode 
Nippostrongylus brasiliensis infected mice, where IL-4 blocking inhibited parasite-
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induced IgE production and blocking of IL-5 completely suppressed blood 
eosinophilia and tissue infiltration (Leung et al., 2013). Th2 responses are 
essential for the expulsion of many parasites such as Nippostrongylus brasiliensis 
and Trichuris muris which is mediated directly by IL-13 production and IL-4 
mediated signalling, which was demonstrated by failed parasite expulsion in IL-13 
and IL-4Rα deficient mice (Urban et al., 1998). However, Th2 responses can also 
be harmful and promote basophil and eosinophil recruitment during allergic 
reactions and lead to IL-13-mediated airway hyperresponsiveness, goblet cell 
metaplasia and mucus hypersecretion during allergic asthma (Wills-Karp, 2004). 
 
B cells also play an important role in intestinal homeostasis and pathogen defence 
and are responsible for producing antibodies that shape the humoral immune 
response. They acquire antigens in secondary lymphoid organs such as the 
Peyer’s patches and the MLNs through their B cell receptors and can become 
activated through T cell dependent or independent activation. Most foreign 
proteins induce T cell dependent activation, by which follicular T helper cells 
recognize the antigen presented by B cells and promote B cell proliferation, 
immunoglobulin class switching, and somatic hypermutation, which are required to 
generate high-affinity antibodies. After cell activation, B cells differentiate into 
short-lived plasmablasts, which provide immediate protection and long-lived 
plasma cells and memory B cells (Pieper et al., 2013). Within the intestine, IgA is 
heavily produced by plasma cells residing within the lamina propria and targets 
microbial antigens (Fig. 2). The production of IgA is dependent on the microbiota, 
as germ-free mice do not produce IgA (Talham et al., 1999). By binding to 
microbial antigens IgA can block bacterial attachment to epithelial cells and IgA-
bound bacteria become trapped within the mucus facilitating their removal (Mantis 
et al., 2011). Thus, IgA plays an important role in bacterial entrapment and 
maintains intestinal homeostasis, which was demonstrated in AID-deficient 
animals, which cannot undergo class switching to IgA, and display lymphoid 
hyperplasia of the gut and an altered microbiota (Suzuki et al., 2004a). They also 
produce antibodies against antigens from pathogens and the production of IgE 
and IgG1 antibodies are hallmarks of type 2 immune responses, both during 
parasite infection and pathogenic conditions, such as allergies (Mountford et al., 
1994). Hereby, IgE antibodies are potent stimulators of type 2 effector cells, such 
as mast cells and basophils, and drive host defence or allergy pathogenesis. Thus, 
cells of the adaptive immune system contribute to intestinal homeostasis and 
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pathogen defence and provide potent, antigen specific acute and memory immune 
responses. 
 
Having introduced innate and adaptive immune responses and their general 
involvement in parasite defence we now focus on S. mansoni infections and the 
immune responses induced by the parasite, in particular by S. mansoni eggs, 
which are the focus of this project.  
 
 
 
Figure 1-2. Anatomical, physiological and immunological differences between the small 
intestine and colon in steady state 
Summary of the main anatomical and physiological differences of the small intestine and colon and 
list of predominant immune cell populations present in both tissues in steady state. 
 
 
	    
Small%intes+ne% Colon%
Anatomy%
Func+on%
Epithelial%structure%
Commensal%bacteria%
Bacterial%defense%
GALT%
Eﬀector%T%cells%
ILCs%
Tolerogenic%T%cells%
B%cells%
Mononuclear%
phagocytes%
Long%and%coiled%
Nutrient%uptake%
Microvillious%enterocytes%
104H108%bacteria/g%content%%
Paneth%cells,%mucus%
Peyer’s%patches,%SILTs%
IELs,%Th1,%Th17,%CD8%T%cells%
ILC1s,%ILC2s,%ILC3s%%
Few%Tregs%
IgA+%plasma%cells%
Macrophages,%dendri+c%
cells%
Thick%and%short%
Water%reabsorp+on%
Smooth%enterocytes%
1012%bacteria/g%content%%
Two%mucus%layers%
Colonic%patches,%SILTs%
IELs,%Th1,%fewer%Th17%%
Mostly%ILC1s%
Many%Tregs%
Many%IgA+%plasma%cells%
Many%macrophages%but%
few%DCs%
	   24 
1.2 Schistosoma mansoni infection and immune responses 
 
As previously mentioned, schistosome infections have an unusually high morbidity 
and mortality rate compared to other helminth parasite infections, which is mostly 
due to damage caused by parasite eggs during chronic infection. 
 
1.2.1 Schistosome life cycle 
 
Infectious cercariae, which represent the free-swimming fresh water larval stage of 
S. mansoni, burrow into the skin of the human host, transform into schistosomula 
and travel with the blood stream to the hepatic portal vein. In the liver they mature 
into adult worms, which migrate into the portal vein and along the vasculature. 
They live as couples, with the female worm lying in the ventral groove of the male, 
and without treatment persist within the host for 5-7 years. Each female produces 
large quantities of eggs and deposits up to 300 eggs along the blood vessel 
endothelium on a daily basis. Around half of these eggs are able to actively cross 
the endothelium and basement membrane of the vein, migrate through the 
intervening tissue and penetrate the intestine (S. mansoni and S. japonicum) or 
the bladder (S. haematobium), causing tissue damage. The other half are carried 
away by the blood flow and become trapped in the liver as they cannot traverse 
the sinusoids. Eggs that penetrate through the intestine are excreted and miracidia 
hatch upon contact with fresh water and infect fresh water snails that represent the 
intermediate host. There they undergo asexual reproduction and develop into 
thousands of infectious cercariae, which are released to infect another definitive 
host (Fig. 1-3) (Pearce and MacDonald, 2002).  
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Figure 1-3. Life cycle of Schistosoma mansoni 
Summary of the life cycle of Schistosoma mansoni during which infectious cercariae infect the 
definitive human host, and develop into adult worms. Adult females lay eggs that actively penetrate 
the blood vessel endothelium, the connective tissue and the intestine and are excreted. Miracidia 
hatch upon contact with water and infect the intermediate host, represented by several species of 
fresh water snails. Elements of this image were obtained from the Dr. Ating Foundation 
(http://www.dratingfoundation.org). 
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immunization and the lack of suitable specific vaccine candidates, no human 
vaccine exists to date. It is therefore crucial to further understand the immune 
responses that are activated during schistosome infections and identify the 
underlying mechanisms, which might reveal suitable candidates for 
immunotherapeutic intervention. 
 
1.2.2 Inflammatory responses characterize acute schistosomiasis 
 
During the schistosomal life cycle the immune system mounts several 
immunological responses against the parasite. Skin-penetrating cercariae induce 
local inflammation and innate immune responses, which can trap and kill some of 
the infecting larvae. However, evidence is also accumulating that cercariae can 
modulate the immune response, by limiting dendritic cell migration and 
downregulating adaptive immune responses in the skin draining lymph nodes, 
which allows the remaining larvae to develop into schistosomula and travel with 
the blood stream to the liver (Jenkins et al., 2005). Clinical symptoms of early 
infection, known as acute schistosomiasis, peak at 6 to 8 weeks after infection and 
immune responses are generally mounted against adult worms. Patients suffer 
from an incapacitating febrile illness, known as Katayama fever, which generally 
occurs before eggs are detected in the stool. In these patients TNF-α is detectable 
in blood plasma, and peripheral-blood mononuclear cells (PBMCs) produce large 
quantities of inflammatory cytokines such as TNF-α, IL-1 and IL-6. Upon 
stimulation with worm antigen these PBMCs produce high levels of IFN-γ, but no 
IL-5, which is associated with Th2 responses (de Jesus et al., 2002). After the 
release of eggs by female adult worms, inflammatory responses are diminished 
and a strong Th2 response becomes detectable. It was experimentally 
demonstrated that IL-4-/- mice, which fail to develop Th2 responses, succumb to S. 
mansoni infection and experience TNF-α-mediated severe acute cachexia, 
hepatotoxicity and high mortality, whereas C57BL/6 mice tolerate infection and 
develop chronic disease (Brunet et al., 1997). Similar observations were made in 
mice that were infected with irradiated or single-sex cercariae, which did not 
produce eggs and thus did not initiate type 2 immune responses (Dunne and 
Cooke, 2005). It has therefore been suggested that the dampening of the initial 
inflammatory responses, by the onset of type 2 immune responses against 
schistosomal eggs, limits damage to the host and initiates chronic rather than 
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harmful acute disease. Type 2 immune responses however are not sufficient to 
destroy the parasite or the eggs, and as adult worms live within the blood vessels 
they cannot be expulsed by the host. Thus, chronic persistence of the worms and 
accumulation of trapped and encased eggs lead to a relatively high morbidity and 
mortality rate compared to other helminth infections. 
 
1.2.3 S. mansoni egg antigens induce Th2 responses 
 
As the induction of Th2 responses against S. mansoni eggs is the focus of this 
thesis the type 2 immune responses induced by egg antigens are presented in the 
following section.  
With the onset of egg production hallmarks of type 2 immune responses, such as 
high levels of IL-4 and IL-13, IgE, eosinophilia and mastocytosis are observed in 
the human and murine host (Pearce and MacDonald, 2002). The induction of Th2 
responses does not require adult worms and can be induced by the injection of 
live or non-viable eggs, water-soluble S. mansoni egg antigens (SEA) or 
excretory/secretory egg products (E/S), collected from live eggs (Cheever et al., 
2002). This indicates that S. mansoni eggs contain and release antigens that are 
sufficient to prime Th2 responses. Two immunogenic proteins have so far been 
identified in the E/S of S. mansoni eggs that can mediate strong type 2 immune 
responses in vitro and in vivo. Omega-1 can condition bone marrow derived DCs 
(BMDCs) to prime Th2 cells in vitro and in vivo and has similar effects to SEA, 
suggesting that it is the primary antigen to induce Th2 responses (Steinfelder et 
al., 2009). The other identified protein, IPSE/alpha-1 triggers IL-4 and IL-13 
release from murine basophils in vitro and in vivo. This release is dependent on 
IgE, but does not require antigen specificity, as basophils from OVA/alum 
sensitized mice reacted to IPSE/alpha-1, whereas basophils from IgE-/- animals 
did not (Schramm et al., 2007). In contrast to omega-1 and SEA, injection of 
IPSE/alpha-1 into the footpad did not induce Th2 responses in the draining 
popliteal lymph nodes (Everts et al., 2009), suggesting that IPSE/alpha-1 is not 
sufficient to induce the priming of Th2 responses but rather amplifies or maintains 
Th2 responses through basophils.  
 
S. mansoni eggs have a size of 100x50 µm and the maturing miracidium is 
encased by a rigid insoluble eggshell. Therefore, eggs that are trapped within 
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tissues such as the intestine or the liver cannot be destroyed but are quickly 
encased by granulomas that consist of collagen fibres, CD4 T cells, eosinophils 
and macrophages (Fig. 1-4). These granulomas protect the surrounding tissue 
from secretory egg molecules and egg proteins released by dying eggs and 
degrade them over time. However, granulomas also damage the surrounding 
tissue and lead to fibrosis (Dunne and Doenhoff, 1983). Fibrosis is primarily 
mediated by IL-13, a key cytokine produced by Th2 cells and S. mansoni infected 
IL-13-/- mice do not develop severe fibrosis or hepatocyte damage (Fallon et al., 
2000). Hepatic fibrosis can also be reduced by blocking IL-13 with monoclonal 
antibodies in vivo (Chiaramonte et al., 1999). Thus, different mechanisms 
contribute to chronic pathology and in the most serious form of chronic 
schistosomiasis can cause a life-threatening hepatosplenic disease, which is 
accompanied by severe hepatic and periportal fibrosis and portal hypertension 
(Dunne and Pearce, 1999).  
 
 
 
 
 
 
Figure 1-4. Granuloma formation leads to tissue damage 
Eggs that become trapped within the intestine or the liver are quickly encased by granulomas. 
These consist of collagen fibres, macrophages, CD4 T cells and eosinophils and protect the 
surrounding tissue from molecules released by live and degrading eggs. Accumulation of 
granulomas however, has damaging effects on the host and can lead to tissue fibrosis and organ 
damage. 
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To prevent excessive tissue damage, Th2 responses are dampened down by 
regulatory mechanisms (Fig. 1-5), which is consistent with the observation that 
reinfection causes less reactive responses than primary infections (Dunne and 
Pearce, 1999). A further presence of a regulatory immune response at later stages 
of S. mansoni infection was experimentally demonstrated by Smits et al. They 
showed that experimental airway inflammation against OVA, which induces 
allergic Th2 responses, was enhanced 8 weeks after parasite infection, whereas 
airway inflammation was suppressed in mice that had been infected with 
schistosomes for 16 weeks (Smits et al., 2007). One of the mechanisms by which 
Th2 responses are controlled is by the production of IL-10. Infected IL-10-/- mice 
showed increased Th2-mediated morbidity with increased granuloma sizes and 
hepatic fibrosis, enhanced production of Th2 cytokines in restimulation cultures 
and an increased mortality during the chronic stages of infection (Hoffmann et al., 
2000). IL-10 is predominantly produced by regulatory T cells, which have also 
been identified in granulomas of chronically infected mice (Hesse et al., 2004). 
Egg antigens can also directly induce the differentiation of Tregs and the injection 
of SEA increases the number of Foxp3+ Tregs in vivo and can induce regulatory T 
cell development in vitro (Zaccone et al., 2009).  
Thus, regulatory responses limit damaging effects caused by Th2 responses 
against trapped and encased eggs. Although the beneficial and detrimental effects 
of Th2 responses during S. mansoni infection are well characterized, less is known 
about how these responses are initiated and the identification of the cells 
responsible for inducing Th2 responses against S. mansoni eggs are the focus of 
this work.  
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Figure 1-5. Development of the immune response during S. mansoni infection 
During acute schistosomiasis inflammatory responses against larvae and adult worms are 
prominent. With the release of eggs by adult worms 6 weeks after infection, inflammatory 
responses are dampened and strong Th2 responses are mounted against egg antigens. With 
chronic persistence of infection these responses are controlled by regulatory T cells (Tregs) to limit 
damage to the host. Elements of this image were obtained from the Dr. Ating Foundation 
(http://www.dratingfoundation.org). 
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1.3 Dendritic cell biology with focus on the intestine 
 
As dendritic cells bridge innate and adaptive immune responses and play an 
important role in responding to foreign antigens and orchestrating the appropriate 
immune responses, they are the focus of this work that aims to identify the cells 
responsible for inducing Th2 responses against S. mansoni eggs. To understand 
the biology of dendritic cells; their development, the functional characteristics of 
antigen uptake, DC activation, migration and antigen presentation and their role in 
T cell differentiation and T cell homing will be discussed. 
 
1.3.1 Discovery and characterization of intestinal dendritic cells 
 
Dendritic cells (DCs) were first described in 1973 by Steinman and Cohn as large 
stellate cells, which had a distinct phenotype from other adherent cells. 
Morphologically, these cells could extend and retract pseudopods, which was a 
unique feature of this novel cell type, and led the authors to coin the term dendritic 
cell. Steinman and Cohn identified these cells in preparations from the spleen, 
mesenteric lymph nodes, cervical nodes and Peyer’s patches, but not the thymus 
and bone marrow and deduced that they preferentially reside in peripheral 
lymphoid organs. Though present in only small numbers, ranging from 0.1-1.5% of 
all nucleated cells, they could identify these cells in several rodent species and 
other mammals (Steinman and Cohn, 1973).  
They also recognized that DCs were morphologically different from macrophages 
but were not able to identify these cells in the intestine. Indeed, DCs can be easily 
identified in peripheral lymph nodes, using more recent technologies like flow 
cytometry, by their expression of the cell surface markers CD11c and MHCII. 
However, as they share these markers with other cells like macrophages, their 
identification in peripheral tissues, like the intestine, is more complex (Cerovic et 
al., 2014). Until recently it was believed that the expression of the fractalkine 
receptor CX3CR1 defined mucosal tissue resident DCs and the expression of the 
integrin CD103 defined migratory DCs. Further experiments however 
demonstrated that CX3CR1hi cells represent sessile macrophages, which are 
influenced by the growth factor CSF1 and in the intestine differentiate from blood 
monocytes, whereas CD103+ cells represent DCs, which respond to the growth 
factor Flt3L and migrate to the MLNs (Varol et al., 2009; Bogunovic et al., 2009). 
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Since then it has become clear that the expression of CX3CR1 on intestinal 
macrophages and CD103 on intestinal DCs are not sufficient to fully separate 
these populations. CX3CR1 is also expressed by a subset of intestinal DCs, 
although at lower levels compared to intestinal macrophages, and CD11b-
expressing DCs have recently been identified in intestinal lymph and the intestine, 
which need to be carefully distinguished from CD11b-expressing macrophages 
(Cerovic et al., 2013; Scott et al., 2016). For an accurate distinction between 
macrophages and DCs in the murine intestine the expression of CD64, F4/80 or 
MerTK can be used to exclusively define macrophages (Gautier et al., 2012). This 
strategy has been adopted in this project and intestinal macrophages were 
characterized by their expression of MHCII, CD11c and CD64, whereas dendritic 
cells were defined as MHCII and CD11c-expressing CD64- cells.  
 
It is important to accurately differentiate these two cell types as they serve distinct 
functions. Macrophages are sessile highly phagocytic cells that do not migrate to 
the mesenteric lymph nodes and cannot prime naive T cells, but are essential for 
tissue remodelling and host defence (Bain and Mowat, 2014). DCs on the other 
hand shape the immune response by taking up antigen in the periphery, migrating 
in lymph and priming naive T cells in the draining lymph nodes, which differentiate 
into effector T cells that respond to the antigen (Schulz et al., 2009). Many 
important discoveries that have advanced our understanding of dendritic cell 
biology were made in the Steinman laboratory, which after the discovery of DCs, 
identified that they were present in the periphery in an immature state, matured 
upon antigen uptake and presented antigen via MHCII, which drove potent T cell 
proliferation (Schuler and Steinman, 1985; Romani et al., 1989). The identification 
of the growth factors CSF2 (GM-CSF) (Inaba et al., 1992a; b) and Flt3L (Karsunky 
et al., 2003; Waskow et al., 2008), necessary for the development of dendritic 
cells, which is described in the following section, enabled the generation of 
dendritic cells in vitro, which facilitated the further characterization of these cells. 
Insights, like the importance of costimulatory markers and secreted cytokines in 
shaping T cell differentiation, which are described in a later section, were thus 
identified. 
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1.3.2 Development of dendritic cells and their subsets 
 
DCs develop from hematopoietic stem cell progenitors and are constantly 
replenished in peripheral tissues and peripheral lymphoid organs. Hematopoietic 
stem cells differentiate into committed macrophage and dendritic cell progenitors 
(MDPs) in the bone marrow, which can give rise to monocytes, macrophages and 
resident spleen DCs in vivo and can differentiate into macrophages and DCs in 
vitro (Fogg et al., 2006). MDPs transition into common dendritic cell progenitors 
(CDPs) in the bone marrow, which have the potential to give rise to splenic 
plasmacytoid DCs (pDCs) and CD8α+ and CD8α- dendritic cells, in vivo and in 
vitro, but can no longer develop into monocytes and macrophages (Naik et al., 
2007). Committed precursors of DCs (pre-DCs), which can no longer differentiate 
into plasmacytoid DCs, then enter the circulation. They travel to high endothelial 
venules through which they enter the lymph nodes (LN) and have been shown to 
give rise to “LN resident” DC populations, which develop from circulating 
progenitors rather than migrate from the periphery, and splenic DCs (Liu et al., 
2009). These DCs can be divided into two distinct subsets; CD8α+ and 
CD11b+CD8α- DCs, which both express MHCII and CD11c (Fig. 1-6) (Vremec and 
Shortman, 1997). CD8α+ DCs highly express BATF3 and are no longer detectable 
in the spleen of BATF3-/- mice (Hildner et al., 2008). CD8α+ DCs also depend on 
IRF8 and CD8α+ DCs are absent from IRF8-/- mice. In contrast, IRF4, but not IRF8, 
is highly expressed in CD11b+CD4+CD8α- DCs and these cells are found at 
reduced frequencies in the spleens of IRF4-/- mice and can not be generated in 
vitro from IRF4-/- bone marrow cells (Suzuki et al., 2004b). 
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Figure 1-6. Differentiation of dendritic cells 
DCs develop from hematopoietic stem cells in the bone marrow, which differentiate into 
macrophage and dendritic cell progenitors (MDPs) and common dendritic cell progenitors (CDPs). 
CDPs give rise to plasmacytoid DCs and committed precursors of DCs (pre-DCs), which enter the 
circulation. In the tissue pre-DCs then differentiate into the two main lineages of CD8α+ and CD8α- 
dendritic cells. 
 
 
Apart from giving rise to DCs in secondary lymphoid tissues, like lymph nodes and 
the spleen, DC progenitors also give rise to DCs in peripheral tissues. Within the 
intestinal lamina propria (LP) adoptive transfers of MDPs into diphtheria toxin-
treated CD11c-diphtheria toxin receptor (DTR) mice, which lack CD11c-positive 
cells, showed that they can give rise to CX3CR1hi macrophages and CD103-
expressing dendritic cells. Furthermore, transferred Ly6C monocytes developed 
into intestinal macrophages and upregulated CX3CR1, whereas the transfer of 
pre-DCs gave rise to DCs within the LP (Varol et al., 2009). Therefore, intestinal 
LN and tissue resident DCs derive from the same bone marrow precursors. Within 
the intestinal mucosa DCs are located diffusely in the lamina propria and gut-
associated lymphoid tissues like Peyer’s patches and smaller lymphoid 
aggregates. Within the lamina propria DCs can be divided into four subsets based 
on their expression of the integrins CD11b and CD103. All four subsets represent 
bona fide DCs that migrate from the lamina propria to the draining lymph nodes, 
prime T cell responses and respond to the dendritic cell specific growth factor 
Flt3L (Cerovic et al., 2013). CD11b-CD103+ DCs (described herein as CD103+ 
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DCs), which also express CD8α, are related to LN resident CD8α+ DCs as they 
express BATF3, which is critical for their development and also depend on IRF8 
(Edelson et al., 2010). CD11b+CD103+ “double positive” (DP) DCs share 
characteristic elements with LN resident CD11b+CD8α- DCs. They share the 
expression of CD11b with LN resident CD11b+CD8α- DCs but have also acquired 
CD103 expression. Similar to LN resident CD11b+CD8α- DCs, they express IRF4 
and fewer DP DCs are observed in the LP and MLNs of IRF4f/f CD11c-cre-positive 
mice, which have IRF4 deficient CD11c-expressing cells (Persson et al., 2013b). It 
has been suggested that IRF4 impacts mucosal DCs by regulating their survival, 
as intestinal IRF4-deficient DP DCs were more prone to enter apoptosis in vitro 
and displayed enhanced Annexin V-staining in vivo, which identifies cells 
undergoing apoptosis (Persson et al., 2013b). Similarly, IRF4-deficient CD11b+ 
DCs from the lung show enhanced mitochondrial fragmentation, which is another 
indicator for cell apoptosis (Schlitzer et al., 2013). It has also been suggested that 
the signalling receptor Notch2 controls the terminal stage of intestinal DP DC 
differentiation. Both splenic CD11b+ and intestinal DP DCs do not develop in 
Notch2f/f CD11c-cre mice as well as other transgenic lines that are deficient in 
Notch2 signalling (Satpathy et al., 2013). The development of intestinal 
CD11b+CD103- (described herein as CD11b+ DCs) DCs and CD11b-CD103- 
“double negative” (DN) DCs are unfortunately less well characterized as most 
studies have not differentiated them from intestinal macrophages or further 
distinguished intestinal total CD103- DCs by the expression of CD11b.  
 
1.3.3 Antigen uptake by intestinal dendritic cells 
 
One of the characteristic features of DCs is the uptake of antigen in the periphery, 
which they fragment and present to naive T cells in the draining lymph nodes. 
Cellular uptake of antigen by DCs has been the focus of many studies, which 
range from simple in vitro experiments to complex multiphoton studies in situ. 
Within the intestine most foreign antigens are present within the luminal content, 
which is physically separated from the lamina propria by a layer of mucus and the 
epithelium. One of the mechanisms by which antigen is transported across the 
epithelium is by microfold cells (M cells), which are located within the epithelial 
layer of Peyer’s patches. They are highly specialized for the phagocytosis and 
transcytosis of luminal antigen and are in close contact with lymphocytes, 
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macrophages and dendritic cells to enable the efficient transfer of lumenal 
antigens (Mabbott et al., 2013). In the absence of M cells (Kanaya et al., 2012) or 
in models where antigen sampling by M cells is impaired (Hase et al., 2009), 
antigen-specific T-cell responses in the Peyer’s patches of mice, which were orally 
infected with pathogenic bacteria were significantly reduced. Furthermore, as 
demonstrated by two-photon microscopy of Peyer’s patch explants, dendritic cells 
can extend their dendrites through M cell-specific transcellular pores and directly 
sample luminal antigen and pathogenic bacteria from the lumen (Lelouard et al., 
2012). 
Several studies have claimed that lamina propria DCs can directly take up luminal 
antigen and extend their dendrites into the intestinal lumen by forming tight-
junction-like structures with intestinal epithelial cells (Rescigno et al., 2001; Niess 
et al., 2005). However, early studies identified these tissue DCs by their 
expression of CX3CR1, which we now know defines macrophages, rather than 
DCs. More recent work has indeed revealed that CX3CR1hi macrophages are 
more efficient in taking up luminal antigen compared to LP DCs. This was 
demonstrated by injecting fluorescently labelled OVA protein or fluorescent 
bacteria and visualized using two-photon microscopy (Farache et al., 2013). DCs 
have been shown to probe the basal surface of the epithelium in steady state but 
do not extend dendrites into the lumen. Furthermore, low molecular weight soluble 
antigens are preferentially transported across the epithelium by goblet cells and 
delivered to LP DCs via goblet-cell-associated antigen passages (McDole et al., 
2012). It has also been suggested that macrophage-acquired antigen is accessible 
to LP DCs via gap junctions (Mazzini et al., 2014).  
Thus, under steady state conditions luminal antigens are acquired by DCs through 
accessory cells, like M cells, goblet cells or macrophages, which transport the 
antigen from the intestinal lumen to the Peyer’s patch or the lamina propria. 
Antigen is then sampled by DCs and presented to naive T cells either within the 
Peyer’s patch or in the draining lymph nodes. In this project S. mansoni eggs are 
delivered into the intestinal lamina propria to represent penetrating and trapped 
eggs within the tissue. We therefore focused on the antigen-dependent activation 
of LP DCs and their migration to the MLNs in the following section. 
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1.3.4 Dendritic cell activation and migration 
 
Early studies in the Steinman laboratory revealed that Langerhans cells (LCs), a 
type of skin dendritic cell, reside as immature cells in the skin, where they capture 
local antigen and migrate to the draining lymph nodes (Macatonia et al., 1987). 
LCs could also be matured in vitro and possessed the capacity to process and 
present antigen, by displaying it on the cell surface via MHCII and upregulated 
costimulatory molecules during their maturation. However, they could no longer 
present novel antigen once they were fully matured (Romani et al., 1989). Several 
pathogen-associated products, like LPS, and other danger signals can induce DC 
maturation and migration. The uptake of these antigens activates DCs by binding 
to pattern recognition receptors, such as Toll-like receptors, which can recognize a 
wide range of extracellular and intracellular motifs from bacterial, viral, fungal and 
parasitic pathogens (Joffre et al., 2009).  
 
In the intestine TLR activation leads to DC activation and the upregulation of 
costimulatory molecules and cytokines. It was shown that murine CD103+ LP DCs 
express TLR3, TLR7 and TLR9 and produce IL-6 and IL-12p40, following TLR 
ligand stimulation (Fujimoto et al., 2011). DP DCs on the other hand expresses 
TLR5 and TLR9 and produce proinflammatory cytokines such as IL-6 and IL-12 in 
response to flagellin and CpG (Uematsu et al., 2008). TLR activation also 
contributes to the migration of DCs from the lamina propria to the draining lymph 
nodes. This was first shown by MacPherson et al. in lymph from 
lymphadenectomized rats. Intravenous injection of endotoxin greatly increased the 
migration of DCs within 6 hours and reached a maximum output of 10 fold 
compared to steady-state migrating DCs. The increase in DC migration was 
hereby completely dependent on TNF-α and treatment with blocking antibodies 
prevented enhanced DC migration (MacPherson et al., 1995). The oral 
administration of R848, a TLR7/8 agonist, (Yrlid et al., 2006) or soluble flagellin 
(Flores-Langarica et al., 2012), which activates TLR5, also induces the migration 
of intestinal DCs from the lamina propria to the MLNs.  
 
Even without the external administration of TLR ligands intestinal DCs 
constitutively migrate through the lymphatic system to the MLNs and were first 
identified by Pugh et al. in lymph from mesenteric lymphadenectomized rats (Pugh 
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et al., 1983). We now know that all four subsets of murine intestinal DCs migrate in 
lymph of mesenteric lymphadenectomized mice under steady state conditions. 
Their relative frequencies resemble those found in the lamina propria and they can 
be distinguished from LN resident DCs in the MLN by their higher expression of 
MHCII (Cerovic et al., 2013). Experiments using two-photon microscopy of MLN-
afferent lymphatics revealed that CD11c-EYFP cells readily migrate under steady 
state conditions and in increased numbers after R848 administration, whereas 
CX3CR1+/GFP cells could not be identified, which clearly indicates that DCs migrate 
from the LP to the MLNs, whereas macrophages do not (Schulz et al., 2009).  
 
The migration of LP DCs is essential for the induction of appropriate immune 
responses in the MLNs. In the case of oral tolerance, tolerance does not occur in 
mesenteric lymphadenectomized animals or transplanted MLNs that are no longer 
connected to the intestinal lymphatics, indicating that cell migration from the LP is 
critical. Indeed, expression of the chemokine receptor CCR7 on DCs is necessary 
for the induction of immune responses, such as oral tolerance, which was not 
induced in CCR7-deficient mice (Worbs et al., 2006). It has been shown in the skin 
and the intestine that the deletion of CCR7 does not affect the number of DCs in 
the periphery but impairs their migration, as they can no longer enter lymphatic 
vessels. Skin migrating DCs directionally move along the CCL21 gradient and bind 
to CCL21, via CCR7, before entering the lymphatic system (Tal et al., 2011). 
Correspondingly, deletion CCL21 also leads to defects in LP DC migration and an 
impaired induction of oral tolerance (Worbs et al., 2006). However, other immune 
responses, such as contact hypersensitivity, autoimmune encephalitis and allergic 
asthma, develop in the absence of CCR7 or its ligands. In these models immune 
responses were delayed but did occur, suggesting that cells which did not depend 
on CCR7 for their migration, or passive transport of antigen in lymph or blood were 
sufficient to drive these immune responses (Förster et al., 2008). Thus, the 
migration of activated conventional DCs to the mesenteric lymph nodes is 
especially important during steady state conditions and is essential to maintain 
tissue homeostasis in the intestine by promoting oral tolerance against benign 
antigens.  
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1.3.5 Antigen presentation and induction of CD4 T cell 
differentiation by intestinal dendritic cells 
 
On reaching the lymph nodes, DCs can present antigens to naive T cells via MHC 
class I or MHC class II. MHCI molecules bind peptides generated from the 
degradation of cytosolic proteins and predominantly display intracellular proteins to 
cytotoxic CD8 T cells. Exogenous proteins that after cellular uptake are released 
into the DC cytoplasm, can also be presented via MHCI, a phenomenon known as 
cross-presentation. However, most exogenous antigens are presented via MHCII. 
Antigens are hereby degraded within the DC and peptides are loaded onto MHC 
molecules through the endocytic pathway. MHC/antigen complexes are then 
transported to the plasma membrane and presented on the cell surface. During 
DC maturation more MHCII/antigen complexes are present on the plasma 
membrane and are necessary to prime CD4 T cells (Villadangos et al., 2005). The 
MHCII/antigen complex is recognized by a particular T cell clone by interacting 
with the corresponding T cell receptor and CD4, which leads to T cell activation. 
The second signal that DCs provide is the expression of co-stimulatory or co-
inhibitory molecules, which determine the functional outcome of T cell receptor 
signalling and either stimulate or inhibit CD4 T cells (Chen and Flies, 2013). 
Activated T cells then produce IL-2 and proliferate. However, a third signal is 
required for the differentiation of T cells into distinct helper subsets, which DCs 
can provide by producing essential cytokines.  
 
Four major groups of CD4 T helper cell subsets (Th1, Th2, Th17 and Treg cells) 
with distinct properties and functions have been identified (Fig. 1-7). In 1993 Ken 
Murphy and colleagues were able to differentiate naive CD4 T cells into IFN-γ 
producing Th1 cell in vitro. This differentiation required antigen presentation and 
stimulation with heat-killed Listeria, which induced IL-12 production, critical for Th1 
differentiation (Hsieh et al., 1993). IL-12 induces minimal levels of IFN-γ 
production in T cells. T cells then upregulate the key transcription factor T-bet and 
develop into fully differentiated Th1 cells, which mainly produce IFN-γ (Szabo et 
al., 2000). IFN-γ then acts in a positive feedback loop by driving the differentiation 
of further Th1 cells. It is also a major effector cytokine of inflammatory responses 
and mediates immune responses against intracellular pathogens like viruses and 
bacteria, by for example activating microbicidal activity in macrophages (Kaiko et 
al., 2008).  
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The second subset of CD4+ T helper cells are Th2 cells, which mediate host 
defences against extracellular parasites but also play a role in pathologic 
conditions like asthma or other allergic diseases. These cells were first identified in 
1990 when naive CD4 T cells were stimulated with the T-cell receptor ligand anti-
CD3, IL-2 and IL-4 in vitro (Le Gros et al., 1990). Their most pronounced feature is 
the production of IL-4 and their in vitro differentiation requires signalling through 
the IL-4 receptor, Stat-6 and GATA-3. Th2 cells produce an array of cytokines 
among which are IL-4, IL-5, IL-9, IL-10, IL-13 and IL-25 (Licona-Limón et al., 
2013). IL-4 is a positive feedback cytokine and is required for the differentiation of 
further Th2 cells. It can be provided by already differentiated Th2 cells, by other 
effector cells such as mast cells, basophils or ILC2s, but is also produced in low 
amounts by naive CD4 cells upon TCR activation in vitro (Yamane et al., 2005). IL-
4 is responsible for IgE class switching in B cells, which can in turn activate 
basophils and mast cells. IL-5 is involved in the recruitment of eosinophils, which 
together with basophils and mast cells participate in host defences against 
parasites or pathologic allergic conditions. Furthermore, Th2 derived IL-10 can 
inhibit Th1 cell proliferation in vitro and suppress proinflammatory responses by 
dendritic cells, including the secretion of IL-12 in vitro, and their capacity to prime 
Th1 cells in vivo (De Smedt et al., 1997). Th2 responses are also essential for the 
expulsion of many parasites such as N. brasiliensis and T. muris, which is 
mediated directly by IL-13 production and IL-4 mediated signalling (Urban et al., 
1998). Thus, Th2 cells play a key role in the defence against multicellular 
organisms, such as parasites, but are also involved in pathologic allergic 
conditions.  
 
A more recently identified T helper cell population are Th17 cells. They were first 
identified by their unique secretion of IL-17 and can be differentiated from naive T 
cells through TCR activation and the addition of IL-6 and TGF-β in vitro (Mangan 
et al., 2006). They express RORγt and produce IL-21 and IL-23, which are 
important in Th17 cell amplification and stabilization. Th17 responses have been 
found to act against many extracellular bacteria and fungi and drive many organ-
specific autoimmune diseases (Weaver et al., 2006). The development of Th17 
cells has been linked to Treg differentiation, as both cell populations require TGF-
β for their development. Natural regulatory T cells (Tregs) develop in the thymus 
and play a critical role in self-tolerance. Induced Tregs are primed in the periphery 
and are involved in peripheral tolerance and immune regulation, such as oral 
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tolerance against benign antigens. Foxp3 has been reported as a master 
transcriptional regulator of these cells, which produce TGF-β and IL-10 and the 
transfer of Foxp3+ cells has been shown to ameliorate many immunological and 
autoimmune conditions, such as allograft rejection and the onset of colitis (Joffre 
et al., 2008; Read et al., 2000). 
 
 
Figure 1-7. T helper cell differentiation 
Activated dendritic cells play a crucial role in differentiating naive CD4 T cells into particular T 
helper cell populations. The cytokines that are produced by dendritic cells to drive this 
differentiation are summarized and the cytokines used to differentiate these T helper cell subsets 
from naive T cells in vitro are shown in brackets. The four main T helper cell populations of Th1, 
Th2, Th17 and Treg cells are illustrated and their characteristic transcription factors, positive 
feedback cytokines, effector cytokines and typical role in immunity are described. 
 
 
The differentiation of these T helper cell subsets requires antigen presentation and 
cytokine production by dendritic cells. Many studies have identified the necessary 
signals in vitro but data are also emerging that specific DC subsets are involved in 
the differentiation of certain T helper cell populations in vivo.  
In regards to the four intestinal DC subsets, CD11b+CD103+ DP DCs from the 
small intestinal lamina propria (SI LP) could induce Th1, Th17 and Foxp3+ 
regulatory T cells in in vitro cocultures (Fujimoto et al., 2011). Similar responses 
have also been observed in vivo. IRF4f/f CD11c-cre-positive mice, which have 
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reduced numbers of SI LP DP DCs, display reduced numbers of Th17 cells in the 
intestine, whereas numbers of IFN-γ+ and Foxp3+ were comparable to control 
animals. Furthermore, transferred OT-II T cells could not differentiate into Th17 
cells after immunization in these mice in vivo. Hereby, IRF4-deficient MLN DCs 
were specifically impaired in the production of IL-6 and IL-6-/- mice failed to support 
Th17 cell differentiation in vivo. It was therefore suggested that IL-6 is produced by 
DP DCs, which is required to drive Th17 differentiation in the MLNs (Persson et 
al., 2013b). Total CD103-expressing DCs from the SI LP and MLNs are also 
particularly potent in converting naive T cells into Foxp3+ Tregs in vitro. This 
conversion is mediated by TGF-β and retinoic acid acts as an important cofactor 
during Foxp3 induction (Coombes et al., 2007). Unfortunately, total CD103-
expressing DCs were not separated into DP and CD103+ DCs in this study. 
However, only DP DCs express Raldh2, which converts Vitamin A into retinoic 
acid, and induce Foxp3+ regulatory T cells in vitro (Fujimoto et al., 2011). These 
cells can also activate TGF-β, through their expression of the integrin αvβ8, and it 
is therefore likely that DP DCs are specialized in the induction of Tregs, and 
therefore play an important role in maintaining oral tolerance against harmless 
antigens from the intestine (Pabst and Mowat, 2012). 
CD103+ single positive SI LP DCs on the other hand have been shown to drive 
IFN-γ responses in vitro, although to a lesser extent than DP DCs. Compared to 
DP DCs, CD103+ single positive DCs did not express Raldh2 and could not induce 
Foxp3+ regulatory T cell in vitro (Fujimoto et al., 2011). Furthermore, CD103+ DCs 
from intestinal lymph have been shown to poorly prime CD4 T cells in vitro but 
preferentially prime CD8 T cells (Cerovic et al., 2013). Correspondingly, they have 
been identified as being uniquely able to cross-present endogenous antigen to 
cytotoxic CD8 T cells both in vitro and in vivo (Cerovic et al., 2015). 
Little is known about the function of intestinal CD11b+ and DN DCs in driving 
immune responses. Combined as CD103- DCs, they have been shown to express 
high levels of IL-12 and IL-23 following overnight culture with anti-CD40 antibodies 
and produce TNF-α and IL-6 after LPS stimulation in vitro (Coombes et al., 2007). 
When isolated from lymph they could prime CD4 and CD8 T cells in vitro (Cerovic 
et al., 2013), suggesting that they may be involved in inflammatory immune 
responses and the priming of Th1 and Th17 cells.  
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To date the colon, which harbours lower numbers of DCs, has been largely 
overlooked in functional studies of DC biology. On a phenotypic level we know that 
colonic CD11b+ DCs outnumber CD11b+CD103+ DP DCs (Denning et al., 2011), 
and that colonic DCs migrate to distinct colonic lymph nodes (Houston et al., 
2016), but little is known about their role in driving immune responses in the colon. 
Recently, a role for CD11b+ DCs was suggested in colonic tolerance. Similar to 
oral tolerance, colonic tolerance was induced by the intracolonic administration of 
OVA protein, which induced proliferation and Treg differentiation of transferred 
OT-II cells in the colonic draining lymph nodes in vivo. Colonic tolerance was not 
affected by the deletion of colonic CD103+ DCs using BATF3-/- mice, suggesting 
that colonic CD11b+ DCs are sufficient to drive colonic tolerance (Veenbergen et 
al., 2016).  
 
Taken together, these data indicate that intestinal dendritic cells have subset 
specific and tissue specific roles in T cell priming and differentiation (Fig. 1-8). 
However, the signals that are produced by dendritic cells to influence T cell 
differentiation in vivo are only just emerging and further work is required to 
elucidate their role in Th2 differentiation. 
 
1.3.6 Intestinal dendritic cells promote gut homing of T and B 
cells 
 
Apart from driving T cell responses, intestinal DCs also influence the homing of 
MLN primed T cells to the intestine. Hereby, effector/memory CD4 T cells primed 
in the MLNs rapidly express the chemokine receptor CCR9 and α4β7. This 
expression is only observed on MLN primed T cells, as cells primed in inguinal 
lymph nodes express the adhesion molecule P-selectin ligand but only low levels 
of α4β7 (Campbell and Butcher, 2002). CCR9 binds to CCL25, which is produced 
by epithelial cells within the small intestine and α4β7 binds to MADCAM1 on 
vascular endothelial cells, enabling CCR9 and α4β7 expressing cells to 
preferentially home to the small intestine (Kunkel et al., 2000). 
The importance of intestinal dendritic cells in providing the signals necessary to 
drive CCR9 and α4β7 expression on T cells was exemplified by the observation 
that gut homing was impaired in CCR7-deficient mice. Transferred OT-I T cells did 
not upregulate CCR9 and α4β7 in the MLNs of CCR7-/- mice and did not migrate to 
	   44 
the SI LP after oral OVA administration. Furthermore, total CD103-expressing DCs 
from the MLN could more efficiently induce CCR9 and α4β7 expression of OT-I 
and OT-II T cells in vitro, compared to total CD103- DCs (Johansson-Lindbom et 
al., 2005). One of the signals provided by DCs that drive α4β7 expression is the 
Vitamin A metabolite retinoic acid. Small intestinal DCs, in particular DP DCs, can 
efficiently generate retinoic acid through the enzyme Raldh2 (Fujimoto et al., 
2011). Cocultures of MLN DCs and the administration of retinol enhanced the 
α4β7 expression of anti-CD3/anti-CD28 stimulated T cells in vitro. This expression 
was suppressed by the retinal dehydrogenase inhibitor citral and the retinoic acid 
receptor antagonist LE135. Upon transfer, these T cells preferentially homed to 
the small intestine, Peyer’s patches and MLNs in vivo. In the absence of retinoic 
acid, accomplished by feeding mice with a Vitamin A deficient diet, the expression 
of α4β7 and small intestinal homing of memory/activated T cells was also reduced 
(Iwata et al., 2004). CCL25 and CCR9 interaction also directs the migration of IgA+ 
plasmablasts to the small intestine. The involvement of dendritic cells in the 
upregulation of CCR9 on plasmablasts however has yet to be demonstrated 
(Kunkel et al., 2000).  
 
In regard to lymphocyte homing to the colon, the interaction of CCL28 and CCR10 
have been shown to play an important role. CCL28 is expressed on epithelial cells 
in the colon and rectum, and CCR10 is expressed by circulating and mucosal IgA+ 
plasmablasts (Kunkel et al., 2003). Another important molecule that is involved in 
T cell homing into the colon is GPR15. It has been demonstrated that GPR15-
deficient mice were prone to develop more severe large intestinal inflammation, 
which was rescued by the transfer of GPR15-sufficient Tregs (Kim et al., 2013). 
The involvement of colonic dendritic cells in driving the expression of CCR10 or 
GPR15 has yet to be demonstrated and it remains to be determined what cells 
and factors influence their expression.  
 
G protein coupled receptors, such as CCR9, CCR10 and GPR15, are therefore 
important for lymphocytes to home to different regions of the intestine. The 
expression of CCR9 and α4β7 drive T and B cell homing to the small intestine and 
intestinal DCs in the MLN influence the expression of α4β7 by generating retinoic 
acid. Thus, intestinal lamina propria DCs provide a critical link between the innate 
and adaptive immune system, by sampling intestinal antigen, migrating through 
the lymphatic system, inducing the appropriate T cell responses within the MLNs 
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and instructing these cells to home to the intestine to serve their immunological 
functions. Furthermore, the idea is emerging that specific DC subsets are 
specialized to perform different roles in T helper cell differentiation and tissue 
homing and one aim of this thesis is to determine if specific intestinal DC subsets 
are specialized to prime Th2 cells and drive Th2 responses against S. mansoni 
egg antigen. Experiments that have demonstrated that dendritic cells are able to 
actively promote Th2 differentiation are therefore discussed in the following 
section. 
 
 
 
Figure 1-8. Functions of intestinal DC subsets 
Summary of the most characteristic phenotypes and functions identified for intestinal DCs, which 
can be separated into four subsets by their expression of the integrins CD11b and CD103. 
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1.4 Involvement of dendritic cells in driving Th2 responses 
 
1.4.1 Dendritic cells actively drive Th2 immunity 
 
Multiple studies have shown that DCs are essential for priming Th2 responses. 
The conditional ablation of DCs in vivo using CD11c-DTR mice has facilitated the 
study of DC-dependent immune responses (Saito et al., 2001). Upon 
administration of diphtheria toxin CD11c+ cells are eliminated, which impact T cell 
priming and differentiation, including the induction of type 2 immune responses. In 
the case of allergen-induced asthma, endogenous or adoptively transferred Th2 
cells did not produce IL-4, IL-5 or IL-13 after the ablation of CD11c+ cells. 
Eosinophilic inflammation and Th2 cytokine secretion were restored by adoptive 
transfer of DCs into these animals. However, the transfer of alveolar 
macrophages, which are also depleted after diphtheria toxin administration, did not 
restore the Th2 phenotype, clearly indicating that DCs were necessary to drive 
allergic immune responses (van Rijt et al., 2005). Similarly, alum induced Th2 
responses did not develop in CD11c-DTR mice. In these experiments, alum acted 
as a Th2 adjuvant for OVA antigen, which was transported by monocyte–derived 
and conventional DCs to the draining lymph nodes and presented to adoptively 
transferred OT-II CD4 T cells. However, only conventional DCs drove OT-II T cell 
proliferation and Th2 cell differentiation. After diphtheria toxin administration both 
monocyte–derived and conventional DCs were ablated and OT-II T cell priming 
and differentiation no longer occurred (Kool et al., 2008). During parasite infection 
with Schistosoma mansoni (Phythian-Adams et al., 2010) or Nippostrongylus  
brasiliensis (Smith et al., 2011), CD11c+ cells also play an important role in driving 
type 2 immune responses as their ablation resulted in dramatically impaired Th2 
responses and a marked shift towards inflammatory IFN-γ production. Thus, 
CD11c+ cells, in particular conventional DCs, are necessary to drive Th2 cell 
differentiation in allergic, adjuvant-driven and parasitic conditions. 
 
The first indication that certain subsets of DCs may be specialized to induce Th2 
responses in vivo came from a study that transferred antigen-pulsed splenic DCs 
into the footpad of recipient animals and assessed their potential to drive T cell 
responses. It was observed that transferred CD8+ DCs induced antigen-specific IL-
2 and IFN-γ secretion, whereas CD8- DCs preferentially induced IL-4, IL-5 and  
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IL-10. Hereby, transferred DCs induced acute responses as well as memory 
responses, measured 14 days after immunization. IFN-γ responses were 
dependent on the ability of DCs to produce IL-12, as transfers of IL-12-/- CD8+ DCs 
demonstrated a reduced potential to induce IFN-γ responses, whereas Th2 
induction by IL-12-/- CD8- DCs remained unaffected (Maldonado-López et al., 
1999). A follow-up study by the same group assessed the necessity of further 
cytokines to be produced by DCs to induce the observed immune responses. 
Apart from IL-12, IFN-γ production by CD8+ DCs was important to drive antigen 
specific Th1 responses in the recipient animals, while IL-12-/- and IFN-γ-/- CD8- 
DCs induced similar Th2 response as their wild-type counterparts. Interestingly, IL-
4 did not seem to be necessary for the induction of the Th2 response, as IL-4-/- 
DCs induced similar Th2 responses as their wild-type counterparts. However, the 
transfer of IL-10 deficient CD8- DCs showed lower Th2 responses, suggesting that 
IL-10 production by DCs is required for optimal Th2 development (Maldonado-
López et al., 2001). Similar results were observed when BMDCs from different 
transgenic mouse strains were pulsed with antigen and transferred into the 
footpad of wild type recipient mice. Heat-killed Propionibacterium acnes (Pa) was 
hereby used for a Th1 and SEA for a Th2 stimulus. As expected, SEA-pulsed 
BMDCs induced Th2 responses, measured by IL-4, IL-5 and IL-13 secretion in 
restimulation cultures, whereas Pa pulsed BMDCs induced strong IFN-γ 
responses. SEA-specific Th2 and Pa-specific Th1 responses were unaffected if 
antigen-pulsed IL-4-/- BMDCs were transferred. However, Pa-specific Th1 
responses were reduced after the transfer of IL-12-/- BMDCs, whereas SEA 
specific Th2 responses were not affected (MacDonald et al., 2002). Taken 
together these data suggest that Th2 differentiation is not a default response in the 
absence of Th1-polarizing signalling but requires specific signals from DCs. 
 
1.4.2 Signalling pathways by which dendritic cells drive Th2 
immune responses 
 
Several mechanisms have been proposed by which dendritic cells influence Th2 
responses. However, it is important to realize that different Th2 inducing stimuli 
can activate different signalling pathways. The signalling pathways presented here 
represent some of the better understood model mechanisms but are neither 
conclusive nor parasite specific. Furthermore, most studies have taken advantage 
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of in vitro differentiated bone marrow dendritic cells (BMDCs), which only have 
little similarity to tissue-derived DCs, and contain heterogeneous populations of 
monocytes, macrophages, monocyte–derived and conventional DCs, which all 
respond differently to the presented stimuli (Helft et al., 2015).  
 
One of the early candidates that was suspected to be produced by DCs to drive 
Th2 differentiation was IL-4. Although IL-4 is required to differentiate Th2 cells in 
vitro and IL-4-/- and IL-4R-/- mice cannot mount Th2 responses, it is not produced 
by DCs and IL-4-/- DCs induce regular Th2 responses (MacDonald and Pearce, 
2002; Maldonado-López et al., 2001). It has been suggested that other cells, like 
basophils, eosinophils or ILC2s exogenously provide the required IL-4 for the initial 
step of Th2 differentiation, but it has also been demonstrated that naive CD4 T 
cells can produce IL-4 in low amounts upon TCR activation in vitro (Yamane et al., 
2005). However, other cytokines have been associated with the ability of DCs to 
drive Th2 differentiation. One of these cytokines is IL-10, and IL-10-deficient DCs 
have been shown to drive less potent Th2 responses. For example, the transfer of 
antigen-pulsed IL-10-/- splenic CD8- DCs induced lower Th2 responses compared 
to the transfer of control DCs. Furthermore, IL-12p40 production was increased in 
these DCs, leading to increased IFN-γ responses after transfer. Incubation with 
exogenous IL-10 inhibited the secretion of IL-12p40, suggesting that IL-10 
regulates Th1 induction rather than directly induce Th2 responses (Maldonado-
López et al., 2001). In accordance, several studies have demonstrated that DCs 
do not undergo conventional maturation when incubated with parasite antigen. For 
instance, in contrast to BMDCs incubated with Propionebacterium acnes, SEA-
exposed BMDCs did not upregulate classical costimulatory markers like CD40, 
CD80 or CD86 and did not produce IL-4, IL-10 or IL-12. Furthermore, no 
phenotypical difference in regards to the expression of the costimulatory markers 
CD40, CD80 and CD86 was observed between CD8- splenic DCs harvested from 
wild type or S. mansoni-infected animals (MacDonald et al., 2001). Similar 
observations were made in human monocyte-derived dendritic cells, which did not 
upregulate CD80, CD83 or CD86, nor produced TNF-α, IL-6 or IL-12 after 
incubation with SEA. Furthermore, Toll-like receptor induced maturation of human 
monocyte-derived DCs with poly-I:C or LPS was reduced by SEA, downregulating 
the expression of CD80, CD83 and CD86 and the production of TNF-α, IL-6 and 
IL-12 (van Liempt et al., 2007). Interestingly, this effect was completely reproduced 
by incubating murine or human derived DCs with the S. mansoni egg antigen  
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omega-1, which also inhibited LPS-induced IL-12 secretion and CD86 expression 
(Everts et al., 2009). This suggests that parasite antigens activate cellular 
pathways in DCs that promote Th2 differentiation while inhibiting proinflammatory 
signals and producing IL-10 (Fig. 1-9). 
 
Another mechanism proposed to drive DCs to induce Th2 responses, is via thymic 
stromal lymphopoietin (TSLP) signalling. TSLP is produced by epithelial cells at 
barrier surfaces, such as the skin, lung and intestine and has been shown to 
promote pathogenic Th2 responses, such as atopic dermatitis and asthma (Ziegler 
and Artis, 2010). TSLP-stimulated human blood DCs responded by upregulating 
the costimulatory markers CD40, CD80 and CD86 and producing the Th2-
attracting chemokine TARC/CCL17. However, no secretion of the proinflammatory 
cytokines IL-1β, IL-6, IL-12 and TNF-α was detected. In vitro cocultures with CD4 
T cells revealed that TSLP-stimulated DCs induced Th2 cell differentiation, which 
secreted IL-4, IL-5 and IL-13 as well as TNF-α and low amounts of IFN-γ 
(Soumelis et al., 2002). In mice, TSLP expression was increased in the lungs of 
mice with allergen-induced asthma and TSLP receptor (TSLPR)-deficient mice 
showed decreased levels of disease. Similar to human DCs, BMDCs upregulated 
CD80 and CD86 during in vitro incubation with TSLP and produced CCL17 (Zhou 
et al., 2005). A proposed signalling pathway for TSLP is the binding to signal 
transducer and activator of transcription 5 (STAT5). STAT5 expression is 
dispensable for DC homeostasis and function but required for TSLP-dependent 
Th2 response-mediated disorders, such as antigen-induced airway inflammation 
and contact hypersensitivity. Flt3L-generated CD11b+ BMDCs from Stat5f/f CD11c-
cre-positive mice showed no upregulation of CD80, CD86 and OX40L nor CCL17 
production in response to TSLP stimulation and were not able to drive TSLP-
potentiated Th2 differentiation in vitro (Bell et al., 2013). Further signalling 
pathways by which TSLP acts on DCs were identified by Arima et al. They 
identified that the activation of the nuclear factor kappa B (NF-κB) subunits p50 
and RelB by TSLP led to the upregulation of OX40L and that the activation of 
STAT6 triggered the secretion of CCL17. In addition, TSLP signalling limited the 
activation of STAT4 and IRF8, which are essential for the production of IL-12. In 
contrast, LPS did not activate STAT6, but instead increased the abundance of 
STAT4 and IRF8, which led to the production of IL-12 in BMDCs (Arima et al., 
2010). Thus, TSLP mainly influences immune responses by blocking 
proinflammatory signalling in DCs that lead to Th1 responses and drives the 
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upregulation of OX40L and the secretion of CCL17, which have been associated 
with promoting Th2 responses.  
 
In addition to pathogenic Th2 responses, like allergy, asthma or atopic dermatitis, 
TSLP-TSLPR interactions also influence host protective immunity after the 
exposure to helminth parasites. Administration of monoclonal antibodies to TSLP 
or deletion of TSLPR in Trichuris muris-infected animals resulted in defective Th2 
responses, elevated production of IFN-γ and IL-17 and a failure to control 
infection. As previously observed, TSLP was necessary to control IL-12 production 
in DCs and TSLPR-/- splenic DCs from uninfected or infected animals produced 
more IL-12 than their wild type counterparts (Taylor et al., 2009). However, TSLP-
TSLPR interactions are not necessary for the induction of Th2 responses in all 
parasitic infections. For example, TSLPR signalling was dispensable for Th2 
responses in Nippostrongylus brasiliensis and Heligmosomoides polygyrus 
infections. The authors demonstrated that excreted or secreted antigens from 
these parasites, but not from T. muris, could directly limit the expression of IL-12 
by BMDCs, making the function of TSLP to suppress IL-12 secretion redundant 
(Massacand et al., 2009). Similarly, S. mansoni infected TSLPR-/- mice showed 
reduced IL-5 and IL-13 responses during acute (9 week) and chronic (12 week) 
infection but the general course of the disease and physiology of the infected 
mice, such as lesion formation and granuloma size, were not affected 
(Ramalingam et al., 2009). Thus, TSLP signalling plays a major role in pathogenic 
Th2 responses, by blocking proinflammatory stimuli in DCs, but is dispensable in 
many parasite infections. 
 
Besides the inhibition of IL-12 production by TSLP or helminth-derived molecules, 
direct activators of Th2 responses also play an important role in DC-driven type 2 
immunity. Maturation of human monocyte-derived dendritic cells with TSLP 
induced the expression of costimulatory molecules such as CD80 and CD86 and 
the secretion of CCL17, but furthermore led to the expression of OX40L, IRF4 and 
Jagged1. Blocking of OX40L using monoclonal antibodies led to impaired Th2 
differentiation in vitro, and OX40-OX40L Th2 differentiation was inhibited by 
providing exogenous IL-12 (Ito et al., 2005). Thus, OX40-OX40L signalling is 
required for the differentiation of Th2 cells but requires the inhibition of IL-12 to 
induce efficient Th2 responses.  
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Similar observations were made in human monocyte-derived dendritic cells 
incubated with SEA or cholera toxin, which drove Th2 responses in vitro and 
expressed OX40L, while their production of IL-12 was inhibited (de Jong et al., 
2002). Treating mice with OX40L-blocking antibodies substantially inhibited TSLP-
induced allergic inflammation in the lung and skin, including Th2 cell infiltration, 
cytokine secretion and IgE production and inhibited antigen-driven asthma in mice 
and rhesus monkeys (Seshasayee et al., 2007). Similarly, murine SEA-pulsed 
OX40L-/- BMDCs could not induce antigen-specific Th2 responses when 
transferred into naive recipient animals, due to ineffective Th2 cell expansion in 
these mice. Th2 responses could hereby be rescued by the injection of agonistic 
anti-OX40 antibodies, indicating that OX40L expression by DCs was important to 
drive appropriate Th2 responses (Jenkins et al., 2007). Further evidence that 
OX40-OX40L interactions directly influence Th2 differentiation of naive T cells was 
provided by Flynn et al. They demonstrated that in vitro stimulation of naive CD4 T 
cells through OX40L promoted IL-4 expression, and inhibited IFN-γ production in 
CD8 T cells and IL-12–stimulated CD4 T cells (Flynn et al., 1998).  
Thus, OX40L expression by DCs, which can be induced by TSLP or SEA, is an 
important factor that directly influences Th2 differentiation (Fig. 1-9). Apart from 
costimulatory molecules such as OX40L and cytokines like IL-10, transcription 
factors like IRF4 have been implicated in type 2 immunity and the experiments 
supporting the role of IRF4 in driving Th2 immune responses are discussed in the 
following section.  
 
 
 	    
	   52 
 
Figure 1-9. Both TSLP and parasite antigen limit proinflammatory signalling and upregulate 
OX40L expression in DCs 
TSLP signals through the TSLP receptor (TSLPR) and upregulates the expression of OX40L 
through the activation of NF-κB and CCL17 through STAT5/6, while blocking STAT4 and IRF8, 
which are important in IL-12 production. Parasite antigens, such as SEA, also limit proinflammatory 
signalling and inhibit the upregulation of the costimulatory molecules CD80 and CD86 and the 
production of TNF-α, IL-6 and IL-12, while promoting OX40L expression and IL-10 production. 
However, the cellular receptors and signalling mechanisms controlling the effects of these parasite 
antigens on DCs are less well understood. 
 
1.4.3 The role of IRF4 in type 2 immunity 
 
IRF4 is an important regulator of type 2 immunity and is expressed in many cell 
types. It is a member of the interferon-regulatory family of transcription factors and 
is expressed by Th2 cells and critical for their differentiation and function. In the 
absence of IRF4, IL-4 fails to induce Th2 cell differentiation in vitro, and Th2 
responses are absent in Leishmania major infected IRF4-/- animals. Although early 
IL-4 signalling is normal in IRF4-/- T cells, GATA-3 is not upregulated, leading to 
impaired Th2 differentiation (Lohoff et al., 2002). Furthermore, the expression of 
IRF4 is also important for the ability of Foxp3+ regulatory T cells to specifically 
inhibit Th2 responses and the specific deletion of IRF4 in Foxp3+ cells leads to 
type 2 mediated autoimmune disease (Zheng et al., 2009). IRF4 also controls 
plasma cell differentiation and class switching, and conditional deletion of IRF4 in 
germinal center B cells blocks their differentiation into post-germinal center plasma 
cells (Klein et al., 2006). 
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Apart from T and B cells, IRF4 also plays an important role in antigen presenting 
cells. It is a key regulator for the alternative activation of macrophages, which are 
induced during type 2 immune responses (Gordon, 2003), and the induction of 
genes associated with alternative activation is severely impaired in IRF4-/- bone 
marrow macrophages or in macrophages harvested from IRF4-/- mice after chitin 
administration (Satoh et al., 2010). IRF4 has also been shown to interact with 
MyD88 and acts as a negative regulator of TLR signalling. TLR-dependent 
induction of the proinflammatory cytokines IL-6, IL-12 and TNF-α is markedly 
enhanced in IRF4-/- peritoneal macrophages in vitro, whereas this induction does 
not occur after ectopic expression of IRF4 in a macrophage cell line (Negishi et al., 
2005). 
The importance of IRF4 expression in dendritic cells has been demonstrated in 
multiple studies and developmental as well as functional roles have been 
identified. As previously described, IRF4 is expressed by CD11b+CD8- splenic 
DCs, CD11b+ lymph node DCs and CD11b-expressing DCs in peripheral tissues. 
In IRF4-/- mice CD11b+CD8- splenic DCs are significantly reduced in number and 
their development is severely impaired. Also CD11b+ BMDCs can not be 
generated from IRF4-/- bone marrow cells in vitro (Suzuki et al., 2004b). 
Furthermore, conditional deletion of IRF4 leads to decreased numbers of 
CD11b+CD103+ DP DCs in the intestine (Persson et al., 2013b) and 
CD11b+CD24+ DCs in the skin (Schlitzer et al., 2013) and impaired survival of 
these subsets has been suggested as a potential mechanism. However, IRF4 also 
acts on the migration of CD11b+ DCs in the skin. In steady state the numbers of 
migratory Langerhans cells and CD11b+ DCs were reduced in the cutaneous 
lymph nodes of IRF4-/- mice. Furthermore, upon induction of skin inflammation, 
IRF4-/- CD11b+ DCs failed to upregulate CCR7 and did not migrate to the 
cutaneous lymph nodes, whereas the migration of Langerhans cells and CD103+ 
DCs was not affected (Bajaña et al., 2012). Similarly, fewer CD11b+CD103- and 
CD11b+CD103+ DP migratory DCs were observed in the MLNs of steady-state 
IRF4f/f CD11c-cre-positive mice (Persson et al., 2013b). Genetic deletion of IRF4 
in CD11c+ cells also led to the absence of PDL2hi CD301b+ migratory DCs from 
the skin-draining lymph nodes but not from the skin itself. Th2 cell-mediated 
responses in these animals were reduced in response to immunization with the 
protease adjuvant papain and after N. brasiliensis infection (Gao et al., 2013). 
Thus, apart from developmental and migratory effects of IRF4 on CD11b+ DCs, 
IRF4 also plays an important direct functional role in driving Th2 responses.  
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One proposed mechanism is the impaired formation of peptide-MHC class II 
complexes by IRF4f/f CD11c-cre-positive CD11b+ DCs, as observed in splenic DCs 
and BMDCs. This deficiency resulted in reduced CD4 T cell proliferation in in vitro 
cocultures and impaired helper T cell but not cytotoxic T lymphocyte responses 
during allergic airway inflammation. Further analyses in BMDCs identified an IRF4-
dependent regulatory module that specifically drives peptide-MHC class II complex 
formation through the genes H2-DMb2, Ctss and Cst3 (Vander Lugt et al., 2014). 
IRF4 also directly targets and activates the Il10 and Il33 genes in DCs. Using a 
late expressed construct of CD11c-cre the authors were able to circumvent the 
developmental effects of IRF4 deletion on DCs and focus on its functional role in 
Th2 immunity. Similar to previous observations, IRF4-expression in DCs was 
necessary for the development of Th2-mediated house dust mite (HDM) allergic 
airway inflammation, but not required for the development of pulmonary Th1 
antiviral responses. IRF4-deficient BMDCs failed to prime Th2 cells in vitro, while 
Th1 and Th17 priming was unaffected. Specifically, IRF4 promoted Th2 
differentiation through the upregulation of IL-10 and IL-33 in BMDCs, and the 
administration of exogenous IL-10 and IL-33 recovered the ability of IRF4-deficient 
DCs to promote Th2 differentiation in vitro. Furthermore, it was observed that IRF4 
and its binding partner PU.1 directly bind to the Il10 and Il33 gene locus (Williams 
et al., 2013). Apart from IL-10, which is involved in regulating inflammatory 
responses, IL-33 is an important mediator that drives allergic responses and has 
been shown to play an important role in DC-driven HDM induced atopic asthma. 
Incubation with HDM in vitro induced the expression of IL-33 in BMDCs, which 
was dependent on FcRγ and TLR4. FcRγ-deficient mice did not develop atopic 
asthma in response to HDM, but exogenous IL-33 was sufficient to restore 
pathogenesis and the development of Th2 responses.  
The critical role for DCs to drive this response was shown by adoptive transfer of 
allergen-pulsed BMDCs. The transfer of wild type BMDCs was sufficient to induce 
allergic responses and Th2 development in FcRγ-/- mice through the production of 
IL-33, whereas FcRγ-deficient BMDCs did not induce such responses (Tjota et al., 
2014). It has also been shown that the binding partner of IRF4, PU.1 directly binds 
to the OX40L promoter in BMDCs and human monocyte-derived DCs and that 
PU.1 knockdown decreased the expression of OX40L in stimulated BMDCs 
(Yashiro et al., 2016).  
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However, most of these insights were identified by using in vitro generated 
BMDCs and it remains to be determined whether the same mechanisms apply to 
tissue derived DCs in vivo. Therefore, one of the aims of this project is to analyse 
the effects of IRF4 deletion on intestinal DCs using IRF4f/f CD11c-cre mice and to 
determine whether they are less able to induce Th2 responses against S. mansoni 
egg antigens. 
 
1.5 Hypothesis and aims 
 
In order to investigate the induction of Th2 responses by S. mansoni eggs our first 
aim was to develop an immunization protocol in the intestine. S. mansoni eggs 
have been shown to drive potent Th2 responses. Inflammatory responses are 
predominant in the first 6-8 weeks of infection. Only upon the production of eggs 
by adult female worms does the immune response shift towards type 2 immunity. 
However, the exact timing and dose of egg production can not be controlled during 
live infection, making the specific study of the induction of Th2 responses against 
S. mansoni eggs impossible during live infection. It has been demonstrated that 
the injection of non-viable freeze-thawed eggs is sufficient to drive Th2 responses 
in the footpad and we adapted this procedure for the intestine (MacDonald et al., 
2002). In order to represent eggs that penetrate the intestinal wall, where they 
cause damage, generate granuloma formation and drive Th2 responses during 
chronic schistosomiasis, we deposited a defined number of eggs into the intestinal 
wall and assessed the immune responses they induced locally and in the draining 
lymph nodes (see chapter 3).  
 
An important regulator of type 2 immunity is the transcription factor IRF4, which 
controls the development of Th2 cells, post-germinal center plasma cells, 
alternatively activated macrophages and CD11b-expressing dendritic cells (DCs), 
which all play a role in type 2 immunity. In the case of DCs IRF4 is not only 
involved in their development but has also been shown to play a role in cell 
migration and directly regulating BMDC-driven Th2 differentiation via peptide-MHC 
class II complex formation (Vander Lugt et al., 2014) and the expression of IL-10, 
IL-33 and OX40L (Williams et al., 2013). However, these effects have not been 
studied in the context of intestinal Th2 responses. Thus, our second aim was to 
analyse the effects of IRF4 deletion on intestinal CD11c-expressing cells in vivo 
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using IRF4f/f CD11c-cre mice. We determined whether this IRF4 deletion caused 
impaired Th2 responses against S. mansoni egg antigens and which CD11c-
expressing cells were affected. We hereby focused on cells that took up egg 
antigens in the intestine and transported them to the draining lymph nodes to be 
presented to T cells (see chapter 4). 
 
As DCs are specialized to sample intestinal antigens, migrate to the draining 
lymph nodes and present and prime antigen specific T cells, we hypothesised that 
DCs are instrumental in this process. The necessity of CD11c+ cells to drive type 2 
immune responses during S. mansoni infection has been demonstrated using 
CD11c-DTR mice (Phythian-Adams et al., 2010). However, it remains unclear 
whether these cells are important for the induction, maintenance or restimulation 
of the response. Furthermore, CD11c is expressed by various antigen presenting 
cells, including macrophages and DCs. Therefore, our third aim was to determine 
which of these CD11c-expressing cell populations was involved in driving Th2 
responses against S. mansoni eggs in the intestine and were sufficient to prime 
antigen specific Th2 cells in the draining lymph nodes. 
The involvement of DCs in driving Th2 responses has been demonstrated in 
multiple model systems. However, the mechanisms by which DCs induce these 
responses are not well understood. Our limited understanding comes from in vitro 
generated BMDCs incubated with soluble egg antigen (SEA) in vitro. These cells 
showed limited upregulation of the costimulatory markers CD40, CD80 and CD86 
in response to SEA (MacDonald et al., 2001), but required OX40L to induce 
effective Th2 responses (Jenkins et al., 2007). However, in vitro generated 
BMDCs contain heterogeneous populations of monocytes, macrophages, 
monocyte–derived and conventional DCs, which can all respond differently to the 
presented stimuli. Thus, we further aimed to investigate the effects of S. mansoni 
egg antigens on tissue-derived intestinal DCs to understand the molecular 
mechanisms that drive the differentiation of Th2 responses (see chapter 5). 
 
Furthermore, the idea is emerging that specific DC subsets are specialized to 
perform different roles in T helper cell differentiation. This has been demonstrated 
for Th1, Th17 and Treg cells in the intestines but it is unclear if it also applies to 
the induction of Th2 cells. Therefore, the final aim of this project was to determine 
if specific intestinal DC subsets are specialized to prime Th2 cells and drive Th2 
responses against S. mansoni egg antigens. It has been observed that the 
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composition of DC subsets varies between different regions of the gastrointestinal 
tract, with the most striking differences observed between the small intestine and 
colon (Denning et al., 2011). The small intestine and colon can be infected by 
numerous helminth parasites, some of which selectively affect the small intestine 
or colon (Grencis, 2015). We therefore defined the role of DC subsets that drive 
intestinal Th2 responses in a tissue-specific context and separately assessed the 
involvement of lamina propria, lymph migrating and lymph node DC subsets, from 
the small intestine and the colon (see chapter 6).  
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Chapter 2: Materials and Methods 
 
2.1 Animals 
 
C57BL/6 mice were ordered from Harlan UK at six weeks of age, whereas all other 
mouse strains were bred in house. C57BL/6.SJL (kindly provided by Prof. Allan 
Mowat from the University of Glasgow) and KN2 mice (kindly provided by Prof. 
Andrew MacDonald for the University of Manchester) were housed under specific 
pathogen free conditions at the Central Research Facility of the University of 
Glasgow. In general mice were housed in conventional cages. However, OT-II 
mice (kindly provided by Prof. Allan Mowat from the University of Glasgow) and 
animals that had undergone surgery were housed in individual ventilated cages. 
Age and gender matched adult animals were used in each individual experiment, 
which were approved by the local ethic committees, and performed under licenses 
issued by the UK Home Office. IRF4f/f CD11c-cre-positive and IRF4f/f cre-negative 
bone marrow chimeras were created by lethally irradiating 6-week old 
C57BL/6.SJL recipients with 10 Greys of irradiation and reconstituting them by 
intravenous injection with 2-4 x 106 IRF4f/f CD11c-cre-positive or IRF4f/f cre-
negative bone marrow cells, which we received from our collaborators Dr. Marcus 
Svensson-Frej and Prof. William Agace from the University of Lund, Sweden. 
Chimeras were housed in individual ventilated cages and animals were monitored 
daily for 3 weeks to ensure animal well-being. Cell chimerism was assessed in 
venous blood 3 weeks after irradiation.  
 
2.2 Surgical procedures 
 
All surgical procedures were carried out under aseptic conditions and inhalation 
anaesthesia with Isoflurane (Abbot Animal Health). Before surgery, mice were 
shaved and treated with the subcutaneous analgesics Carprofen at a dose of 0.1 
ml/100 g  (Rimadyl; Pfizer) and Buprenorphine at 0.15 ml/100 g  (Vetergesic; 
Reckitt Benckiser Healthcare).  
For intestinal injections the intestines were exposed by midline incision and 1,000 
non-viable freeze-thawed S. mansoni eggs (van der Werf et al., 2003), 
resuspended in 20 µl DPBS (Gibco); or 20 µl of DPBS or soluble antigen were 
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injected into the intestinal lamina propria of anaesthetized mice using a Micro-Fine 
Plus Hypodermic Syringe (29G x 12.7mm; BD). Prof. Andrew MacDonald from the 
University of Manchester kindly provided S. mansoni eggs that had been isolated 
under sterile conditions from the livers of infected C57BL/6 mice prior to 
cryopreservation (MacDonald et al., 2002). After injection the intestines were 
replaced into the body cavity, the muscle layer was sutured with 6.0 vicryl 
absorbable sutures (Johnson and Johnson) and the skin closed using surgical 
clips (Autoclip Wound Clip System, Harvard Apparatus). 
Similarly, subcapsular injections were carried out on anaesthetized mice that had 
been fed 0.2 ml olive oil to visualize the MLN capsule 30 minutes prior to surgery. 
Intestines and MLNs were exposed and cells resuspended in 5 µl DPBS were 
injected under the MLN subcapsule using a Micro-Fine Plus Hypodermic Syringe 
(29G x 12.7mm; BD).  
 
Mesenteric lymphadenectomy and thoracic duct cannulation procedures were 
carried out as previously described (Cerovic et al., 2015). For mesenteric 
lymphadenectomy an abdominal midline incision was made in 6-week-old male 
mice and the intestine exposed. For MLNx, all visible MLNs located above the 
superior mesenteric vein were removed by blunt dissection. For partial MLNx, the 
specific lymph nodes that drain the small intestine (sMLNx) or the colon (cMLNx) 
were removed (Houston et al., 2016). Upon completion the intestine was placed 
back into the body cavity, the muscle layer was sutured and the skin closed using 
surgical clips. 
Six weeks after the MLNx procedure, mice were fed 0.2 ml olive oil, to visualize 
the lymphatics, 30 minutes prior to the surgical procedure. An incision of around 2-
3 cm was made underneath the rib cage and a polyurethane medical grade 
intravascular tube (2Fr; Linton Instrumentation) was inserted into the thoracic duct, 
fixed in place using surgical glue, exteriorized between the ears and fed into a 
Covance harness (Harvard Apparatus). The muscle layer was then sutured, and 
the skin closed using surgical glue. Pseudo-afferent lymph was then collected for 
18 hours on ice in DPBS supplemented with 20 U/ml of heparin sodium 
(Wockhardt).  
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2.3 Reagents 
 
Complete RPMI contained RPMI 1640 medium supplemented with 5% FCS, 2 mM 
L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 50 µM 2-
mercaptoethanol (all Gibco). FACS buffer consisted of DPBS supplemented with 2 
mM EDTA and 1% FCS (all Gibco). 
 
2.4 Cell isolations 
 
Lymph collected overnight was passed through a 40 µm cell strainer (Greiner), 
and red blood cells lysed with 3 ml ammonium chloride potassium lysis buffer 
(Sigma Aldrich) for 1 minute and washed twice in complete RPMI.  
MLNs were enzymatically digested as previously described (Houston et al., 2016) 
using RPMI (Gibco) supplemented with 8 U/ml Liberase and 10 µg/ml DNase 
(Sigma-Aldrich). MLNs were cut into small pieces and digested for 45 minutes at 
37°C in a shaking incubator. To obtain single cell suspensions cells were passed 
through a 40 µm cell strainer (Greiner). 
Intestinal digests were performed as described (Scott et al., 2016), with small 
intestines being digested in RPMI supplemented with 1 mg/ml Collagenase VIII 
(Sigma-Aldrich) and 10% FCS. Small intestines were excised and washed in 
Hanks’ Balanced Salt Solution (HBSS, Gibco) supplemented with 2% FCS. 
Peyer’s Patches and fat were removed and the intestine cut longitudinally and into 
0.5 cm sections. Tissue was shaken vigorously in HBSS/2% FCS and filtered 
through a 50 µm Nitex mesh (Cadisch and Sons). Tissues were washed twice in 
HBSS supplemented with 2 mM EDTA at 37°C for 20 minutes, and then digested 
for 15 minutes at 37°C in a shaking incubator. Cells were subsequently passed 
through a 100 µm and a 40 µm cell strainer (BD Biosciences) and washed twice in 
complete RPMI. Similarly, colons were harvested and after removing fat and 
faeces, the colon was opened longitudinally and cut into 0.5 cm segments. After 
being filtered through a 50 µm Nitex mesh (Cadisch and Sons) and washed in 
HBSS/EDTA, colons were digested in RPMI supplemented with 0.425 mg/ml 
Collagenase V (Sigma-Aldrich), 0.425 mg/ml Collagenase D (Roche), 1 mg/ml 
Dispase (Gibco), 30 µg/ml DNase (Roche) and 10% FCS for 30-40 minutes at 
37°C in a shaking incubator. Then cells were passed through a 40 µm cell strainer 
(BD Biosciences) and washed twice in complete RPMI. 
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2.5 Flow cytometry and cell sorting 
 
Mouse tissue cell surface markers and intracellular cytokines were stained using 
combinations of fluorescently labelled primary antibodies at a standard dilution of 
1:200. These included anti-CD4 (GK1.5 and RM4-5), anti-CD8a (53-6.7), anti-
CD44 (IM7), anti-CD45R/B220 (RA3-6B2), anti-CD11c (N418), anti-I-A/I-E 
(M5/114.15.2), anti-CD11b (M1/70), anti-CD103 (2E7), anti-CD64 (X54-5/7.1), 
anti-Ly6C (HK1.4), anti-TCR Vα2 (B20.1), anti-CD45 (30-F11), anti-CD45.1 (A20), 
anti-CD45.2 (104) and anti-human CD2 (RPA-2.10) purchased from Biolegend, 
and IFN-γ (XMG1.2) and anti-IL13 (eBio13A) from eBioscience. SEA was 
fluorescently labelled using the Microscale Antibody Labelling Kit (Life 
Technologies) as instructed. Cell surface staining was performed on freshly 
isolated cells resuspended in FACS buffer and samples were stained in 12x75 mm 
polystyrene tubes (BD Biosciences) with up to 10 x 106 cells per 200 µl of FACS 
buffer. Non-specific binding of antibodies to Fc receptors was blocked by the 
addition of Fc block (anti-CD16/CD32, Biolegend) diluted 1:200 for 10 minutes at 
4°C. Required antibodies or isotype controls were then added to samples for 30 
minutes at 4°C and 5 µl 7AAD (Biolegend) or Fixable Viability Dye eFluor780 
(eBioscience) diluted at 1:1000 were added to exclude dead cells from analysis. 
After staining, cells were washed twice in FACS buffer and analysed using a LSRII 
flow cytometer running FACSDiva Software (BD Bioscience) and analysed using 
Flowjo Software (Tree Star).  
 
For cell sorting, cells were stained under sterile conditions and DCs were gated on 
by selecting live CD45+ CD45R/B220- CD64- Ly6C- CD11chi MHCIIhi single cells 
and CD11b/CD103 expressing subsets sorted separately using an AriaIII cell 
sorter (BD Bioscience). Cells were collected in complete RPMI on ice and, for 
subsequent antigen loading, were incubated in supplemented (as above) X-vivo 
15 media (Lonza) with 15 µg/ml SEA for 6 hours or 2 mg/ml OVA protein (Sigma-
Aldrich) for 2 hours at 37°C and 5% CO2. 
 
2.6 In vitro cell cultures 
 
For restimulation cultures 1 x 106 MLN cells were cultured in X-vivo 15 media 
(Lonza) supplemented with 1% L-glutamine (Invitrogen), 0.1% 2-mercaptoethanol 
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(Sigma-Aldrich) and 15 µg/ml SEA in round bottom 96-well plates (Corning) at 
37°C and 5% CO2. SEA was kindly provided by Prof. Andrew MacDonald from the 
University of Manchester and prepared as previously described (MacDonald et al., 
2002). Supernatants were collected after three days and cytokines detected using 
the IL-4, IL-5, IL-13 and IFN-γ ”ready-set-go” ELISA kits (eBioscience) following 
the manufacturer’s instructions.  
 
For intracellular staining experiments 2-4 x 106 MLN cells were incubated in RPMI 
supplemented with 2.5 ng/ml PMA (Sigma-Aldrich), 1 µg/ml ionomycin 
(Invitrogen), 0.5% GolgiStop (BD Bioscience) and 10% FCS for 4 hours at 37°C 
after which cell surface markers were stained. Alternatively, cells were incubated 
in flat-bottom 96 well plates (Corning) with 5 µg/ml plate-bound anti-CD3 and 2 
µg/ml soluble anti-CD28 for 18 hours at 37°C and 5% CO2. Subsequently cells 
were fixed and permeabilized using the eBioscience Foxp3/Transcription Factor 
Staining Buffer Set and intracellular staining was performed following the 
manufacturer’s instructions. 
 
For in vitro OT-II cocultures 2 x 105 OT-II MLN cells were labelled with CFSE 
(eBioscience) diluted at 1:1000 for 1 minute in DPBS, washed twice with complete 
RPMI and cocultured with 6,000 sMLN or 3,000 cMLN FACS-sorted DCs from 
each subset. Each subset had been pulsed with 2 mg/ml of OVA (Worthington, 
Lakewood) for 2 hours at 37°C and then extensively washed. After 3 days of 
coculture in round bottom 96 well plates (Corning) at 37°C and 5% CO2, cells were 
stained for flow cytometry and CFSE dilution was assessed to measure OT-II T 
cell proliferation. 
 
2.7 Statistical analysis  
 
Prism Software (GraphPad) was used to calculate the SEM. Statistical differences 
between groups were calculated using Student’s t tests, Mann-Whitney U tests 
and Kruskal-Wallis tests, were appropriate, with P < 0.05 being considered as 
significant. Non-parametric Mann-Whitney U tests were applied when samples 
were not normally distributed but followed a skewed distribution. 
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Chapter 3: Intestinal Schistosoma mansoni egg 
injections induce robust Th2 responses in the draining 
lymph nodes 
 
3.1 Results 
 
Type 2 immune responses are mounted against parasitic or allergic stimuli, that 
either protect against parasites, or exacerbate allergic conditions (Licona-Limón et 
al., 2013). The majority of parasites affect the gastrointestinal tract (Pulendran and 
Artis, 2012), many of which selectively affect the small intestine or colon (Grencis, 
2015). 
 
Schistosoma mansoni eggs, which penetrate the small intestine during live 
infection, are strong inducers of Th2 responses (Pearce and MacDonald, 2002). 
Intact live eggs, non-viable freeze-thawed eggs and their soluble egg antigens 
(SEA) all drive potent Th2 responses in both the parasitic infection (Pearce et al., 
2004; Pearce and MacDonald, 2002) and in experimental models of egg or SEA 
injections (MacDonald et al., 2002; Klaver et al., 2015). Despite the facts that S. 
mansoni eggs predominately affect the small intestine, and that most parasites 
invade the gastrointestinal tract, little work has been done to specifically 
investigate the induction of the immune responses mounted against parasite 
antigens in the intestine. 
 
Therefore, we aimed to establish an experimental immunization protocol using S. 
mansoni eggs in the intestine that would allow us to study the cellular mechanisms 
in the small intestine and colon that induce type 2 immune responses under 
controlled and physiologically relevant conditions.  
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3.1.1 Subserosal injection of Schistosoma mansoni eggs induces 
antigen specific immune responses in the MLNs 
 
Non-viable freeze-thawed S. mansoni eggs and SEA were supplied by our 
collaborator Andrew MacDonald, who collected them from the livers of S. mansoni 
infected mice (MacDonald et al., 2002). In already published S. mansoni egg 
immunization models, eggs were injected into the footpad (Phythian-Adams et al., 
2010), a tissue that is readily accessible. To deliver eggs into the gastrointestinal 
tract, we first considered the use of non-surgical procedures, like oral gavage and 
intrarectal administration. However, these methods were considered not to be 
suitable, as the number of eggs that would reach the small intestine or colon could 
not be precisely controlled using oral gavage, and intrarectal injections would not 
allow delivery of eggs into the small intestine. Furthermore, using these techniques 
eggs would be delivered into the intestinal lumen. However during live infection, 
eggs are located within the intestinal tissue as they penetrate the intestinal wall, 
the lamina propria and the epithelium to reach the intestinal lumen and be 
excreted. 
 
 
 
Figure 3-1. Injection of S. mansoni eggs into the intestinal lamina propria serves as an 
experimental model that represents penetrating eggs during live infection 
Schematic illustrating the injection of S. mansoni eggs into the lamina propria of the small intestine 
(A). The cluster of injected eggs remained visible after injection, confirming that eggs were 
correctly delivered into the lamina propria and not the intestinal lumen (B). After immunization, 
lymph nodes were harvested and restimulated with soluble egg antigen in vitro. Released 
cytokines were detected by ELISA (C), revealing the magnitude of the induced immune response. 
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We therefore considered that injection into the intestine was potentially a suitable 
method for accurate delivery of eggs. The injection of eggs directly into the 
subserosal layer of the intestine was considered to be a relevant physiological 
location. During live infection S. mansoni eggs penetrate the intestinal wall to 
reach the intestinal lumen and be excreted. Some eggs become lodged within the 
intestine and induce strong Th2 responses, which after prolonged exposure lead 
to granuloma formation, a key hallmark of schistosomiasis (Wynn et al., 2004). 
The lamina propria is furthermore an important tissue for intestinal immune 
responses. Here, tissue resident antigen presenting cells (APCs), such as 
macrophages and migratory dendritic cells (DCs), detect and sample antigen. The 
APCs then communicate with T cells and other effector cells to mount appropriate 
immune responses, both within the tissue and the draining lymph nodes. As the 
intestinal lamina propria is drained by the afferent lymphatics that feed into the 
mesenteric lymph nodes (MLN) we monitored the induction of immune responses 
in the MLNs (Fig. 3-1 A). Here, DCs that migrate from the intestine to the draining 
lymph nodes present antigen to naive T cells and thus induce T cell responses. 
 
To inject eggs under the serosal layer of the intestine, mice were anaesthetized, 
the skin and muscle layer were opened and the gastrointestinal tract was 
displayed. 1,000 non-viable S. mansoni eggs, resuspended in 20 µl of DPBS, 
were then injected into the subserosal layer (Fig. 3-1 B). The single injection site 
displayed no bleeding or other damage after injection and the injected cluster of 
eggs remained clearly visible and could even be located 5 days after the surgery. 
This demonstrated that the precise injection into the intestinal tissue caused 
minimal damage to the tissue, and simulated lodged eggs that remained at the site 
of injection for at least 5 days. After injection, the intestines were moved back into 
the abdominal cavity. The muscle layer and skin incisions were closed and the 
mouse was placed in a heat cabinet for recovery. After an immunization period of 
5 days, the draining lymph nodes were harvested and the induction of antigen 
specific Th2 responses analysed. Initially these Th2 responses were assessed 
using restimulation cultures, as previously described in the literature (MacDonald 
et al., 2001; MacDonald and Pearce, 2002). 1 x 106 cells, obtained from lymph 
node cell suspensions, were cultured with soluble egg antigen in vitro. After 3 days 
supernatants were collected and the production of the cytokines IFN-γ, IL-4, IL-5 
and IL-13 was measured by ELISA (Fig. 3-1 C). 
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Figure 3-2. Intestinal egg injection induces antigen specific immune responses in the MLNs 
after restimulation with SEA 
5 days after egg injection, 3-day restimulation cultures were prepared from MLN cells by culturing 
1x106 MLN cells with 7.5 µg/ml SEA. The release of IFN-γ, IL-4, IL-5 and IL-13 was measured by 
ELISA in supernatants from cells that were not restimulated (unstim) or were restimulated (restim) 
with SEA (A). Cytokine responses were also measured after SEA restimulation of PBS or egg 
injected mice, 5 days after injection (B). Responses after SEA restimulation of MLN cells harvested 
5 days after egg injection into BALB/c or C57BL/6 mice (C). Data represent at least three 
independent experiments (mean ± SEM) with at least three animals per group. Mann-Whitney U 
tests were applied for statistical analysis (***P ≤ 0.001).  
 
 
By using restimulation cultures we could measure an antigen specific immune 
response that developed in the draining lymph node during the immunization 
period. Responses to the restimulating agent, in our case soluble egg antigen 
(SEA) derived from S. mansoni eggs, could be detected by measuring cytokines 
released into the supernatant. The level of produced cytokines also indicated the 
strength of the induced immune response. By analysing different key cytokines we 
were able to classify the nature of the immune response and measured IFN-γ, 
which is an inflammatory cytokine that is also induced by S. mansoni egg antigens 
(Cook et al., 2015), and IL-4, IL-5 and IL-13, which are associated with type 2 
immune responses and produced by Th2 cells (Constant and Bottomly, 1997).  
 
In an initial experiment MLNs were harvested 5 days after subserosal egg 
injection. After 3 days of in vitro culture the supernatants of unstimulated and 
restimulated MLN cells were analysed. We could detect IFN-γ as well as IL-4, IL-5 
and IL-13 in the wells that were restimulated with SEA but none of these cytokines 
were detected in unstimulated wells (Fig. 3-2 A). IL-4, IL-5 and IL-13 were present 
at different concentrations after restimulation as they are produced by Th2 cells in 
different amounts (Paul, 2010). IL-4 was detected with an average concentration 
of 0.15 ng/ml, whereas the levels of IL-5 and IL-13 were 0.5 ng/ml and 4 ng/ml on 
average. The production of IFN-γ, a Type 1 cytokine, was not surprising, as S. 
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mansoni eggs contain a complex pool of different antigens, some of which can 
induce Type 1 responses (Cheever et al., 2002). As we did not detect any of these 
cytokines in unstimulated cell cultures, these cytokines were only secreted upon 
antigen specific restimulation. We therefore concluded that the use of restimulation 
cultures allowed the detection of an antigen specific response induced after 
subserosal injection in the MLNs without detectable background expression of 
cytokines. We could also measure the strength of the induced immune response 
by evaluating the concentrations of cytokines that were produced. 
 
To determine if the surgical procedure of subserosal injections affected the 
immune response we compared egg injected and PBS injected mice after 5 days 
of immunization and measured antigen specific cytokines of MLN cells 3 days after 
restimulation. We observed that no cytokines were detectable in the supernatants 
from PBS-injected control mice, whereas the level of cytokine measured in egg-
injected mice was comparable to what we had previously observed (Fig. 3-2 B). 
We therefore determined that the injection of eggs into small intestinal tissue 
provided a robust method of delivery, which induced antigen specific immune 
responses, and that the injection itself did not stimulate any background 
expression of cytokines that could interfere with our analysis. 
 
Different mouse strains have been shown to have intrinsic preferences towards 
eliciting different immune responses due to their genetic background. For example 
immune responses against Trichuris muris in C57BL/6 and BALB/c mice are 
characterized by the production of Th2 associated cytokines and the expulsion of 
worms while Th1-associated cytokines promote chronic infections in genetically 
susceptible AKR/J mice (Antignano et al., 2011; Cliffe and Grencis, 2004). 
Infections with S. mansoni demonstrated that the different genetic background of 
C57BL/6 and BALB/c mice did not impact resistance, measured by worm and egg 
burden. However, larger granuloma sizes were observed in the livers of infected 
BALB/c mice and significantly higher IL-4 and IL-13 cytokines were produced by 
splenic T cells after infection and reinfection, suggesting that BALB/c mice 
produced stronger Th2 responses against S. mansoni eggs (Alves et al., 2016). To 
address whether genetic host backgrounds would influence our intestinal S. 
mansoni egg immunization model we compared the immune responses induced 
by subserosal egg injection in C57BL/6 and BALB/c mice. Again, we injected 
1,000 non-viable eggs under the serosal layer of the small intestine and harvested 
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the MLNs 5 days after egg injection. We observed that restimulated MLN cells 
from both mouse strains produced similar amounts of IFN-γ, IL-4, IL-5 and IL-13 
and we could not detect any statistically significant difference between any of 
these cytokines (Fig. 3-2 C). This suggested that the intestinal injection of S. 
mansoni eggs induced a comparable immune response in the MLNs of C57BL/6 
and BALB/c mice and that transgenic mice from both backgrounds could be used 
to further examine the underlying cellular processes involved in the induction of 
this response. 
 
 
 
Figure 3-3. The intestinal wall represents a physiologically relevant location for intestinal 
egg injection 
Cytokine responses were measured in restimulation cultures from MLN cells that were harvested 5 
days after luminal (luminal inj) or subserosal (subs inj) egg injections into small intestines of mice 
(A). The release of IFN-γ, IL-4, IL-5 and IL-13 after 3 days of restimulation with SEA was compared 
between intestinal injections of 20 µg soluble egg antigen (SEA inj) or 1,000 non-viable eggs (egg 
inj) (B). Immune responses were measured after egg injection into the MLN subcapsular space 
(subcaps inj) or the intestinal subserosal tissue (subs inj) (C). MLNs were harvested after 5 days 
and restimulated with SEA for another 3 days. Data represent at least three independent 
experiments (mean ± SEM) with at least three animals per group. Mann-Whitney U tests were 
applied for statistical analysis (***P ≤ 0.001).  
 
 
We had established that intestinal egg injections induced robust immune 
responses in the MLNs, which we detected using restimulation cultures. We 
proceeded by testing whether the injection of eggs into different layers of the 
intestine had an impact on the induced immune response.  
In live infections of S. mansoni eggs penetrate the small intestine to reach the 
intestinal lumen. Although the pathology of schistosomiasis is caused by lodged 
eggs within the intestine tissues (Wilson et al., 2007), immune cells can also 
sample luminal antigen. Dendritic cells can extend their dendrites into the intestinal 
lumen to directly sample antigen or soluble antigen can be transported across the 
epithelium into the lamina propria, where it is then sampled (Rescigno et al., 2001; 
Farache et al., 2013). To investigate whether luminal egg antigen could also 
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induce immune responses we injected eggs into the intestinal lumen and 
compared the induced responses to subserosal egg injections. We observed that, 
in contrast to the subserosal injection, the cluster of eggs was not visible after 
injection nor at the time of MLN harvest. 5 days after immunization MLNs were 
harvested and prepared for in vitro restimulation. After 3 days cytokines were 
measured by ELISA in the supernatants. We observed that both the subserosal 
and luminal injection of eggs induced antigen specific immune responses. The 
amount of detected IFN-γ was comparable. Concentrations of IL-4, IL-5 and IL-13, 
however, appeared somewhat, but not significantly, lower in luminal egg injection 
cell cultures (Fig. 3-3 A). These data suggested that luminal egg injections, despite 
being less relevant in a physiological context, can also induce antigen specific 
immune responses in the MLNs. 
 
Non-viable S. mansoni eggs and the derived soluble egg antigen (SEA) have been 
reported to contain different compositions of antigen, but the immunologically 
relevant antigens, that have so far been identified are present in both preparations 
(Silva-Moraes et al., 2014; Everts et al., 2009). Both eggs and SEA have been 
used to induce Th2 responses in experimental settings (MacDonald et al., 2002; 
Klaver et al., 2015). To compare their effectiveness in our intestinal immunization 
model we injected either non-viable S. mansoni eggs or soluble egg antigen into 
the subserosa. 1,000 non-viable eggs in 20 µl PBS were compared to 20 µg SEA. 
5 days after immunization MLN cells were harvested and 3-day restimulation 
cultures were set up. We observed that the injection of eggs and SEA induced 
very similar immune responses in the MLNs, with very similar amounts of IFN-γ, 
IL-4, IL-5 and IL-13 being detected (Fig. 3-3 B). We hypothesized that SEA 
injections would induce a slightly lower response, due to the soluble and more 
transient character of the antigen, but did not make this observation. Therefore, we 
concluded that the subserosal injection of SEA is, in our hands, as potent in 
inducing antigen specific immune responses in the MLNs as injected eggs. 
 
We had observed that the subserosal injection of eggs induced immune responses 
in the MLNs. Therefore, some immunogenic component of egg antigen needed to 
be transported from the lamina propria to the draining lymph nodes, to be 
presented to naive T cells. To verify this, we compared immune responses 
induced by subserosally injected eggs to the responses induced by eggs that were 
directly injected into the MLN. Hence, we injected 1,000 eggs into the small 
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intestinal subserosa or into the subcapsular sinus of the MLN, as described 
previously (Cerovic et al., 2015). The cluster of eggs in both experiments was 
clearly visible after injection and 5 days after immunization. After 5 days, MLNs 
were harvested and restimulated with SEA for 3 days. We observed that the levels 
of the Th2 associated cytokines IL-4, IL-5 and IL-13 were comparable between the 
two types of injections. However, the amount of IFN-γ was 6-fold higher in MLN-
injected mice compared to subserosally-injected animals (Fig. 3-3 C). The different 
response between subcapsular and subserosal injection suggested that locally 
available antigen was processed in a different way. Presumably, lamina propria 
DCs sampled subserosally injected antigen and migrated to the MLNs in order to 
present it whereas subcapsular egg antigen was likely taken up and presented by 
lymph node resident DCs. 
 
 
 
Figure 3-4. Optimization of experimental egg immunization protocol defines experimental 
parameters 
To optimize our experiments, different parameters of the experimental egg immunization protocol 
were investigated. First, immune responses were compared 5 or 7 days after egg injection, and 
levels of cytokines were measured 3 days after restimulation (A). The restimulated cytokine 
response was also compared between mice that were injected with 500 or 1,000 non-viable eggs 
(B). Using MLNs harvested 5 days after injection, and restimulated for another 3 days, MLN cells 
were restimulated with different amounts of SEA and IFN-γ, IL-4, IL-5 and IL-13 were measured in 
the supernatants (C). Data represent at least three independent experiments (mean ± SEM) with at 
least three animals per group. Mann-Whitney U tests (A&B) or Kruskal-Wallis tests (C) were 
applied for statistical analysis.  
 
 
Up to this point the experimental procedure involved the injection of 1,000 non-
viable eggs, an immunization period of 5 days and restimulation of MLN cells for 3 
days with 7.5 µg/ml SEA. These parameters had been adapted from previous 
publications (MacDonald et al., 2001; MacDonald and Pearce, 2002) and protocols 
available from our collaborator Andrew MacDonald. However, most of the 
available data were based on other tissue injection sites, especially the footpad, 
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and were not optimized for the intestine. The immunization period was one of the 
parameters that required validation. To focus on early immune induction events 
the optimal period of immunization would be the shortest time that robust immune 
responses would develop in the draining lymph nodes. Published data suggested 
a period between 5 and 7 days (MacDonald et al., 2001; MacDonald and Pearce, 
2002). We therefore injected 1,000 non-viable eggs into the small intestinal 
subserosa of two groups of mice. One group was immunized for 5 days, which 
was the immunization period we had used in our previous experiments, the other 
group was immunized for 7 days. MLNs were harvested afterwards and 
restimulated with 7.5 µg/ml SEA for 3 days. The amount of cytokine that was 
produced in these restimulation cultures was almost identical between the two 
groups (Fig. 3-4 A), indicating that both 5 and 7 days were suitable periods to 
induce a robust T cell response against the injected eggs. 
 
Another parameter that was not optimized was the number of injected eggs. Here, 
the lowest number of eggs that induced a robust immune response would be 
preferable, as this would decrease the chances of any unintended off-target 
effects. Furthermore, it would reduce the amount of material needed for each 
experiment. In the footpad the injection of 2,500 eggs had previously been used 
(MacDonald et al., 2001; MacDonald and Pearce, 2002). We had already reduced 
this number to 1,000 eggs for intestinal injections and tested if it could be reduced 
even further. We injected 500 or 1,000 non-viable eggs into the subserosal layer of 
the small intestine, harvested the MLNs after 5 days and restimulated them for an 
additional 3 days with 7.5 µg/ml SEA. We observed that the injection of 500 eggs 
was less consistent compared to 1,000 eggs and that the cluster of injected eggs 
was not visible after injection in all cases. However, the cytokines IFN-γ, IL-4, IL-5 
and IL-13 could all be detected in restimulation cultures after the injection of 500 
eggs, indicating that they induced a comparable immune response (Fig. 3-4 B). 
However, the amount of cytokine was slightly lower and more variable compared 
to the injection of 1,000 eggs, although the differences were not statistically 
significant. On balance, we concluded that the injection of 1,000 eggs was the 
optimal amount for intestinal injection inducing a robust and consistent immune 
response. 
 
The last parameter we optimized was the amount of SEA used during 
restimulation. Again, we aimed for a concentration that would optimally restimulate 
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MLN cells in vitro, while minimizing the amount of material used. Previous 
publications had used 15 µg/ml of SEA during restimulation (MacDonald et al., 
2001; MacDonald and Pearce, 2002). We had already reduced this amount to 7.5 
µg/ml and tested if it could be reduced even further. We injected 1,000 cells into 
the subserosal layer of the small intestine, harvested the MLNs after 5 days and 
restimulated these cells with varying concentrations of SEA ranging from 15 µg/ml 
and 7.5 µg/ml to 3.75 µg/ml. We observed that all three concentrations could 
successfully restimulate T cells in vitro and that similar amounts of cytokines were 
produced (Fig. 3-4 C). It was surprising that the 4-fold lower concentration of SEA, 
compared to the literature, was almost as potent in restimulating T cells as higher 
concentrations. We could however observe that the amount of cytokines produced 
with 3.75 µg/ml SEA was lower compared to 15 µg/ml, suggesting a linear 
relationship between the concentration of SEA used and the amount of cytokines 
detected. However, this difference was not statistically significant. From this 
experiment we concluded that 7.5 µg/ml SEA was the optimal concentration for 
restimulating MLN cells, which produced an equally consistent response as 
published concentrations but reduced the amount of SEA needed for each 
experiment. We had therefore tested important experimental parameters and 
optimized our intestinal egg immunization protocol. 
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3.1.2 T cells responses against egg antigens are primed in the 
MLNs  
 
Figure 3-5. Intestinal egg injection induces classical Th2 immune responses in the draining 
MLNs and not in other lymphoid organs 
Based on our previous findings a standard experimental egg immunization protocol was defined. 
1,000 non-viable S. mansoni eggs were subserosally injected into the intestine. After 5 days of 
immunization lymph nodes were harvested and restimulated with 7.5 µg/ml SEA for 72 hours. 
Released cytokines were then measured in the supernatants by ELISA. The experimental scheme 
is shown in (A). Immune responses were measured in restimulation cultures from inguinal lymph 
nodes (iLNs), MLNs and the spleen (B). Similarly, cytokines were measured in the same tissues 3 
days after restimulation. Here, mice were treated with 1.5 µg FTY720 during day 1 and day 3 of the 
immunization (C). Amounts of IFN-γ, IL-4, IL-5 and IL-13 were measured in MLN restimulation 
cultures of egg injected homozygous KN2 (IL-4-/-) or C57BL/6 mice (D). Data represent at least 
three independent experiments (mean ± SEM) with at least three animals per group. Mann-
Whitney U tests (D) were applied for statistical analysis (*P ≤ 0.05; ***P ≤ 0.001).  
 
 
Based on these results we defined a standard experimental protocol for intestinal 
injections, whereby the subserosal injection of 1,000 eggs with an immunization 
period of five days followed by a 3-day restimulation period with 7.5 µg/ml SEA 
would result in a robust Th2 response in the draining lymph nodes (Fig. 3-5 A). 
Using this standard egg injection protocol we injected 1,000 non-viable eggs 
subserosally into the small intestine and harvested inguinal lymph nodes (iLN), 
mesenteric lymph nodes (MLN) and the spleen after 5 days. Cell suspensions 
were restimulated with 7.5 µg/ml SEA for 3 days and immune responses 
characterized by measuring the cytokines released in the supernatants of these 
cultures. We hypothesized that immune responses should only occur in the MLNs, 
and not the iLNs or the spleen, as the MLNs were the only tissue directly draining 
the injection site. As expected we could detect IFN-γ, IL-4, IL-5 and IL-13 in the 
supernatants of MLN restimulation cultures at levels comparable to those 
measured in previous experiments. As expected, we could not detect any 
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cytokines in restimulation cultures of iLN cells, but observed robust cytokine 
responses in spleen restimulation cultures. Here, the level of IFN-γ responses 
were higher and Th2 cytokines lower compared to the MLNs, but Th2 cytokines 
were clearly detectable suggesting the presence of primed Th2 cells in the spleen 
(Fig. 3-5 B).  
 
To address whether antigen was directly transported to the spleen or if 
recirculating primed T cells were responding to in vitro restimulation we combined 
intestinal egg injections with the administration of FTY720. This molecule inhibits 
the egress and recirculation of T cells from lymph nodes (Brinkmann et al., 2004), 
and would therefore clarify if splenic immune responses were due to the 
recirculation of T cells or direct priming in the spleen itself. During the 5 day 
immunization period 1.5 µg FTY720 in 30 µl DMSO was injected i.p. on days 1 
and 3. MLNs, iLNs and spleens were harvested on day 5 and restimulated with 
SEA. We could not detect any cytokines produced by iLN or spleen cells in the 
supernatants of these cultures. Furthermore, we observed that the level of IFN-γ, 
IL-4, IL-5 and IL-13 responses from MLN cells had all increased up to 3-fold, 
compared to non-treated egg injections (Fig. 3-5 C). These results clearly 
indicated that the responses observed in the spleen were due to recirculating T 
cells that had been primed in the MLNs and not directly primed in the spleen. By 
blocking the egress of these primed cells by administrating FTY720, primed T cells 
accumulated in the MLNs, which increased the observed immune responses. 
 
These immune responses are controlled by key cytokines. IFN-γ is involved in 
many proinflammatory conditions, whereas IL-4 is a key cytokine of the type 2 
immune response and is produced by Th2 cells. It is an important signalling 
molecule and affects other effector cells such as B cells, but more importantly is 
required for the differentiation of naive T cells into Th2 cells. It also has an impact 
on other T helper cells and limits the development of Th1 cells and the production 
of IFN-γ (Constant and Bottomly, 1997). Thus, in the absence of IL-4 or its 
receptor IL-4R, Th2 responses are inhibited (Jankovic et al., 2000). To verify that 
the immune responses we observed upon egg injections into the intestine were 
indeed driving an IL-4 dependent Th2 response we used homozygous KN2 mice 
(IL-4-/-), which did not express functional IL-4 (Mohrs et al., 2005). 5 days after 
injection MLNs were harvested and immune responses were quantified by 
measuring the cytokines IFN-γ, IL-4, IL-5 and IL-13 in supernatants 3 days after 
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restimulation with SEA. We could only detect minute levels of the Th2 associated 
cytokines IL-4, IL-5 and IL-13 in the supernatants of IL-4-/- mice, which were at 
least 10-fold lower than the responses observed in C57BL/6 mice. Furthermore, 
IFN-γ was present at increased amounts, with levels 4-fold higher than observed 
in C57BL/6 MLN cell cultures (Fig. 3-5 D). These observations indicated that the 
injection of S. mansoni eggs in the intestine induced a genuine Th2 response in 
the draining lymph nodes, which produced IL-4, IL-5 and IL-13 and could not 
develop in IL-4 deficient mice. As Th2 cells also actively control and inhibit Th1 
responses (Pearce et al., 1991), the absence of these cells in IL-4-/- mice, led to an 
increase in IFN-γ levels.  
 
3.1.3 CD4 T cells secrete cytokines detected in restimulation 
cultures 
 
 
Figure 3-6. Heterozygous KN2 mice report IL-4 secretion of CD4 T cells in the MLNs of egg 
injected mice 
Cells were harvested from heterozygous KN2 mice and stained for flow cytometry. Live CD4+ cells 
were selected and the expression of huCD2, which reports IL-4 secretion in KN2 mice, measured 
in MLN cells from naive mice and iLN and MLN cells from egg injected mice (A). Six mice were 
analysed in total and the percentage of huCD2/IL-4+ CD4 T cells presented in B. Data represent 
two independent experiments (mean ± SEM) with each point representing one animal. Kruskal-
Wallis tests (B) were applied for statistical analysis (**P ≤ 0.01).  
 
 
To confirm that the type 2 cytokines we measured in MLN restimulation cultures 
were indeed secreted by CD4+ Th2 cells we again used the KN2 mouse strain, 
which can also be used to detect cell-specific IL-4 secretion using flow cytometry. 
In this mouse strain the first two exons of IL-4 are replaced by human CD2 
(huCD2) (Mohrs et al., 2005). Upon expression and secretion of IL-4 the reporter 
gene huCD2 is produced instead and expressed as a cell surface marker, which 
can be detected with a monoclonal antibody. Therefore, cells that were actively 
na
ive
 M
LN iLNML
N
0.0
0.5
1.0
1.5
2.0
2.5
hu
C
D
2/
IL
-4
+ 
(%
) **
A naive MLN 
CD4 
hu
C
D
2/
IL
-4
 
egg inj iLN egg inj MLN B 
	   76 
secreting IL-4 label positive for huCD2, which allows a precise understanding of 
active Th2 responses. In heterozygous KN2 mice one allele serves as the huCD2 
reporter allele, while the wild type allele ensures normal IL-4 production. 
Heterozygous mice have been reported to not have any IL-4-related defects, 
whereas homozygous mice do not produce any functional IL-4 and are effectively 
IL-4 deficient (Mohrs et al., 2005). 
 
To study cellular IL-4 secretion, we injected heterozygous KN2 mice with S. 
mansoni eggs following our standard egg injection protocol and harvested inguinal 
lymph nodes and MLNs from egg injected and naive mice five days after 
immunization. Instead of restimulating these cells with SEA we stained the cell 
suspensions with monoclonal fluorescently labelled anti-CD4 and anti-huCD2 
antibodies and used a viability dye to exclude dead cells from analysis. By gating 
on live CD4+ cells, we selected all CD4 T cells and assessed their secretion of IL-4 
by detecting the expression of huCD2 (Fig. 3-6 A). Flow cytometric analysis 
revealed that no huCD2 expressing cells could be detected in naive MLNs or 
inguinal LNs of egg injected mice. However, in the MLNs of egg injected animals 
CD4+ cells were the only cells that expressed huCD2. 1.5% of all CD4+ T cell 
expressed huCD2, indicating that a substantial number of CD4 T cells secreted IL-
4 and had differentiated into Th2 cells after egg injection (Fig. 3-6 B). These 
observations were in line with our previous findings using restimulation cultures 
and confirmed that T cells are only primed upon egg injection in the draining lymph 
nodes, where they differentiate into IFN-γ-producing cells and IL-4-secreting Th2 
cells. 
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Figure 3-7. Different cell stimulation protocols promote differences in IL-4 secretion of CD4 
T cells of egg injected heterozygous KN2 mice. 
MLN cells were harvested from heterozygous KN2 mice 5 days after egg injection. Cells were 
subjected to different cell stimulation protocols or stained directly for flow cytometry. Cell 
stimulations included 2.5 ng/ml PMA and 1 µg/ml ionomycin for 4 hours (4h PMA), 5 µg/ml plate-
bound anti-CD3 and 2 µg/ml soluble anti-CD28 overnight (o/n aCD3) or 18 hours (o/n SEA) or 72 
hours (3d SEA) of restimulation with 7.5 µg/ml SEA. CD4+ T cells were selected from all live cells 
and their secretion of IL-4 measured by the detection of the reporting surface marker huCD2 (A). 
Two independent experiments were performed and data was pooled and presented as the 
percentage of huCD2+ CD4 T cells in panel B. Data represent two independent experiments (mean 
± SEM) with each point representing a data point from an individual animal. 
 
 
Having established that heterozygous KN2 mice could be used to monitor active 
IL-4 secretion by Th2 cells we used this method to compare different in vitro cell 
stimulation protocols to assess whether IL-4 secretion would differ between 
antigen specific and non-specific restimulation. We injected 1,000 non-viable eggs 
into the subserosal layer of the small intestine of heterozygous KN2 mice, 
harvested the MLNs after five days and subjected them to different in vitro cell 
stimulation and restimulation protocols. One group was treated with 2.5 ng/ml 
PMA and 1 µg/ml ionomycin for 4 hours, a common method used for intracellular 
flow cytometry staining. Another group was stimulated with 5 µg/ml plate-bound 
anti-CD3 and 2 µg/ml soluble anti-CD28 overnight. PMA/ionomycin and anti-
CD3/anti-CD28 stimulation are both antigen non-specific ways to stimulate T cells 
and have extensively been used in the literature. These stimulation methods were 
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compared to freshly isolated cells, overnight restimulation with 7.5 µg/ml SEA and 
3 day restimulation with 7.5 µg/ml SEA. After each treatment cells were stained 
with fluorescently labelled anti-CD4 and anti-huCD2 antibodies and a viability dye 
was used to exclude dead cells from analysis. Cells survival was comparable 
between the different in vitro restimulation protocols and live CD4+ T cells were 
assessed for their secretion of IL-4 by measuring the expression of huCD2 (Fig. 3-
7 A). All in vitro stimulation protocols, excluding overnight restimulation with SEA, 
induced increased frequencies of IL-4 secreting Th2 cells, compared to the freshly 
isolated control group (Fig. 3-7 B). Comparable amounts of IL-4 secreting T cells 
between antigen specific restimulation with SEA and non-specific stimulation with 
PMA/ionomycin or anti-CD3/anti-CD28 showed that both methods were sufficient 
to stimulate and detect Th2 cells primed after egg injection.  
 
 
 
Figure 3-8. Stimulated CD44hi CD4 T cells from the MLN express GATA3 and produce IL-4 
and IL-13 after egg injection 
MLN cells from uninjected (un inj) and egg injected (egg inj) C57BL/6 mice were harvested after 5 
days of immunization and stimulated with 2.5 ng/ml PMA, 1 µg/ml ionomycin and 0.5% GolgiStop 
for 4 hours. Cells were then stained for cell surface markers, fixed and permeabilized and stained 
intracellularly. Live cells were selected and CD44hi CD4 T cells were analysed for their expression 
of GATA3 or the production of cytokines (A). Percentages of CD44hi CD4 T cells were compared 
between naive and egg injected animals (B). The expression of GATA3 (C) and the production of 
IFN-γ, IL-4, IL-5 (D) by CD44hi CD4 T cells from naive and egg injected mice was measured. Data 
represent at least two independent experiments (mean ± SEM) with each point representing one 
animal. Mann-Whitney U tests were applied for statistical analysis (**P ≤ 0.01; ***P ≤ 0.001).  
 
 
We assumed that the IFN-γ we had detected in in vitro restimulation cultures was 
produced by Th1 cells, whereas IL-4, IL-5 and IL-13 were produced by Th2 cells. 
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However, we had not identified the cellular source of these cytokines, except for 
IL-4, which was exclusively secreted by CD4 T cells after egg injection.  Having 
established that cell stimulation with PMA/ionomycin was sufficient to optimally 
stimulate heterozygous KN2 cells, we hypothesized that this stimulation would 
also be sufficient to detect other cytokines by flow cytometry. 
 
We injected eggs into the serosa of the small intestine, harvested the MLNs after 5 
days and stimulated MLN cell suspensions from naive and egg injected mice with 
2.5 ng/ml PMA and 1 µg/ml ionomycin for 4 hours. In addition, we added 0.5% 
GolgiStop solution, which prevents cytokine secretion and allows the intracellular 
detection of the produced cytokines. After stimulation we stained the cells with 
Fixable Viability Dye eFluor780 and fluorescently labelled antibodies against the 
cell surface markers CD4, CD8 and CD44. Cells were fixed and permeabilized 
using the eBioscience Foxp3/Transcription Factor Staining Buffer Set and stained 
for the intracellular cytokines IFN-γ, IL-4 and IL-13 and the Th2 associated 
transcription factor GATA3 (Amsen et al., 2004). Cells were gated on live CD44hi 
CD4 T cells, that represented activated T cells, and we assessed the percentage 
of cytokine expressing cells (Fig. 3-8 A). We observed a significant increase of 
CD44hi cells in egg-injected mice compared to naive controls (Fig. 3-8 B), which 
demonstrated that naive T cells had been primed and activated after egg injection. 
In naive animals the percentage of GATA3 expressing cells was negligible, 
whereas upon egg injection around 12% of activated T cells expressed GATA3 
(Fig. 3-8 C). This indicated that no activated Th2 cells were present in naive 
animals but were specifically induced upon egg injection, which was consistent 
with our results from in vitro restimulation cultures. We also observed a strong 
increase of IL-4 and IL-13 producing T cells after egg injection along with a slight 
increase of IFN-γ+ cells (Fig. 3-8 D). IFN-γ+ cells did not co-express IL-4 or IL-13, 
whereas IL-4 and IL-13 were produced by overlapping cell populations. This 
indicated that in response to egg antigens IFN-γ-producing cells as well as Th2 
cells were induced.  
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3.1.4 Injections of S. mansoni eggs into different segments of the 
murine intestine induce immune responses in specific MLNs 
 
 
Figure 3-9. Anatomical segments of the murine gastrointestinal tract 
The small intestine, caecum and colon are drained by individual MLNs. These were identified as 
sMLN1-3 and cMLN1/2. Anatomical segments of the small intestine included the duodenum, 
jejunum and ileum, whereas the colon was divided into the ascending, transverse and descending 
colon (not shown). 
 
 
Having confirmed that small intestinal S. mansoni egg injections are a suitable 
model to induce Th2 responses in the draining lymph nodes, we tested whether 
the injection of S. mansoni eggs would also result in Th2 responses in other 
segments of the gastrointestinal tract.  
The small intestine and colon have evolved as separate organs, with a distinct 
anatomy, that serves physiologically distinct functions such as nutrient uptake and 
water resorption, harbour distinct populations of microbiota, have evolved distinct 
immune systems and can be affected by distinct pathologies including parasites 
that either populate the small intestine or colon  
(Mowat and Agace, 2014; Grencis, 2015). Both organs drain into anatomically 
separate MLNs: the small intestinal sMLNs and colon draining cMLNs (Houston et 
al., 2016). The sMLNs can further be divided into at least three easily 
distinguishable lymph nodes that are arranged in a chain (Fig. 3-9). We have here 
termed these separate lymph nodes sMLN1, 2 and 3. We had not previously 
tested whether these individual sMLNs also drain anatomically distinct segments 
of the small intestine, which can further be subdivided into the duodenum, jejunum 
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and ileum. The small intestine is followed by the caecum and the ascending, 
transverse and descending colon, which are drained by the colon draining lymph 
nodes cMLN1 and cMLN2 and other lymph nodes distributed within the body 
cavity (Carter and Collins, 1974). 
 
 
 
Figure 3-10. Distinct anatomical segments of the small intestine are drained by individual 
sMLNs 
The duodenum (A), jejunum (B) and ileum (C) were injected with 1,000 S. mansoni eggs. The 
approximate injection site is marked with an arrow. FTY720 was administered at days 1 and 3. 
Individual MLNs were harvested 5 days after immunization and restimulated for 3 days with SEA. 
Cytokine responses were measured in each individual lymph node and responding lymph nodes 
highlighted in each corresponding schematic. Data represent at least two independent experiments 
(mean ± SEM) with at least three animals per group. 
 
 
In order to understand whether different segments of the gastrointestinal tract 
could mount similar immune responses against injected S. mansoni eggs, eggs 
were injected in different parts of the small intestine and colon. We predicted that 
these responses would develop in distinct MLNs that selectively drained specific 
anatomical segments of the intestine. Therefore, all mesenteric lymph nodes were 
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harvested individually 5 days after egg injection and restimulated with SEA for 
another 3 days. During immunization FTY720 was administered at day 1 and day 
3 to prevent T cell egress and recirculation. This guaranteed that the detected 
cytokines were generated by T cells primed in the harvested draining lymph node, 
and not by recirculating T cells that had originally been primed at another site. By 
analysing the produced cytokines in restimulation cultures of all the individual 
MLNs we were able to identify which draining lymph nodes responded and thus 
drained the injected segment of the intestine. In general we observed that egg 
injections into all segments of the intestine generated antigen-specific immune 
responses against injected eggs, and that these immune responses developed in 
distinct draining lymph nodes. In particular, egg injections in the duodenum 
resulted in strong responses in sMLN3 and to a smaller extent in sMLN2 (Fig. 3-10 
A). The jejunum was drained by sMLN1 and sMLN2, where we detected the 
cytokines IFN-γ, IL-4, IL-5 and IL-13 (Fig. 3-10 B) and injections in the ileum 
resulted in T cells responses predominantly in the lymph node sMLN1 (Fig. 3-10 
C). All injections in different segments of the small intestine induced comparable 
levels of Th2 responses measured by the amount of cytokines released during 
restimulation and we concluded that the anatomical segments of the small 
intestine were drained by individual small intestinal draining lymph nodes. In 
particular, the duodenum was drained by sMLN3, the jejunum drained into 
sMLN1/2 and the ileum was drained by sMLN1. 
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Figure 3-11. Egg injection into the colon induced immune responses in the cMLNs 
1,000 non-viable S. mansoni eggs were injected into the ascending (A) and transverse (B) colon. 
The approximate injection site is marked with an arrow. FTY720 was administered at days 1 and 3. 
Individual MLNs were harvested 5 days after immunization and restimulated for 3 days with SEA. 
Cytokine responses were measured in each individual lymph node and responding lymph nodes 
highlighted in each corresponding schematic. Data represent at least two independent experiments 
(mean ± SEM) with at least three animals per group. 
 
 
Similarly, eggs were injected into different parts of the colon. The descending 
colon was excluded from further analysis, as it was not accessible during the 
surgical procedure used for egg injection. 1,000 non-viable eggs were injected into 
the ascending or transverse colon and FTY720 was administered at day 1 and day 
3. After 5 days individual MLNs were harvested and restimulated with SEA for 3 
days and immune responses were detected by measuring the released cytokines 
in the supernatants. Egg injections in the ascending colon resulted in immune 
responses in cMLN1 (Fig. 3-11 A). The levels of IFN-γ, IL-4, IL-5 and IL-13 were 
slightly lower compared to values measured upon small intestinal injection. 
However, they indicated that S. mansoni eggs could not only induce robust T cell 
responses in the small intestine but also in the colon. Cytokines were also 
detected in cMLN1 and cMLN2 upon transverse colon egg injection, however to a 
much lower extend (Fig. 3-11 B). We hypothesize that these low responses were 
due to inappropriate egg injections in the transverse colon and did not represent 
tissue-specific deficiencies in T cell priming. 
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We thus concluded that S. mansoni egg injections also represented a suitable 
model to induce parasite-specific Th2 immune responses in the colon, which was 
drained by specific cMLNs.  
 
 
Figure 3-12. Egg injections into the ileum induce immune responses in sMLN1 whereas 
immune responses against egg injections into the ascending colon develop in cMLN1 
1,000 non-viable eggs were injected into the ileum (A) or the ascending colon (B). 5 days after 
immunization the lymph nodes sMLN1 and cMLN1 were harvested and restimulated with SEA for 3 
days. IFN-γ, IL-4, IL-5 and IL-13 were measured in the supernatants of these restimulation 
cultures. Data represent at least three independent experiments (mean ± SEM) with at least three 
animals per group. Mann-Whitney U tests were applied for statistical analysis (*P ≤ 0.05; **P ≤ 
0.01; ***P ≤ 0.001).  
 
 
Having established that distinct anatomical segments of the intestine were drained 
by specific individual lymph nodes we repeated this experiment without the 
administration of FTY720. We had previously observed that five days after 
immunization recirculating T cells had not yet migrated to other lymph nodes, like 
the iLNs, suggesting that recirculation to other lymph nodes is unlikely within that 
time. To compare small intestinal and colonic immune responses we chose 
representative regions of each tissue that were readily accessible during surgery 
and were physiologically relevant. The ileum of the small intestine is heavily 
affected by penetrating S. mansoni eggs during live infection (Pearce and 
MacDonald, 2002), and was thus chosen to represent the small intestine in this 
and further experiments. The ascending colon was the only region of the colon 
that was readily accessible during surgery and mounted robust immune responses 
against injected eggs. Hence, it was chosen as the injection site for the colon. 5 
days after egg injection in the ileum or the ascending colon individual MLNs were 
harvested. Previous experiments indicated that the ileum was predominantly 
drained by sMLN1 and the ascending colon by cMLN1. Therefore, only these two 
lymph nodes were collected. After a 3-day restimulation with SEA, supernatants 
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were assessed for secreted cytokines by ELISA. We observed that the responses 
were comparable to our previous findings, where we had administered FTY720. 
This was consistent with our hypothesis that recirculation of T cells into other 
lymph nodes does not occur within the 5 days of immunization. After egg injection 
into the ileum high levels of IFN-γ, IL-4, IL-5 and IL-13 were detected in sMLN1, 
with only minor concentrations detectable in cMLN1 (Fig. 3-12 A). Conversely, egg 
injections in the ascending colon predominantly induced immune responses in 
cMLN1 and not in sMLN1 (Fig. 3-12 B). Thus, our observations clearly indicated 
that parasite antigen could induce strong Th2 responses both in the small intestine 
and the colon, which are each drained by specific MLNs, and that S. mansoni egg 
injections are a suitable model to study the cellular mechanisms driving Th2 
responses in both organs. 
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3.2 Discussion 
 
We have established a novel and physiologically relevant method of S. mansoni 
egg immunization in the intestine. This method of injecting non-viable eggs into the 
subserosal layer of the small intestine and colon will allow us to specifically 
investigate the immune responses mounted against parasite antigens in the 
intestine and study their induction. The induction of Th2 responses from the 
intestine has been largely overlooked despite the facts that S. mansoni eggs 
predominately affect the small intestine during live infections, and that most 
parasites invade the gastrointestinal tract (Grencis et al., 2014). We have shown 
that eggs induced strong antigen specific immune responses in the draining lymph 
nodes, where in vitro restimulated MLN cells secreted IFN-γ, IL-4, IL-5 and IL-13, 
which are commonly induced by S. mansoni eggs (MacDonald and Pearce, 2002; 
MacDonald and Maizels, 2008; Cook et al., 2015) (Fig. 3-2). 
 
In live infections of S. mansoni, eggs penetrate the small intestinal wall to reach 
the intestinal lumen. Some of these eggs become lodged within the intestine, 
where they induce strong immune responses, lead to granuloma formation and 
drive the pathology of schistosomiasis (Wilson et al., 2007). Most eggs however 
reach the intestinal lumen and are excreted and we observed that injections of 
eggs into the small intestinal lumen could also induce similar immune responses 
compared to injections into the intestinal subserosa. This suggested that antigen 
from luminally-injected eggs were detected by the immune system and induced 
antigen specific immune responses in the MLNs. Reported mechanisms by which 
lamina propria immune cells sample luminal antigen include dendritic cells that 
extend their dendrites into the intestinal lumen or the transport of soluble antigen 
across the epithelium into the lamina propria (Farache et al., 2013). However, 
uptake of luminal antigen is not an efficient process and mostly involves 
professional phagocytes such as macrophages or M cells located in the Peyer’s 
patches. Furthermore, limited antigen availability and its more transient presence, 
due to the continuous movement of luminal content, reduce antigen uptake from 
the lumen (Mowat and Agace, 2014). Surprisingly, we observed few differences of 
the induced immune responses from luminal egg injections compared to 
subserosal injections (Fig. 3-3 A). However, it needs to taken into account that 
during the injection into the lumen the intestinal tissue was penetrated and the 
epithelium damaged, which might have facilitated the entry of egg antigen into the 
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lamina propria. Thus, our luminal injection of eggs more closely resemble eggs 
that penetrate the intestine and reach the lumen, creating tissue damage along the 
way, and is less representative of the uptake of luminal antigen by intact intestinal 
tissue. We therefore chose to continue our experiments using the subserosal 
injection of antigen as we considered it likely that this would generate more robust 
and consistent immune responses. Subserosal injections also better represent 
trapped eggs within the intestinal subserosal tissue, where they elicit type 2 
immune responses during live infection, lead to granuloma formation and cause 
fibrotic lesions, which are all key features of chronic schistosomiasis (Wynn et al., 
2004).  
 
Interestingly, we observed that the injection of eggs in other tissues, such as the 
MLN, caused higher proinflammatory responses, measured by the amount of IFN-
γ produced after restimulation, whereas Th2 responses were comparable (Fig. 3-3 
C). Our interpretation of these results was that after subserosal injection lamina 
propria DCs sampled egg antigens and migrated to the MLNs in order to present 
them to and prime naive T cells. In the experiments that follow, we have indeed 
shown that migrating DCs take up subserosally injected egg antigen and transport 
it to the draining lymph nodes, where they induce immune responses. Contrarily, 
egg antigen that was injected under the MLN subcapsule was likely taken up and 
presented by lymph node resident DCs. Our observation that type 1 immune 
responses were significantly increased when eggs were directly injected into the 
MLN suggests that an inhibiting factor, that specifically inhibits proinflammatory 
responses, was not present in the MLNs. Indeed a tolerogenic environment exists 
within the intestinal lamina propria, which dampens intestinal proinflammatory 
immune responses, through the presence of regulatory T cells, the production of 
IL-10 and tolerogenic macrophages (Mowat and Agace, 2014). This allows the 
intestinal immune system to tolerate harmless proinflammatory stimuli from the 
microbiota and food antigens, and can also affect immune responses to inert 
antigens, e.g. during oral tolerance. We suggest that proinflammatory responses 
against egg antigens were also suppressed within the intestinal microenvironment. 
However, as we did not observe a downregulated response of type 2 immune 
responses, we suggest that they are not inhibited by this tolerogenic environment. 
This could ensure that intestinal parasite infections prompt an immediate reaction 
and induce potent Th2 responses.  
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We also observed that the injection of eggs into the intestine induced antigen 
specific immune responses in the draining lymph nodes and the spleen but not the 
inguinal draining lymph nodes (iLNs) (Fig. 3-5 B). This was surprising as the 
spleen does not directly drain the intestines but rather responds to systemic 
infections. During live infection of S. mansoni Th2 immune responses can be 
detected in locally affected organs such as the liver as well as systemically in the 
spleen (Dunne and Pearce, 1999). However, it has been reported in the house 
dust mite model of Th2 induction in the lung that bona fide immune responses 
both develop in lung draining lymph nodes and in the spleen. It was identified that 
this is due to the destruction of the lung epithelial barrier during infection, antigen 
transport in blood and priming of naive T cells against these antigens in the 
spleen. Thus, the administration of FTY720, which inhibits the egress and 
recirculation of T cells from lymph nodes (Brinkmann et al., 2004), did not affect 
splenic immune responses in this model (Plantinga et al., 2013).  
In contrast, in our intestinal egg injection model splenic responses were no longer 
detectable after FTY720 administration, indicating that they were due to 
recirculating T cells (Fig. 3-5 C). A possible explanation why we did not observe 
recirculating T cells responses in the iLNs might be the low number of primed 
recirculating Th2 cells in the iLNs, which could have been under the detection limit 
of in vitro restimulation iLN cultures. Using heterozygous KN2 mice, which report 
IL-4 secretion, we indeed showed that only around 0.1% of CD4 T cells secreted 
IL-4 after subserosal egg injection in the iLNs, whereas around 1.3% secreted IL-4 
in the MLNs (Fig. 3-6).  
 
When using different in vitro T cell stimulation protocols to stimulate MLN cells 
from egg injected mice we observed that more huCD2 expressing cells were 
detected after PMA/ionomycin and anti-CD3/anti-CD28 stimulation, compared to 
the freshly isolated control group (Fig. 3-7 B). This increase indicated that these 
stimulation protocols induced active secretion of IL-4 in more cells compared to 
the non-treated controls, suggesting that not all Th2 cells that were primed actively 
secreted IL-4 after being freshly isolated. Furthermore, we observed that overnight 
restimulation with SEA was not sufficient to induce IL-4 secretion, as only a low 
percentage of cells responded. However, three days of restimulation induced a 
high percentage of IL-4 secreting CD4+ T cells, which was comparable to the 
percentages observed with PMA/ionomycin and anti-CD3/CD28 stimulation. As 
SEA is a complex antigen that first needs to be processed by antigen presenting 
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cells and does not directly have an impact on T cells (Cervi et al., 2004), it was of 
no surprise that the overnight restimulation with SEA was ineffective. Thus, 
antigen specific restimulation by SEA and non-specific stimulation with 
PMA/ionomycin or anti-CD3/anti-CD28 were suitable to stimulate Th2 cells primed 
after egg injection in vitro.  
Similarly we observed that 12% of activated CD44hi CD4 T cells expressed 
GATA3 after egg injection and PMA/ionomycin stimulation but only half of these 
cells (6% of activated CD44hi CD4 T cells) actively produced IL-4 and IL-13 (Fig. 
3-8). This suggested that not all Th2-committed cells actively secreted IL-4 and IL-
13, which we had observed in our IL-4 reporter mice. IFN-γ was not co-expressed 
with any of these Th2-associated markers suggesting that they were produced by 
separate Th1 cells. In contrast to the Th2 markers, IFN-γ secretion could already 
be detected in naive animals and only increased slightly after egg injection. Most 
likely PMA/ionomycin stimulation was sufficient to induce IFN-γ secretion in 
activated T cells that were already primed against other antigens, and the slight 
increase of IFN-γ after egg injection represented Th1 cells that were specifically 
primed against egg antigen. This would correspond to our findings that in MLN 
restimulation cultures IFN-γ, IL-4, IL-5 and IL-13 were all secreted in an antigen 
dependent manner. 
 
We observed that specific anatomical segments of the gastrointestinal tract were 
drained by individual lymph nodes. Compared to previous experiments, where the 
entire MLN chain was harvested after egg injection, the concentration of IFN-γ, IL-
4, IL-5 and IL-13 were increased in restimulation cultures of individually harvested 
lymph nodes (Fig. 3-10). This suggested that harvesting the entire MLN chain led 
to a dilution of primed T cells that were only present in an individual lymph node, 
reducing the restimulation response. However, we observed that injections into the 
colon resulted in more variable responses. Due to the arrangement of the 
intestines during egg injection surgery the descending colon could not be 
adequately reached. Furthermore, immune responses after egg injection in the 
transverse colon were much lower compared to those measured after injection into 
the ascending colon (Fig. 3-11). This relatively inadequate induction was most 
likely due to difficulties in accessing the transverse colon during egg injection. 
During the surgical procedure we observed that the correct placement of the 
needle into the subserosal tissue of the transverse colon was obstructed by 
surrounding tissue and that the cluster of eggs was not visible after injection. 
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Furthermore, Carter et al. demonstrated that the transverse colon is also drained 
by the pancreatic nodes, which were not harvested in these experiments (Carter 
and Collins, 1974).  
 
We furthermore observed that the immune responses after colonic egg injections 
generated lower cytokine concentrations than those in the small intestine, 
suggesting that organ specific differences might exist (Fig. 3-12). A possible 
explanation is the different anatomical architecture of the colon. The thicker 
muscle layer might hinder immune cells to reach and take up injected egg 
antigens. It has also been reported that fewer DCs are present in the colonic 
lamina propria and the draining lymph nodes (Denning et al., 2011; Houston et al., 
2016), which would reduce the number of migratory antigen presenting cells and 
might affect the immune response they induce in the colonic draining lymph 
nodes.  
 
In general, we have demonstrated that different anatomical segments of the small 
intestine and colon were drained by individual lymph nodes, which were part of the 
MLN chain. This confirmed early findings by Carter et al. that an anatomical 
drainage network connects particular segments of the gastrointestinal tract to 
individual lymph nodes (Carter and Collins, 1974). To our knowledge we are the 
first to show that this network is important to drive appropriate immune responses 
and enables the intestine to mount fast and effective immune responses to local 
stimuli. Several G protein coupled receptors encoding CC-Chemokine ligands and 
receptors have been identified to influence T cell homing to the small intestine or 
colon (Habtezion et al., 2016). However, it remains to be determined whether T 
cell homing also occurs to individual segments within the small intestine and colon 
or if generally recruited effector T cells locally expand at the affected area. 
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3.3 Conclusions 
 
We have established that S. mansoni egg injections into the intestine induce 
strong immune responses in the draining lymph nodes. Subserosal injection of 
eggs into the intestine thus serve as a model system that represents eggs that 
penetrated the intestine and became trapped within the lamina propria, leading to 
granuloma formation during live infection. Upon egg injection, IFN-γ, IL-4, IL-5 and 
IL-13 were produced in the draining lymph nodes. IL-4, IL-5 and IL-13 were hereby 
released by GATA3-expressing CD4 T cells that have differentiated into Th2 cells, 
recognizing egg antigens. Hereby, T cell priming occurred directly in the 
mesenteric lymph nodes and not in other lymphoid tissues, indicating the likely 
involvement of migratory antigen presenting cells that transport and present egg 
antigens in the MLNs.  
Immune responses also developed after egg injection in the colon, specifically in 
the colon draining cMLNs. Further analysis revealed that different anatomical 
segments of the small intestine and colon were drained by individual lymph nodes, 
which were part of the MLN chain. These findings confirm the presence of an 
anatomical drainage network that connects segments of the gastrointestinal tract 
to individual lymph nodes. Thus, intestinal S. mansoni egg injections provide a 
novel model system to examine the cellular mechanisms that are required to 
induce Th2 responses in the intestine, and investigate whether different 
mechanisms exist in the small intestine and colon.  
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Chapter 4: IRF4+ dendritic cells are required for the 
induction of an effective Th2 response 
 
4.1 Results 
 
Th2 responses are involved in many pathologies such as allergies and parasitic 
infections and different studies have shown the involvement of multiple cell types 
that can induce or maintain these responses. Both non-conventional antigen 
presenting cells, including basophils (Yoshimoto, 2010) and monocyte derived 
inflammatory dendritic cells (Plantinga et al., 2013), as well as conventional 
dendritic cells (DCs) (Connor et al., 2014; Phythian-Adams et al., 2010) have all 
been shown to play roles, either in the induction, maintenance or restimulation of 
the Th2 response. As we had concluded from our previous experiments that 
antigen is transported from the lamina propria to the MLNs, where antigen specific 
T cell responses were initiated, we hypothesized that conventional dendritic cells 
were involved. Intestinal DCs migrate through the lymphatics to the draining 
mesenteric lymph nodes (Cerovic et al., 2013), where they can prime naive T 
cells. In the small intestine and colon four different subsets of conventional 
dendritic cells can be identified by their differential expression of the integrins 
CD11b and CD103 (Persson et al., 2013a). These subsets are present at different 
frequencies in the small intestine and colon (Denning et al., 2011; Houston et al., 
2016). Specific intestinal DC subsets are specialized to induce different facets of 
the T cell response. As such, CD103+ DCs are able to cross present antigen to 
CD8+ T cells and drive proinflammatory responses (Cerovic et al., 2015).  CD11b+ 
CD103+ DCs are involved in the induction of Th17 responses (Persson et al., 
2013b) and we reasoned that a specific DC population might also be specialized 
to promote Th2 responses in the intestine.  
The development of both CD11b+ CD103- and CD11b+CD103+ DC subsets is 
controlled by the transcription factor IRF4 (Guilliams et al., 2014) as well as local 
stimuli (Yokota-Nakatsuma et al., 2014). Recent studies have indeed shown that 
IRF4+ dendritic cells are necessary for the induction of Th2 responses in the lung 
and skin (Gao et al., 2013; Williams et al., 2013). However, this has not been 
demonstrated in the gastrointestinal tract, where most parasitic Th2 responses 
occur.  
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The use of the IRF4f/f CD11c-cre mouse model allows the targeted deletion of 
IRF4 in CD11c-expressing cells, which include dendritic cells and macrophages. It 
has been observed that the frequency of CD11b+ CD103+ DCs is reduced in the 
small intestine of IRF4f/f CD11c-cre-positive mice (Persson et al., 2013b) but it 
remains unclear whether reduced cell numbers or a functional defect caused by 
IRF4 deletion, would impact Th2 immune responses in the intestine. We therefore 
addressed whether IRF4-deficiency in DCs impaired the induction of intestinal Th2 
responses, and whether specific IRF4-expressing DC subsets in the small 
intestine and colon were developmentally or functionally affected. 
 
4.1.1 IRF4f/f CD11c-cre bone marrow chimeras can be used to 
investigate the effects of IRF4 deficiency on dendritic cells 
 
 
Figure 4-1. Antigen presenting cells are fully reconstituted by IRF4f/f CD11c-cre-positive or 
IRF4f/f cre-negative cells in bone marrow chimeras 
Cell chimerism was assessed in IRF4f/f CD11c-cre-positive or IRF4f/f cre-negative bone marrow 
chimeras in blood 3 weeks after bone marrow reconstitution. The percentage of CD45.2+ donor 
cells was measured in B220+ B cells, Ly6C+ monocytes and CD3+ T cells by flow cytometry (A) and 
compared between cre+ and cre- mice (B). 6 weeks after reconstitution tissue cells were 
harvested. In the small intestinal lamina propria antigen presenting cells were defined as MHCII+ 
CD11c+ cells that could further be divided into CD64-expressing macrophages and CD11chi 
dendritic cells (DCs) (C). The percentage of reconstituted donor cells was again compared 
between cre+ and cre- mice (D). Data are representative of five independent experiments. 
 
 
To address the question whether IRF4-deficiency in DCs impaired the induction of 
intestinal Th2 responses we generated IRF4f/f CD11c-cre-positive and IRF4f/f cre-
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collaborators Dr. Marcus Svensson-Frej and Prof. William Agace from the 
University of Lund, Sweden. Bone marrow chimeras were created by lethally 
irradiating 6-week old C57BL/6.SJL recipient mice and reconstituting them with 
age and sex matched 2-4 x 106 IRF4f/f CD11c-cre-positive or IRF4f/f cre-negative 
bone marrow cells. After reconstitution, cell chimerism was monitored in blood 
after 3 weeks. By this time it was assumed that short-lived cells from the recipient 
would have been replaced by newly differentiated cells from the donor bone 
marrow. Blood was collected from the tail vein and red blood cells lysed using the 
STEMCELL EasySep™ Red Blood Cell Lysis Buffer. Cell surface markers were 
stained by fluorescent monoclonal antibodies and a viability dye added to exclude 
dead cells from analysis. Lymphocytes were distinguished from the remaining red 
blood cells by their larger forward scatter profile (FSC). Live single cells were 
separated into B cells, which express B220, T cells which were B220- Ly6C- CD3+ 
and blood monocytes, which stained positive for Ly6C (Fig. 4-1 A). These cell 
populations were further analysed for their expression of CD45.2 and CD45.1. The 
cells that originated from the C57BL/6.SJL recipient bone marrow were CD45.1+, 
whereas the IRF4f/f CD11c-cre-positive or IRF4f/f cre-negative bone marrow cells 
were CD45.2+. These distinct expression profiles allowed the separation of 
recipient and donor cells and allowed to assess the efficacy of bone marrow 
replacement. B cells and blood monocytes were almost completely replaced by 
cells derived from the donor bone marrow and stained for CD45.2. T cells, which 
are known to be more radio-resistant and long-lived, derived from donor bone 
marrow to around 50% (Fig. 4-1 B). No differences in cell chimerism were 
observed between cre+ and cre- mice and we therefore concluded that the bone 
marrow of all chimeras was successfully replaced, as short-lived cells that 
circulated in blood were completely derived from the donor bone marrow 3 weeks 
after reconstitution. 
 
At the time of tissue harvest, cell chimerism was again assessed directly in the 
tissues. In this example, the small intestinal lamina propria was harvested 6 weeks 
after bone marrow reconstitution. The small intestine was dissected, cleaned, 
washed with HBSS/EDTA and digested in RPMI supplemented with 1 mg/ml 
Collagenase VIII and 10% FCS at 37° C for 15 minutes, as previously described 
(Houston et al., 2016). After straining, cells were stained for flow cytometry and a 
viability dye was added to exclude dead cells from analysis. Lymphocytes were 
identified by their forward and side scatter profiles and antigen presenting cells 
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(APCs) selected as live B220- MHCIIhi CD11c+ cells. These were further divided in 
CD64-expressing macrophages and CD64- CD11chi DCs (Fig. 4-1 C). All live cells, 
macrophages and DCs were further analysed for their expression of CD45.2 and 
CD45.1. 60-80% of all live cells were derived from the donor, indicating that 
certain radioresistant cells from the recipient were still present. However 
macrophages and dendritic cells, which we aimed to analyse and reconstitute in 
these chimeras, were derived from the donor bone marrow by 98% in both cre+ 
and cre- bone marrow chimeras (Fig. 4-1 D).  
These data indicated that tissue macrophages and DCs were completely replaced 
by IRF4f/f CD11c-cre-positive or IRF4f/f cre-negative cells 6 weeks after 
reconstitution, and that bone marrow chimeras would provide a suitable model to 
study the immunological effects of IRF4-deletion in these cells during S. mansoni 
egg injection. 
 
4.1.2 Intestinal Th2 responses are impaired in IRF4f/f CD11c-cre-
positive mice 	  	  
 
Figure 4-2. Th2 responses are impaired in the small intestine and colon of IRF4f/f CD11c-cre-
positive mice 
1,000 non-viable eggs were injected into the ileum (A) or the ascending colon (B) of IRF4f/f CD11c-
cre-positive (cre+) or IRF4f/f cre-negative (cre-) mice. 5 days after immunization the individual 
draining lymph nodes were harvested and restimulated with SEA for 3 days. IFN-γ, IL-4, IL-5 and 
IL-13 were measured in the supernatants of these restimulation cultures. Data represent at least 
three independent experiments (mean ± SEM) with at least three animals per group. Mann-
Whitney U tests were applied for statistical analysis (***P ≤ 0.001).  
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IRF4f/f cre-negative bone marrow chimeric mice. As we had previously 
demonstrated that the ileum is drained selectively by sMLN1, this node was 
individually harvested 5 days after immunization. Cells were restimulated with 7.5 
µg/ml SEA for 3 days. Antigen specific immune responses that had developed in 
response to egg injection, were assessed by measuring cytokines that were 
released after in vitro restimulation. We observed that IRF4f/f cre-negative mice 
mounted immune responses comparable to C57BL/6 mice. We detected the 
cytokines IFN-γ, IL-4, IL-5 and IL-13 at similar concentrations to previous 
experiments and measured 20 ng/ml of IFN-γ, 1 ng/ml of IL-4 and IL-5 and 30 
ng/ml of IL-13 in restimulation cultures. In IRF4f/f CD11c-cre-positive mice IL-4, IL-
5 and IL-13 were reduced to such a great extent that they were almost not 
detectable (Fig. 4-2 A). Levels of IFN-γ, on the other hand, more than doubled in 
cre-positive compared to cre-negative mice. This absence of Th2 associated 
cytokines and the increased production of IFN-γ indicated that Th2 responses did 
not develop upon small intestinal egg injection in IRF4f/f CD11c-cre-positive mice.  
To determine whether these responses were also impaired in the colon we 
injected 1,000 non-viable S. mansoni eggs in the ascending colon. 5 days after 
egg injection, cMLN1 was harvested in IRF4f/f CD11c-cre-positive and IRF4f/f cre-
negative control animals and immune responses were measured after 
restimulation. We observed that IRF4f/f cre-negative mice produced antigen 
specific IFN-γ, IL-4, IL-5 and IL-13 upon restimulation. Similar to what we had 
previously observed in C57BL/6 mice, levels of Th2 cytokines were lower 
compared to small intestinal egg injections, with 40 ng/ml of IFN-γ, 0.5 ng/ml of IL-
4 and IL-5 and 20 ng/ml of IL-13 secreted after restimulation. As observed in the 
small intestine, Th2 responses towards injected eggs were also affected by the 
deletion of IRF4 in CD11c+ cells in the colon, revealed by the lack of IL-4, IL-5 and 
IL-13 and increased levels of IFN-γ in the restimulation cultures from the cre-
positive animals (Fig. 4-2 B). 
 
We concluded that IRF4 expression by CD11c+ cells was essential for the effective 
induction of Th2 responses in the intestine, which corresponded with published 
findings that had shown that IRF4 expression was required in lung DCs to mount 
Th2 responses against house dust mite antigen (Williams et al., 2013). However, it 
still remained unclear if IRF4+ CD11c+ cells played a role specifically in the 
induction, maintenance or restimulation of the Th2 response and whether a 
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particular IRF4-expressing subset of cells was specialized to induce Th2 
responses in the small intestine and colon. 
 
4.1.3 IRF4 is expressed by certain subsets of dendritic cells but 
not by macrophages 
 
 
Figure 4-3. IRF4 is expressed by three intestinal DC subsets but not by macrophages or 
CD11b-CD103+ DCs 
Small intestinal cells were stained for flow cytometry and CD64-expressing macrophages and 
CD11chi DCs identified among all MHCII+ CD11c+ cells. Four DC subsets were identified by their 
expression of CD11b and CD103 (A). This gating strategy was used for all intestinal digests. 
Intracellular staining showed the percentage of IRF4-expressing macrophages and DCs (B), and of 
each individual DC subset (C). Data are representative of three independent experiments. 
 
 
Having shown that both intestinal lamina propria DCs and macrophages were 
replaced by IRF4f/f CD11c-cre-positive or IRF4f/f cre-negative cells in bone marrow 
chimeras, we examined which CD11c+ cells expressed IRF4 and would therefore 
be affected by a CD11c-cre-driven deletion. We harvested small intestines from 
C57BL/6 mice and digested them in RPMI supplemented with 1 mg/ml 
Collagenase VIII and 10% FCS. Cell surface markers CD45, B220, MHCII, CD11c, 
CD64, Ly6C, CD11b and CD103 were stained and Fixable Viability Dye eFluor780 
added. Cells were fixed and permeabilized using the eBioscience 
Foxp3/Transcription Factor Staining Buffer Set and cells were then stained 
intracellularly for IRF4. Lymphocytes were selected by their forward and side 
scatter profile and their expression of CD45. Antigen presenting cells were 
selected from live single B220- cells by their expression of MHCII and CD11c. 
They were divided into CD64+ macrophages and CD64- CD11chi Ly6C- DCs. DCs 
were further divided into their respective subsets by their expression of CD11b and 
macrophages 
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CD103 (Fig. 4-3 A). Four DC subsets were identified: CD11b “single positive” 
(CD11b+) DCs, CD11b+ CD103+ “double positive” (DP) DCs, CD11b- CD103- 
“double negative” (DN) DCs and CD103 single positive (CD103+) DCs. 
 
We observed that the levels of IRF4 expression were different between intestinal 
macrophages and DCs. Only around 1% of macrophages expressed IRF4 
whereas 40% of all DCs were IRF4+ (Fig. 4-3 B). We therefore reasoned that DCs 
would be more affected by the deletion of IRF4 in IRF4f/f CD11c-cre-positive bone 
marrow chimeras. As DCs are also professional antigen presenting cells that 
migrate, transport antigen, and prime T cell responses in the draining lymph 
nodes, we hypothesized that the defect in Th2 induction that we had observed in 
IRF4f/f CD11c-cre-positive chimeric mice was due to IRF4-dependent effects on 
DCs and not macrophages. 
 
We furthermore observed that the expression profile of IRF4 was different among 
the individual DC subsets. 40% of CD11b+ DCs expressed IRF4; DP DCs 
represented the subset with the highest percentage of IRF4+ cells (67%); 47% of 
DN DCs were IRF4+ and only 5% of CD103+ DCs expressed IRF4 (Fig. 4-3 C). We 
therefore hypothesized that CD103+ DCs would be the least affected by IRF4-
deletion and were the least likely subset to be involved in the induction of intestinal 
Th2 responses. This hypothesis was supported by reports from the literature, 
which demonstrated that intestinal CD103+ DCs were uniquely able to cross 
present antigen to CD8 T cells and drive proinflammatory responses (Cerovic et 
al., 2015). 
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Figure 4-4. CD11b+ and DP DCs express the highest amount of IRF4 in small intestinal and 
colonic MLNs 
Migratory DCs were identified as MHCIIhi CD11c+ cells in mesenteric draining lymph nodes and 
could be divided into four subsets based on their expression of CD11b and CD103 (A). This gating 
strategy was used for all MLN digests. The expression of IRF4 in CD11b+ and DP DCs was 
assessed by intracellular staining in small intestinal draining sMLNs (B) and colonic draining 
cMLNs (C). Expression levels were also assessed by qPCR of sorted sMLN CD11b+ and DP DCs 
using two different primer pairs (IRF4 1, and IRF4 2). The relative expression of IRF4 was 
normalized to DP DCs. Data are representative of three independent experiments. 
 
 
It is known from the literature that DCs migrate from the intestinal lamina propria to 
the MLNs via the lymphatics to prime naive T cells (Cerovic et al., 2013). All four 
subsets of intestinal DCs migrate at steady state and are present in small intestine 
or colon draining MLNs at similar proportions as in the small intestinal or colonic 
lamina propria (Denning et al., 2011; Houston et al., 2016). These migratory DCs 
can be distinguished from MLN resident DCs by their higher expression of MHCII, 
when stained by flow cytometry. We had observed that lamina propria DC subsets 
expressed IRF4 to varying degrees and assessed whether migratory DCs in the 
MLNs expressed IRF4 to a similar extent. In order to distinguish between DCs that 
migrated from the small intestine or the colon, sMLNs or cMLNs of C57BL/6 mice 
were individually harvested. MLNs were digested as previously described 
(Houston et al., 2016), using RPMI supplemented with 8 U/ml Liberase and 10 
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µg/ml DNase for 45 minutes at 37° C. Fluorescently labelled monoclonal 
antibodies against the cell surface markers B220, MHCII, CD11c, Ly6C, CD11b, 
CD103 and Fixable Viability Dye eFluor780 were added. Cells were fixed and 
permeabilized using the eBioscience Foxp3/Transcription Factor Staining Buffer 
Set and cells were then stained intracellularly for IRF4. Migratory DCs were 
selected from live B220- single cells as CD11c+ MHCIIhi cells and distinguished 
from resident DCs by their higher expression of MHCII. Ly6C- cells were then 
divided into the four CD11b and CD103 expressing subsets. All four subsets could 
be identified and were present at similar proportions as their intestinal counterparts 
(Fig. 4-4 A).  
 
In our previous experiment we had shown that IRF4 was expressed by CD11b+, 
DP and DN DCs in the intestine but not by CD103+ DCs. In sMLNs IRF4 
expression was greater compared to the intestine, with 79% of CD11b+ DCs, 84% 
of DP DCs, 58% of DN DCs and 50% of CD103+ DCs expressing IRF4 (Fig. 4-4 
B). Again, DP DCs represented the subset with the highest proportion of IRF4-
expressing cells. However contrary to the intestine, 50% of CD103+ DCs in the 
MLN expressed IRF4. However, the staining profile was unlike the other subsets 
and resembled a positive shift rather than a distinct IRF4+ population. In cMLNs 
the proportion of IRF4-expressing migratory DCs was lower compared to the 
sMLNs with 59% of CD11b+ DCs, 48% of DP DCs, 46% of DN DCs and 27% of 
CD103+ DCs expressing IRF4 (Fig. 4-4 C). These data indicated that different 
proportions of IRF4+ DCs were present in the sMLNs and cMLNs and contrary to 
our findings in the small intestine, certain CD103+ DCs in the MLNs also 
upregulated their expression of IRF4. Thus, we concluded that distinct populations 
of CD11b+, DP and DN DCs expressed IRF4 in the intestine and the draining 
MLNs and would likely be affected by the deletion of IRF4.  
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4.1.4 IRF4 affects the development of dendritic cells in the 
intestine but does not affect antigen uptake 
 
 
 
Figure 4-5. IRF4f/f CD11c-cre-positive bone marrow chimeras manifest no changes in overall 
tissue cell numbers but have fewer dendritic cells 
Total number of cells collected from digested small intestines (SI), colons, sMLNs and cMLNs of 
IRF4f/f CD11c-cre-positive or IRF4f/f cre-negative bone marrow chimeras (A). Percentage of total 
DCs (B) and total number (C) after flow cytometric analysis of these tissues. Data represent at 
least three independent experiments (mean ± SEM) with each point representing one animal. 
Mann-Whitney U tests were applied between cre+ and cre- groups for statistical analysis (**P ≤ 
0.01; ***P ≤ 0.001).  
 
 
To further clarify whether the deletion of IRF4 impaired the development or the 
cellular functions of DCs we phenotyped the intestines and MLNs of IRF4f/f 
CD11c-cre-positive or IRF4f/f cre-negative bone marrow chimeras and assessed 
the total number of cells and total DCs in these tissues. Small intestines, colons 
and MLNs were enzymatically digested and after cell straining single cell 
suspensions were counted and total cell numbers recorded for each tissue. As 
expected around 20 million cells could be isolated from the small intestine and 
around 7 million cells were obtained from the colon. We collected 12 million cells 
from sMLNs and 4 million from cMLNs. No differences in total cell numbers were 
observed between cre+ and cre- mice in these tissues (Fig. 4-5 A), indicating that 
the deletion of IRF4 in CD11c-expressing cells did not cause major disruption in 
the tissues, such as tissue damage or developmental defects.  
 
We stained single cell suspensions from each tissue with fluorescent monoclonal 
antibodies and were able to distinguish DC populations as previously described. In 
the intestines total DCs were selected as live single CD45+ B220- MHCII+ CD11c+ 
CD64- Ly6C- cells and in the MLNs migratory DCs were distinguished by gating on 
live single B220- MHCIIhi CD11c+ Ly6C- cells. DCs accounted for around 0.5-1% of 
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all total cells. We had previously shown that DCs where the major IRF4-
expressing CD11c+ cell population in the intestine and observed a general 
decrease of DCs in the intestines and MLNs of IRF4f/f CD11c-cre-positive bone 
marrow chimeras. Despite not being statistically significant, the percentage of DCs 
tended to decrease in the small intestine and decreased to a significant level in the 
colon. Significant decreases were also observed in the percentage of migratory 
DCs in the sMLNs and cMLNs (Fig. 4-5 B). Using the total number of cells that we 
had counted and the respective percentage of DCs we calculated the number of 
DCs for each sample. Again we observed a reduction in the numbers of DCs in all 
tissues. Here numbers decreased significantly in the small intestine, colon and 
cMLN (Fig. 4-5 C). 
 
We concluded that the deletion of IRF4 in DCs did not have a general impact on 
the integrity of the intestines or MLNs, as total cell numbers were comparable 
between IRF4f/f CD11c-cre-positive and IRF4f/f cre-negative bone marrow 
chimeras. However, DCs were reduced both in percentage and total number after 
IRF4 deletion, which suggested that IRF4 had an impact on DC development or 
differentiation.   
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Figure 4-6. IRF4 deletion in CD11c+ cells leads to a decrease in DP DCs in the small intestine 
and to a general reduction of DCs in the colon 
DC subsets were identified by flow cytometry in small intestinal cell suspensions of IRF4f/f CD11c-
cre-positive and IRF4f/f cre-negative bone marrow chimeras (A). The percentage (B) and total 
number (C) of small intestinal DC subsets are displayed. DC subsets were also identified in the 
colon of cre+ and cre- mice (D) and their percentages (E) and total numbers (F) compared 
between both genotypes. Data represent at least three independent experiments (mean ± SEM) 
with each point representing one animal. Mann-Whitney U tests were applied between cre+ and 
cre- groups for statistical analysis (*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001).  
 
 
To assess whether the impact of IRF4 on DC development was subset specific or 
if it affected all DCs equally we analysed small intestinal and colonic LP DC 
subsets of IRF4f/f CD11c-cre-positive and IRF4f/f cre-negative bone marrow 
chimeras. It has previously been reported that the deletion of IRF4 resulted in a 
decrease of the DP DC subset in the small intestine (Persson et al., 2013b). After 
digesting the small intestine with RPMI containing 1 mg/ml Collagenase VIII and 
10% FCS, single cell suspensions were obtained by cell straining and stained for 
flow cytometry. DCs were selected as live single CD45+ B220- MHCII+ CD11c+ 
CD64- Ly6C- cells and separated into four subsets by the expression of CD11b 
and CD103. We observed that in IRF4f/f CD11c-cre-positive bone marrow 
chimeras the distribution of DC subsets was proportionally different compared to 
IRF4f/f cre-negative controls. We observed that the proportion of DP DCs 
decreased from 35% in cre- mice to around 20% in cre+ mice. Furthermore, we 
observed that CD11b+ and CD103+ subsets increased proportionally (Fig. 4-6 
A&B). To test whether this increase of CD11b+ and CD103+ DCs was caused by 
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an increase in cell numbers, or was just a proportional increase to compensate for 
the decrease in DP DCs, we analysed total cell numbers. Hereby total tissue cell 
counts were multiplied with the percentage of total DCs and the percentage of 
each respective subset. We observed that the number of DP DCs decreased 
significantly by the deletion of IRF4. The absolute numbers of CD11b+ and 
CD103+ DCs however were not affected (Fig. 4-6 C). We concluded that the DP 
DC subset was the only subset in the small intestinal lamina propria that was 
affected by the deletion of IRF4 and decreased in number, confirming already 
published findings (Persson et al., 2013b).  
 
However, it remained unknown how the deletion of IRF4 in CD11c cells affected 
the composition of DC subsets in the colonic lamina propria. We harvested the 
colons of IRF4f/f CD11c-cre-positive and IRF4f/f cre-negative bone marrow 
chimeric mice and digested them enzymatically. Cells were stained with 
fluorescent monoclonal antibodies and DC subsets identified as CD11b/CD103 
expressing live single CD45+ B220- MHCII+ CD11c+ CD64- Ly6C- cells. Whereas 
DP and CD103+ DCs comprised the majority of DCs in the small intestine, CD11b+ 
and CD103+ DCs were the most abundant subsets in the colon. We observed that 
the proportion of DC subsets was different in cre+ mice, with an increase of 
CD11b+ DCs from 30% to 40% and a reciprocal decrease of DP DCs from 15% to 
5% (Fig. 4-6 D&E). The proportion of CD103+ and DN DCs was not statistically 
affected but CD103+ were slightly increased. These proportional changes were 
similar to our observations in the small intestine and showed a decrease of DP 
DCs and a reciprocal increase of CD11b+ and CD103+ DCs. 
 
However, the analysis of total cell numbers revealed that only DP DCs were 
decreased in the small intestine. When we analysed total cell numbers of colonic 
DCs we observed that they were generally 10-fold lower compared to the small 
intestine, due to a lower percentage of DCs and smaller tissue size. This 
difference had been observed in C57BL/6, cre+ and cre- mice and has also been 
reported in the literature (Denning et al., 2011; Houston et al., 2016). Comparing 
total cell numbers between IRF4f/f CD11c-cre-positive and IRF4f/f cre-negative 
mice in the colon, we noticed that all DC subsets were reduced. Hereby, DP DCs 
were the most affected population, whereas CD103+ DCs showed the least 
decrease in cell numbers (Fig. 4-6 F). This suggested that IRF4 deletion had a 
general developmental effect on colonic DCs and decreased their number in the 
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lamina propria. Overall, DP DCs were the most affected subset in both the small 
intestine and colon, whereas CD103+ DCs were the least affected. We therefore 
hypothesized that DP DCs were important for the induction of Th2 responses and 
that their decrease was the cause for the defective Th2 response in IRF4f/f CD11c-
cre-positive bone marrow chimeras after egg injection. 
 
 
 
Figure 4-7. Antigen uptake by intestinal DCs is not affected by the deletion of IRF4 
20 µg of AlexaFluor660-labled SEA was injected into the small intestinal lamina propria of IRF4f/f 
CD11c-cre-positive and IRF4f/f cre-negative bone marrow chimeras. Levels of SEA uptake by DCs 
were measured 24 hours after injection (A). Total numbers of AF660-SEA+ SI LP DCs were 
compared between cre+ and cre- mice (B). SEA-AF660 was also injected into the colonic lamina 
propria and uptake by LP DCs assessed after 24 hours (C). Total numbers of AF660-SEA+ colon 
LP DCs were compared between cre+ and cre- mice (D). Data represent at least three 
independent experiments (mean ± SEM) with each point representing one animal. Mann-Whitney 
U tests were applied between cre+ and cre- groups for statistical analysis.  
 
 
As we hypothesised that the decrease of DP DCs in the small intestinal lamina 
propria and the colon affected the induction of Th2 responses we tested whether 
antigen uptake by lamina propria DCs was adversely affected in IRF4f/f CD11c-
cre-positive mice. We fluorescently labelled soluble egg antigen with 
AlexaFluor660 and injected 20 µg into the small intestinal lamina propria of IRF4f/f 
CD11c-cre-positive and IRF4f/f cre-negative bone marrow chimeric mice. From 
previous experiments we knew that this amount was equivalent to amounts used 
to drive robust Th2 responses, which suggested that it was likely to be taken up by 
DCs in the lamina propria and transported to the draining lymph nodes. 24 hours 
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after AF660-SEA injection the injected area of the small intestine was excised and 
digested with Collagenase VIII. Cells were stained with fluorescent monoclonal 
antibodies and analysed by flow cytometry. We gated on total lamina propria DCs 
and analysed the level of AF660 fluorescence as a measure of antigen uptake. We 
observed that around 8% of all DCs labelled positive for AF660-SEA in both cre+ 
and cre- mice (Fig. 4-7 A). This suggested that despite the change in DC subset 
composition in cre+ mice uptake of parasite antigen was not affected in the lamina 
propria. This was confirmed by comparing the total number of SEA-labelled DCs in 
the small intestine where also no difference between cre+ and cre- mice was 
observed (Fig. 4-7 B). 
 
We had observed that IRF4f/f CD11c-cre-positive bone marrow chimeras had 
generally fewer colonic DCs compared to their IRF4f/f cre-negative littermates, with 
DP DCs being the most affected subset. To test whether this decrease in DC 
numbers affected the uptake of parasite antigen in the colon, we injected 20 µg 
AF660-SEA in the colonic lamina propria. 24 hours after AF660-SEA injection, 
colons were harvested from injected IRF4f/f CD11c-cre-positive and IRF4f/f cre-
negative bone marrow chimeras and digested with Collagenase V, Collagenase D, 
Dispase and DNase. Cells were stained for flow cytometry and levels of AF660 
measured to indicate AF660-SEA uptake. We gated on total colonic DCs and 
observed that around 20% of cre+ and cre- cells had taken up AF660-SEA and 
that the total number of AF660-SEA+ colonic DCs was comparable between cre+ 
and cre- mice (Fig. 4-7 C&D). This again suggested that uptake of antigen was not 
affected in IRF4f/f CD11c-cre-positive mice despite the fact that numbers of DCs 
were reduced in these mice. Taken together, we had observed no difference in the 
uptake of AF660-labeled SEA by small intestinal and colonic DCs in IRF4f/f 
CD11c-cre-positive and IRF4f/f cre-negative mice. This suggested that IRF4-
deficiency and the decrease of DP DCs in the lamina propria of cre+ mice did not 
have an impact on antigen uptake and could not explain the impairment of Th2 
responses in these mice. 
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4.1.5 CD11b-expressing dendritic cells are dramatically reduced 
in the MLNs of IRF4f/f CD11c-cre-positive mice, which affects 
antigen availability 
 
 
Figure 4-8. Fewer CD11b+ and DP migratory DCs are present in the sMLNs and cMLNs of 
IRF4f/f CD11c-cre-positive mice 
Small intestinal draining MLNs were harvested from IRF4f/f CD11c-cre-positive and IRF4f/f cre-
negative bone marrow chimeras, digested and analysed by flow cytometry (A). The percentage (B) 
and total number (C) of migratory DC subsets was compared between cre+ and cre- mice. 
Migratory cMLN DCs were also assessed by flow cytometry (D) and percentages (E) and total 
numbers (F) compared between cre+ and cre- mice. Data represent at least three independent 
experiments (mean ± SEM) with each point representing one animal. Mann-Whitney U tests were 
applied between cre+ and cre- groups for statistical analysis (**P ≤ 0.01; ***P ≤ 0.001). 
 
 
In addition to an intestinal phenotype it has also been reported that IRF4-deletion 
affected DC migration in the skin (Bajaña et al., 2012) and reduced numbers of 
CD11b+ and DP DCs have also been observed in the MLNs of IRF4f/f CD11c-cre-
positive mice (Persson et al., 2013b). We therefore investigated if the deletion of 
IRF4 also had an impact on DC subsets in the small intestinal and colonic draining 
MLNs. We harvested the small intestinal draining sMLNs from IRF4f/f CD11c-cre-
positive and IRF4f/f cre-negative bone marrow chimeras and digested them with 8 
U/ml Liberase and 10 µg/ml DNase in RPMI. Single cell suspensions were stained 
with fluorescent monoclonal antibodies against the cell surface markers B220, 
MHCII, CD11c, Ly6C, CD11b and CD103. Migratory DCs that expressed higher 
levels of MHCII compared to resident DCs, were divided into four subsets by their 
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differential expression of CD11b and CD103. All four subset were clearly 
distinguishable and CD11b+, DP and CD103+ were present in equal proportions in 
cre- mice. In IRF4f/f CD11c-cre-positive mice we observed that CD11b+ DCs 
decreased by 50% compared to cre-negative littermates. Furthermore, DP DCs 
decreased by over 90%, making this population hardly detectable. Reciprocally the 
proportion of CD103+ DCs increased from 30% to 70% (Fig. 4-8 A&B). The 
decrease of CD11b+ and DP DCs was also observed when we compared total 
numbers of DCs. The number of CD11b+ DCs dropped from 10,000 in cre- mice to 
2,000 in cre+ mice and DP DCs were even further reduced and decreased from 
13,000 to 1,000 cells. The number of CD103+ DCs was however not affected by 
the deletion of IRF4, an observation that we had also made in the small intestinal 
lamina propria (Fig. 4-8 C). However, contrary to our findings in the lamina propria, 
where only DP DCs were decreased, sMLNs showed a more pronounced effect. 
CD11b+ DCs were reduced by 50% and DP DCs were hardly present in IRF4f/f 
CD11c-cre-positive mice, suggesting that changes in DC proportions in the MLNs 
rather than the small intestine might contribute to the observed defects of Th2 
immunity.  
 
As the deletion of IRF4 also affected DCs in the colonic lamina propria, by 
reducing the number of all DC subsets in particular of DP DCs, we hypothesised 
that migratory DCs in the colon draining cMLNs would also be affected. We 
harvested cMLNs from IRF4f/f CD11c-cre-positive and IRF4f/f cre-negative bone 
marrow chimeric mice and digested them with Liberase and DNase. Cells were 
stained with fluorescent antibodies and analysed by flow cytometry. We observed 
that the general distribution of DC subsets was different to sMLNs. Whereas 
CD11b+, DP and CD103+ DCs were present at similar proportions in the sMLNs, 
CD103+ DCs were the most abundant subset in cMLNs. The deletion of IRF4 had 
a similar effect in cMLNs as it had in sMLNs reducing CD11b+ and DP DCs and 
increasing the proportion of CD103+ DCs. However the decrease of CD11b+ DCs 
was not statistically significant and the reduction of DP DCs was not as 
pronounced but decreased from 20% in cre- mice to 5% in cre+ mice (Fig. 4-8 
D&E). The total number of each DC subset in the cMLN followed a similar trend as 
we had already observed in sMLNs. The number of CD103+ DCs was not affected 
by the deletion of IRF4, whereas the number of CD11b+ DCs was reduced and the 
number of DP DCs even more affected (Fig. 4-8 F).  
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We therefore observed that the deletion of IRF4 not only affected DC subsets in 
the lamina propria of the small intestine and colon, where we had observed the 
most pronounced reduction in DP DCs, but also reduced DC subsets in the MLNs. 
In both small intestinal and colonic draining MLNs CD11b+ DCs were reduced by 
50% and DP DCs were hardly present. We therefore hypothesized that the 
pronounced decrease of MLN CD11b+ and DP DCs in IRF4f/f CD11c-cre-positive 
mice affected T cell priming, which could lead to the impairment of Th2 immunity 
observed in these mice. 
 
 
 
Figure 4-9. IRF4 deletion in CD11c+ cells reduces the number of antigen-carrying DCs in the 
MLNs 
Antigen-carrying migratory DCs were visualized by the injection of 20 µg SEA-AF660 into the small 
intestinal lamina propria. 24 hours after injection the sMLN that drained the injection site was 
harvested, digested and cells stained for flow cytometry (A). Total numbers of AF660-SEA+ 
migratory sMLN DCs were compared between cre+ and cre- mice (B). SEA-AF660 was also 
injected into the colonic lamina propria and transport to the cMLNs assessed after 24 hours (C). 
Total numbers of AF660-SEA+ migratory cMLN DCs were compared between cre+ and cre- mice 
(D). Data represent at least three independent experiments (mean ± SEM) with each point 
representing one animal. Mann-Whitney U tests were applied between cre+ and cre- groups for 
statistical analysis (*P ≤ 0.05; ***P ≤ 0.001).  
 
 
We had observed that antigen uptake by lamina propria DCs was not affected by 
IRF4-deficiency. However, we hypothesized that the severe reduction of CD11b+ 
and DP DCs in the MLNs would affect the number of antigen-carrying DCs in 
IRF4f/f CD11c-cre-positive mice. To test this hypothesis, we injected 20 µg AF660-
labelled SEA into the small intestinal lamina propria of IRF4f/f CD11c-cre-positive 
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and IRF4f/f cre-negative bone marrow chimeras. 24 hours after injection the 
individual sMLN that drained the injection site was harvested and digested with 8 
U/ml Liberase and 10 µg/ml DNase. Cells were stained for flow cytometry and 
migratory DCs selected as live single B220- MHCIIhi CD11c+ Ly6C- cells. DCs that 
labelled positive for AF660-SEA were considered to be antigen-transporting cells 
that had taken up AF660-SEA from the lamina propria and migrated through the 
lymphatics to the draining lymph nodes. We observed that 8% of DCs had taken 
up antigen in cre- mice but only 1% of DCs were AF660-SEA+ in cre+ animals 
(Fig. 4-9 A). We observed a similar reduction comparing total numbers of AF660-
SEA+ DCs where an average of 800 cells was present in cre- sMLNs but only 200 
AF660-SEA+ DCs were collected from cre+ sMLNs (Fig. 4-9 B). This observation 
supported our hypothesis that the reduced number of CD11b+ and DP DCs in the 
sMLNs of IRF4f/f CD11c-cre-positive mice resulted in decreased numbers of 
antigen-carrying DCs. This reduction in cell numbers and available antigen in the 
MLNs would likely affect T cell priming and could explain the impaired induction of 
Th2 responses in these mice.  
 
As we had observed a similar reduction of CD11b+ and DP DCs in the colonic 
draining lymph nodes we expected a comparable decrease of antigen-carrying 
DCs in the cMLNs. We injected AF660-SEA in the colonic lamina propria of IRF4f/f 
CD11c-cre-positive and IRF4f/f cre-negative bone marrow chimeric mice. Colon 
draining cMLNs were harvested 24 hours after injection and digested using 
Liberase and DNase. Cells were stained for flow cytometry and the levels of 
AF660 fluorescence analysed on migratory DCs. Similar to our observations in 
sMLNs, 8% of cMLN DCs were AF660-SEA+ in cre- mice, which was equivalent to 
1,000 cells, whereas in cre+ mice the percentage of AF660-SEA+ DCs was 
reduced and only 300 DCs labelled positive for AF660-SEA (Fig. 4-9 C&D). These 
results were comparable to what we had observed in the small intestinal draining 
MLNs and showed that fewer antigen-carrying migratory DCs were present in the 
MLNs of IRF4f/f CD11c-cre-positive mice. DC migration as well as survival have 
been suggested in the literature to contribute to the reduction of migratory CD11b-
expressing DCs in the draining lymph nodes (Bajaña et al., 2012; Schlitzer et al., 
2013; Persson et al., 2013b). However, no direct consequence for antigen 
availability had been demonstrated in these studies. We concluded that the 
decrease of CD11b+ and DP migratory DCs in the MLNs of cre+ mice and the 
concurrent reduction of transported antigen could impact T cell priming and 
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contribute to the impaired T cell responses observed in IRF4f/f CD11c-cre-positive 
mice.  
 
 
 
Figure 4-10. Antigen presentation is not affected on a cell-to-cell basis in IRF4f/f CD11c-cre-
positive MLN DCs 
Antigen presentation by individually FACS purified MLN DC subsets was assessed in OVA/OT-II 
cocultures with CFSE-labelled OT-II MLN cells. After 3 days of incubation cocultures were stained 
with anti-CD4, anti-Va2 and a viability dye. Proliferated CD4 OT-II T cells were identified by their 
reduced concentration of CFSE (A). The level of proliferation induced by 6,000 migratory sMLN 
DCs (B) or 3,000 migratory cMLN DCs (C) from IRF4f/f CD11c-cre-positive or IRF4f/f cre-negative 
mice was compared. Data represent at least three independent experiments (mean ± SEM) with 
each point representing one coculture. Mann-Whitney U tests were applied between cre+ and cre- 
groups for statistical analysis. 
 
 
To demonstrate that reduced numbers of CD11b+ and DP migratory DCs in the 
MLNs and the concurrent reduction of transported antigen, and not functional 
defects in T cell priming, contributed to the impaired Th2 induction in IRF4f/f 
CD11c-cre-positive mice, we assessed T cell priming capabilities by DCs in vitro. 
To assess if IRF4-deficiency in DCs affected antigen presentation and T cell 
priming we used OVA/OT-II in vitro cocultures to monitor T cell priming by DCs. 
Transgenic OT-II mice have been genetically modified so that CD4 T cells only 
express a specific T cell receptor especially designed to recognize OVA peptide 
(Robertson et al., 2000). Upon presentation of OVA by antigen presenting cells 
CD4 T cells proliferate and T cell priming can thus be selectively monitored. To 
test whether IRF4f/f CD11c-cre-positive DCs were impaired in processing and 
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presenting antigen, we harvested small intestinal draining lymph nodes and 
digested them with Liberase and DNase. Cre+ and cre- cells were stained with 
monoclonal fluorescent antibodies and DC subsets were individually sorted by 
FACS and cells were loaded with 2 mg/ml OVA protein in vitro. After two hours, 
cells were washed thoroughly and 6,000 DCs of each subset from cre+ or cre- 
mice were incubated with 200,000 CFSE-labelled MLN cells from OT-II mice. After 
3 days of coculture, cells were stained with anti-CD4, anti-Vα2 and a cell viability 
dye. Cells were analysed by flow cytometry and OT-II CD4 T cells selected by 
their expression of CD4 and the TCR Vα2 (Fig. 4-10 A) (Leung et al., 2013). 
Proliferated T cells were assessed by their reduced signal of CFSE. This 
fluorescent molecule is taken up by cells and remains within the cytosol where it is 
distributed between both daughter cells during cell division. Thus, reduced levels 
of fluorescence mark proliferated cells which contain lower concentrations of 
CFSE compared to undivided cells (Quah et al., 2007). We observed that roughly 
80% of all OT-II CD4 T cells proliferated after coculture with OVA-loaded DCs and 
CD103+ DCs induced the lowest amount of proliferation of around 70%. We did 
not observe any difference in OTII proliferation between cre+ and cre- DC 
cocultures, suggesting that IRF4-deficient DCs were as efficient in priming naive T 
cells as equal numbers of IRF4f/f cre-negative DCs (Fig. 4-10 B). This suggested 
that antigen presentation and T cell priming were not affected by the absence of 
IRF4 in small intestinal MLN DCs.  
 
As IRF4-deletion also reduced numbers of CD11b+ and DP migratory DCs as well 
as the number of antigen-carrying DCs in the cMLNs, we assessed the impact of 
IRF4-deficiency on antigen presentation and T cell priming by migratory cMLN 
DCs. As DCs in the cMLN were less abundant, only 3,000 DCs from each subset 
were FACS sorted from IRF4f/f CD11c-cre-positive and IRF4f/f cre-negative mice 
and incubated with 2 mg/ml OVA protein for two hours. DCs were cocultured with 
200,000 CFSE labelled MLN cells from OTII mice, and after 3 days T cell 
proliferation was assessed by flow cytometry. Again, we observed that around 
80% of CD4 OTII T cells proliferated after coculture with each individual cMLN DC 
subset. CD103+ DCs were the least effective in priming CD4 OTII T cells with 
around 60% proliferation and no difference in proliferation of CD4 OTII T cells 
cocultured with cre+ or cre- DC subsets was observed (Fig. 4-10 C). This 
confirmed that IRF4-deficiency did not impair antigen presentation or priming of 
CD4 OTII T cells by small intestinal and colonic MLN DCs but rather indicated that 
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the reduced number of antigen-carrying migratory DCs in cre+ mice affected the 
induction of T cell responses in these mice. 	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4.2 Discussion 
 
It has been shown in the literature that the transcription factor IRF4 controls type 2 
immune responses in a number of cell types. IRF4 directly controls Th2 cell 
differentiation, alternative activation of macrophages and dendritic cell 
development. Furthermore, IRF4 has also been suggested to control functional 
mechanisms in DCs that specifically enable them to drive Th2 responses. 
 
Using the IRF4f/f CD11c-cre chimeric mouse model we were able to address the 
IRF4 dependency of CD11c+ cell development and its necessity for the adequate 
induction of Th2 responses in the intestine. It has previously been reported that 
IRF4+ CD11c+ cells are specialized to drive Th2 responses against house dust 
mite in the lung, which did not develop in IRF4f/f CD11c-cre-positive mice (Williams 
et al., 2013). We observed a similar effect when we injected S. mansoni eggs into 
the intestines of IRF4f/f CD11c-cre-positive bone marrow chimeras and observed 
that Th2 responses were impaired and IFN-γ responses were increased in MLN 
restimulation cultures (Fig. 4-2). We had previously observed a similar reciprocal 
increase in IFN-γ responses in IL-4-/- mice, which indicated that the 
proinflammatory responses against egg antigens are dampened by type 2 immune 
responses and are increased in their absence. The observation that 
proinflammatory responses were not reduced by the deletion of IRF4 in DCs has 
also previously been observed in cytotoxic T lymphocyte responses during allergic 
airway inflammation (Vander Lugt et al., 2014), suggesting that IRF4 deletion 
specifically affects the induction of type 2 immune responses. Therefore, our 
findings corresponded with the literature and confirmed an IRF4 dependency of 
CD11c+ cells in inducing efficient Th2 responses. In fact, Th2 responses in the 
small intestine as well as the colon were impaired, suggesting a common 
underlying mechanism.  
 
To assess which antigen presenting cells expressed IRF4, and were therefore 
candidates for priming Th2 cells, we performed intracellular staining on intestinal 
CD11c+ cells. We observed that DCs but not macrophages expressed IRF4. As 
DCs are specialized in the uptake of tissue antigen, and migrate to the draining 
lymph nodes to induce T cell responses, it is likely that they are also involved in 
priming Th2 responses in the intestine. The expression of IRF4 was variable 
among DC subsets and was expressed by intestinal CD11b+, DP and DN DCs but 
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not by CD103+ DCs in the intestine (Fig. 4-3). Hereby, DP DCs represented the 
subset with the highest proportion of IRF4+ cells, suggesting that they might be 
most affected by the deletion of IRF4. To understand whether IRF4 affected the 
development of DCs, we harvested intestines and MLNs from IRF4f/f CD11c-cre+ 
and cre- bone marrow chimeras. We observed that total cell numbers in the 
intestines and MLNs were not affected by the deletion of IRF4 in CD11c-
expressing cells, indicating that this deletion did not cause major disruption in the 
tissues, such as tissue damage or developmental defects. However, the 
percentage and number of DCs was affected in all tissues (Fig. 4-5). More detailed 
analysis showed that the number of DP DCs was reduced in the small intestine 
and that all DCs were reduced in the colon, with DP DCs being the most affected 
colonic DC subset (Fig. 4-6). Consistently, a reduction in small intestinal DP DCs 
has previously been reported in IRF4f/f CD11c-cre-positive mice (Persson et al., 
2013b). The reduction of DC numbers indicated that IRF4 was involved in the 
development of DCs and, consistent with its highest expression in DP DCs, mostly 
affected this subset in the intestine. However, uptake of fluorescently labelled 
parasite antigen by DCs in the intestine was not affected in IRF4f/f CD11c-cre-
positive bone marrow chimeras (Fig. 4-7), suggesting that the function of IRF4-
deficient DCs was not impaired.  
 
Analysis of DC subsets in the small intestinal and colonic MLNs revealed an even 
more striking reduction of CD11b+ DCs and a near absence of DP DCs, whereas 
CD103+ DCs were not affected (Fig. 4-8). A similar reduction of CD11b+ and DP 
DCs in the MLNs has also been observed in the literature (Persson et al., 2013b), 
although it remains unclear if defects in migration, development or cell survival, 
which have all been suggested (Schlitzer et al., 2013; Persson et al., 2013b; 
Bajaña et al., 2012), affected migratory DCs in the MLNs of IRF4f/f CD11c-cre-
positive mice. Concurrently, the number of antigen-carrying DCs was also reduced 
in the MLNs (Fig. 4-9), suggesting that reduced numbers of antigen-presenting 
DCs and available antigen in the MLNs led to the inefficient priming of Th2 
responses in IRF4f/f CD11c-cre-positive mice. This hypothesis was further 
strengthened by our observation that the remaining IRF4-deficient DCs were as 
efficient as cre-negative DCs in presenting OVA protein and priming OT-II T cells 
in in vitro cocultures, which showed that they were not functionally impaired (Fig. 
4-10). However, further experiments are needed to verify that IRF4-deficiency in 
DCs does not specifically inhibit their capacity to induce Th2 responses, as has 
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been suggested by Williams et al., who have shown that IRF4 directly regulates IL-
10 and IL-33 expression in DCs (Williams et al., 2013).  
 
From the low expression of IRF4 on CD103+ DCs, their unchanged presence in 
the intestines and MLNs of IRF4f/f CD11c-cre-positive mice and published findings 
that indicate that intestinal CD103+ DCs are specialized to cross present antigen to 
CD8 T cells and elicit proinflammatory responses (Cerovic et al., 2015), we 
considered it likely that intestinal CD103+ DCs were not involved in the induction of 
Th2 responses. From the literature as well as our own observations, CD11b-
expressing DCs were the most likely candidates. However, as both CD11b+ and 
DP DCs were reduced in the MLNs of IRF4f/f CD11c-cre-positive mice, which is the 
tissue where T cell priming occurs, it remained unclear which subset was 
specialized to induce Th2 responses in the intestine. We therefore continued our 
research using C57BL/6 mice and separately assessed the involvement of the 
different DC subsets in the induction of Th2 responses. 
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4.3 Conclusions 
 
We confirmed in our intestinal S. mansoni egg injection model that Th2 responses 
were impaired if CD11c-expressing cells did not express IRF4. IRF4 was 
predominantly expressed by intestinal DCs but not by macrophages. We observed 
changes in the composition of lamina propria and MLN DC subsets in IRF4f/f 
CD11c-cre-positive bone marrow chimeras, where CD11c cells were fully replaced 
in blood and tissues after 3 and 6 weeks. The number of DP DCs was greatly 
reduced in the small intestine. In the colon all DC subsets were reduced, but DP 
DCs were again the most affected DC subset. However, these changes did not 
interfere with the uptake of AlexaFluor660-labeled SEA, and no difference 
between the numbers of AF660-SEA+ DCs was observed in the small intestinal or 
colonic lamina propria of IRF4f/f CD11c-cre-positive and IRF4f/f cre-negative mice. 
Consistent with published findings, migratory DC subsets in the MLN were greatly 
affected by the deletion of IRF4. Here, CD11b+ DCs were reduced by 50% and DP 
DCs were almost completely absent in small intestinal and colonic draining MLNs, 
leading to a significant decrease in antigen-carrying cells. Antigen presentation 
and T cell priming capabilities were however not impaired in cre+ mice, when 
equal numbers of DCs were loaded with OVA and cocultured with CFSE-labelled 
MLN cells from OT-II mice. We therefore concluded that it was not functional 
defects of IRF4-deficient DCs that influenced the induction of Th2 responses 
against S. mansoni eggs. Instead, we suggest that the reduction of CD11b+ and 
DP DCs in the MLNs and the concurrent decrease in antigen-carrying cells led to 
the impaired Th2 response in IRF4f/f CD11c-cre-positive mice, although specific 
Th2-inducing defects by IRF4-deletion have to be considered and need further 
investigation. 
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Chapter 5: Characterization of lymph migratory 
immune cells after intestinal injection of Schistosoma 
mansoni eggs 
 
5.1 Results 
 
Our observations in IRF4f/f CD11c-cre-positive bone marrow chimeras showed that 
the numbers of CD11b-expressing DC subsets were reduced in the MLNs, which 
impaired transport of egg antigen to the MLNs and likely affected the induction of 
Th2 responses against S. mansoni eggs. These DCs must have migrated from the 
lamina propria through the lymphatics to reach the individual draining MLNs. In 
order to assess the effects of S. mansoni egg injection on migratory intestinal DCs 
we directly analysed these cells in lymph. Thoracic duct lymph was collected from 
mesenteric lymphadenectomized mice by the surgical insertion of a cannula 
(Cerovic et al., 2013). To separately assess if specific DC subsets were 
specialized to transport parasite antigen from the small intestine and colon, either 
the sMLNs or cMLNs were removed prior to thoracic duct cannulation. Following 
removal of sMLNs (“sMLNx”), DCs in thoracic duct lymph were small-intestine-
derived, whereas cMLN removal (“cMLNx”) enabled colonic DCs to migrate to the 
thoracic duct (Houston et al., 2016). 	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5.1.1 Thoracic duct cannulations allow the collection of intestinal 
lymph 
 
 
 
Figure 5-1. Cannulation of lymphadenectomized mice allows the collection of DCs in 
thoracic duct lymph 
Schematic illustrating the flow of lymph and migration of DCs from the intestinal lamina propria to 
the MLNs (A). Surgical removal of the MLNs allowed DC migration to the thoracic duct where 
lymph was collected by cannulation (B). 
 
 
Thoracic duct cannulations are based on the principle that lymph flows from the 
intestinal lamina propria to the MLNs as afferent lymph, transporting cells and 
soluble factors. Lymph exits the MLN through the efferent lymphatics and feeds 
into the thoracic duct. We have developed a surgical method that allows the 
insertion of a polyurethane medical grade intravascular tube into the thoracic duct. 
After surgical recovery, lymph can thus be collected for up to 18 hours. Analysis of 
lymph from cannulated C57BL/6 mice has identified immune cell populations such 
as B cells and T cells. However, dendritic cells were not identified as they do not 
exit the MLNs to reach the thoracic duct  (Fig. 5-1 A). Surgical removal of the 
MLNs 6 weeks prior to cannulation enables the collection of “pseudoafferent” 
lymph. Following the removal of the lymph nodes, the afferent and efferent 
lymphatics reanastamose, which allows the collection of DCs in thoracic duct 
lymph  (Fig. 5-1 B). The fact that DCs cannot migrate beyond the draining lymph 
nodes allows further anatomical manipulation. By selectively removing the sMLNs, 
only small intestinal draining DCs will reach the thoracic duct, whereas removing 
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the cMLNs ensures that only colonic DCs are collected (Houston et al., 2016). It is 
thus possible to separately assess lymph migratory DCs from the small intestine or 
colon. 
 
 
 
Figure 5-2. Intestinal egg injections do not significantly affect the migration of B cells, T 
cells and total DCs in lymph 
B cells, DCs and CD4 and CD8 T cells were analysed in lymph from cannulated MLNx mice 
following the presented gating strategy (A). The percentage (B) and total number (C) of these 
immune cells were compared between uninjected (steady state), PBS and egg injected mice. Data 
represent two independent experiments (mean ± SEM) with each point representing one animal. 
Mann-Whitney U tests were applied between PBS injected and egg injected groups for statistical 
analysis. 
 
 
To address if the injection of material into the intestine, particularly of S. mansoni 
eggs, affected the migration of immune cells in lymph, we analysed thoracic duct 
lymph from uninjected, PBS injected and egg injected animals. Total MLNx mice 
were cannulated, 20 µl PBS or 1,000 non-viable eggs were injected into the small 
intestinal lamina propria, and lymph was collected on ice for 18 hours. As lymph 
cells were already in suspension, no tissue digest was necessary to obtain single 
cells for flow cytometric analysis. After cell straining, fluorescent monoclonal 
antibodies against B220, CD19, CD4, CD8, MHCII and CD11c and a dead cell 
exclusion dye were added and cells were analysed by flow cytometry. From total 
live cells, B cells were selected as B220+ CD19+ cells. B220- CD19- cells were 
separated into MHCII+ CD11c+ DCs and CD4 and CD8 T cells (Fig. 5-2 A). We 
observed that B cells comprised around 50% of all lymph cells in steady state, 
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whereas 20% were CD4 and 10% CD8 T cells and DCs represented around 1%. 
The frequency of these lymph migrating immune cells were compared between 
uninjected, PBS injected, and egg injected animals. Percentages of CD8 T cells 
and DCs increased slightly after egg injection whereas percentages of B cells 
decreased, but no statistical difference was observed (Fig. 5-2 B). As the thoracic 
duct also collects lymph draining from visceral tissues and lymph nodes other than 
the intestine, we could not determine what proportion of T and B cells derived from 
the intestine. However, we were confident that all DCs originated from intestinal 
tissues, as the MLNs were the only lymph nodes that had been removed in these 
animals. Thus, equal proportions of intestinal DCs migrated to the MLNs in steady 
state and during PBS or egg injection and could be collected in lymph of MLNx 
cannulated mice. We also recorded the total cell number for each sample and 
were able to calculate the total number of cells for each lymph population. In total 
around 5-8 million cells were collected per animal. However, cell numbers were 
somewhat variable, and were likely dependent on the overall quality of the surgical 
cannulation procedure. B cells accounted for 2-4 million cells and CD4 T cells 
were present at 1-2 million and CD8 T cells at 300,000-1 million cells. Around 
60,000-200,000 lymph DCs were collected from uninjected, PBS injected or egg 
injected mice (Fig. 5-2 C). Again no difference in cell numbers could be observed 
between the different groups of mice. Thus we could demonstrate that thoracic 
duct cannulation is a powerful procedure that allows the direct assessment of 
lymph migratory immune cells. We furthermore established that intestinal egg 
injections did not have a significant effect on the migration of B cells, T cells and 
total DCs in lymph compared to steady state or PBS injected control groups.  
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5.1.2 In lymph intestinal egg antigens are transported by dendritic 
cells and B cells  
 
 
Figure 5-3. Lymph migrating DCs and B cells transport SEA from the small intestine to the 
MLNs 
Uptake of SEA was measured by conjugating fluorescent AF660 to SEA. AF660 signal in B220+ B 
cells and CD11c+ MHCIIhi DCs is shown in lymph collected from PBS or SEA-AF660 injected mice 
18 hours after injection (A). Percentage (B) and total number (C) of lymph migrating CD4 and CD8 
T cells, B cells and DCs that carry labelled antigen after SEA-AF660 injection in the small intestine. 
Data represent three independent experiments (mean ± SEM) with each point representing one 
animal. Mann-Whitney U tests were applied between B cells and DCs for statistical analysis (**P ≤ 
0.01).  
 
 
We had observed that large numbers of immune cells could be identified in lymph 
from uninjected mice and that intestinal egg injections did not induce any 
significant changes in cell migration. This suggested that steady state migratory 
cells were sufficient to transport parasite antigen to the draining lymph nodes 
where they induced Th2 responses. In order to visualize lymph migratory cells that 
were responsible for transporting egg antigen to the MLNs, we fluorescently 
labelled soluble egg antigen with Alexa Fluor 660. We injected 20 µg of AF660-
SEA into the lamina propria of cannulated MLNx mice. This amount was 
equivalent to the amount of SEA used in priming experiments and thus 
represented an immunologically relevant quantity (see chapter 3). Lymph was 
collected for 18 hours after injection and CD4 and CD8 T cells, B220+ B cells and 
total CD11c+ MHCIIhi DCs stained for flow cytometry and analysed. Uptake of SEA 
by these cells was quantified by the level of AF660 fluorescence and SEA-AF660+ 
cells were selected by gating on AF660+ cells that were present in SEA-AF660 
injected mice but not in PBS injected controls (Fig. 5-3 A). Cells from PBS injected 
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controls showed no background fluorescence, whereas AF660 fluorescence was 
clearly detectable in lymph cells from SEA-AF660 injected mice. CD4 and CD8 T 
cells did not acquire any detectable fluorescence, whereas around 3% of B cells 
and 10% of total DCs were AF660+ in lymph (Fig. 5-3 B). As B cells are far more 
abundant than DCs, the total number of AF66-carrying B cells reached up to 
40,000 whereas SEA+ DCs accounted for 1,000-4,000 cells (Fig. 5-3 C).  
By cannulating AF660-SEA injected mice we were able to directly monitor lymph 
migrating cells and observed that both DCs and B cells transported intestinally 
injected SEA in lymph. 
 
5.1.3 Distinct subsets of intestinal dendritic cells migrate in 
increased frequency after injection of eggs in the small 
intestine or colon and transport egg antigens to the 
respective draining lymph nodes 
 
 
Figure 5-4. Egg injections into the small intestine affect the frequency of migrating lymph 
DC subsets 
Lymph from sMLNx animals was stained for flow cytometry and CD11b and CD103 expressing DC 
subsets were identified using the gating strategy shown in (A). Frequency (B) and total number (C) 
of sMLNx lymph DC subsets was compared between PBS and egg-injected animals. Data 
represent at least three independent experiments (mean ± SEM) with each point representing one 
animal. Student’s t tests were applied between DC subsets from PBS and egg injected animals for 
statistical analysis (*P ≤ 0.05).  
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We had observed in previous experiments using the IRF4f/f CD11c-cre mouse 
model that CD11c+ cells, which excludes B cells, were necessary for the induction 
of Th2 responses against S. mansoni eggs. Furthermore, we tested the functions 
of antigen-carrying B cells and DCs in additional experiments that are described in 
chapter 6 and found that only DCs were able to induce Th2 responses. We 
therefore concentrated on the effects of egg injection and antigen transport on 
DCs and their subsets, which are described in the experiments that follow. It has 
been reported that DC activation, for example by TLR agonists, induced the 
migration of all or certain DC subsets and assessed whether egg antigens induced 
a similar effect. We had observed that the injection of eggs did not cause changes 
in the migration pattern of total DCs in lymph when compared to uninjected and 
PBS injected animals. However, changes in certain DC subsets could have been 
masked when analysing total DCs.  
 
In agreement with the literature, we had observed that different DC subset 
compositions are found in the small intestine and colon. In the small intestine DP 
DCs are the most abundant subset, whereas in the colon CD11b+ DCs are the 
majority subset. To separately assess the effects of egg antigen on these tissue-
specific DC subsets, we performed thoracic duct cannulation experiments using 
mice from which only the sMLNs or cMLNs had been previously removed, allowing 
the collection of small intestinal or colonic derived DCs respectively. To determine 
if changes in small intestinal migrating DCs occurred after egg injection, sMLNx 
mice were cannulated and 20 µl PBS or 1,000 eggs were injected into the small 
intestine. Lymph was collected for 18 hours on ice and single cell suspensions 
stained with fluorescent monoclonal antibodies against B220, MHCII, CD11c, 
Ly6C, CD11b and CD103. DCs were identified as live B220- MHCIIhi CD11c+ 
Ly6C- single cells and represented 1-2% of all lymph cells. Subsets were 
distinguished by their expression of CD11b and CD103. All four subsets could be 
identified in lymph draining the small intestine. Hereby DP and CD103+ DCs were 
the most numerous subsets, each representing around 40% of sMLNx lymph DCs 
(Fig. 5-4 A). Around 10% of DCs were CD11b single positive and 2% were CD11b- 
CD103-. We compared lymph from PBS and egg injected animals and observed a 
significant increase in DP DCs after egg injection. Reciprocally, the percentage of 
CD103+ DCs decreased (Fig. 5-4 B), which suggested that the migration of DP 
DCs increased after egg injection into the small intestine. To better understand 
these changes we compared total cell numbers. Around 10,000 cells from each 
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cannulated animal were CD11b+ DCs; 50,000-60,000 cells were DP or CD103+ 
DCs and 1,000-2,000 DCs stained negative for both CD11b and CD103. However, 
the collected volume of lymph was quite variable between animals affecting the 
total number of cells. Thus, differences in the total number of DP DCs in lymph 
increased in egg injected mice but were no longer significant. However, the 
decrease in CD103+ DCs was again observed to a significant degree (Fig. 5-4 C). 
Taken together these data indicate that upon egg injection in the small intestine 
DP DCs could be found at an increased frequency in lymph, suggesting that they 
might selectively respond to egg antigen leading to their enhanced migration. 
 
 
 
Figure 5-5. Increased frequencies of CD11b+ cMLNx lymph DCs are observed after egg 
injections into the colon 
Lymph from cMLNx animals was stained for flow cytometry and DC subsets identified by their 
expression of CD11b and CD103 using the presented gating strategy (A). Frequency (B) and total 
number (C) of cMLNx lymph DC subsets was compared between PBS and egg-injected animals. 
Data represent three independent experiments (mean ± SEM) with each point representing one 
animal. Student’s t tests were applied between DC subsets from PBS and egg injected animals for 
statistical analysis (*P ≤ 0.05).  
 
 
To assess whether the migration of specific DC subsets that migrate from the 
colon was also affected by egg injection, 20 µl of PBS or 1,000 S. mansoni eggs 
were injected into the colonic lamina propria of cMLNx mice. Thoracic duct lymph 
was collected from cannulated animals for 18 hours and stained for flow 
cytometry. DCs were again identified as live B220- MHCIIhi CD11c+ Ly6C- single 
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cells. As already observed in the colonic lamina propria and the cMLNs, DCs were 
present at a much lower frequency compared to their small intestinal counterparts. 
The total number of cells collected from cMLNx animals was comparable to those 
from sMLNx mice, however the percentage of DCs was 10-fold lower. All four 
subsets of DCs could be identified in lymph and their composition was comparable 
to those found in the colonic lamina propria or the cMLNs. CD11b+ and CD103+ 
subsets represented the majority of DCs with each comprising 30-40% of cMLNx 
lymph DCs, whereas DP DCs comprised 20% and DN DCs 3% (Fig. 5-5 A). In 
lymph collected from egg injected mice the percentage of CD11b+ DCs increased 
from 30% to 40% compared to PBS injected controls, while DP and CD103+ DCs 
became less frequent (Fig. 5-5 B). This increase was also observed in total cell 
numbers, but was not statistically significant, as variable volumes of lymph 
collected from each animal resulted in a high variability between samples. The 
total number of DCs hereby ranged from 500 DN DCs to 7,000 CD11b+ cMLNx 
lymph DCs (Fig. 5-5 C), which was much lower compared to sMLNx lymph DC 
subsets, where up to 150,000 DP DCs could be collected from a single animal. 
Subset specific changes in lymph DCs were however observed upon egg injection 
in both sMLNx and cMLNx mice, suggesting a subset specific effect on DC 
migration. Surprisingly, DP DCs were increased in small intestinal draining lymph 
whereas CD11b+ DCs were affected after colonic egg injection. We therefore 
hypothesized that small intestinal DCs and colonic DCs respond differently to S. 
mansoni egg injection. 
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Figure 5-6. DP DCs in the small intestine and CD11b+ DCs in the colon are the predominant 
subsets that carry S. mansoni egg antigen in lymph 
Uptake of SEA-AF660 injected in the small intestine was assessed in lymph DC subsets from 
sMLNx mice (A). Frequency (B) and total number (C) of SEA+ sMLNx DC subsets are shown. 
Conversely, SEA-AF660 was injected in the colonic lamina propria of cMLNx mice and lymph 
collected for 18 hours. Uptake of antigen was measured by AF660 fluorescence in lymph DC 
subsets (D). Frequency (E) and total number (F) of SEA+ cMLNx DC subsets are shown. Data 
represent three independent experiments (mean ± SEM) with each point representing one animal. 
Kruskal-Wallis tests were applied for statistical analysis (**P ≤ 0.01; ***P ≤ 0.001).  
 
 
As we had observed that lymph DCs transported parasite antigen from the lamina 
propria to the MLNs and that specific DC subsets selectively responded to egg 
injection in the small intestine and colon, we assessed whether egg antigen was 
also selectively transported by specific DC subsets. To determine whether antigen 
was transported by specific DC subsets from the small intestine, SEA-AF660 was 
injected into the small intestinal lamina propria of sMLNx mice. Lymph was 
collected from cannulated mice for 18 hours and cells stained for flow cytometry. 
DC subsets were identified by their expression of CD11b and CD103 and uptake 
of antigen measured by AF660 fluorescence (Fig. 5-6 A). We observed that 
around 20% of CD11b+ and 9% of DP DCs in lymph draining the small intestine 
were SEA-AF660+, whereas CD103+ and DN sMLNx lymph DCs did not carry 
AF660 (Fig. 5-6 B). Although a higher frequency of CD11b+ DCs carried AF660, 
SEA-AF660+ DP DCs were more numerous when we compared total numbers, as 
DP DCs are the most abundant subset in small intestinal lymph (Fig. 5-6 C). 
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Taken together with our previous findings, which demonstrated that DP DCs were 
more frequent in lymph after small intestinal egg injection, we hypothesized that 
DP DCs from the small intestine were specialized to respond to S. mansoni egg 
antigen and represented the main subset involved in inducing Th2 responses in 
the small intestine.  
 
To determine which DC subset was involved in carrying antigen from the colonic 
lamina propria, 20 µg SEA-AF660 was injected into the colons of cMLNx mice. 
Mice were cannulated and lymph collected for 18 hours, after which cells were 
stained with fluorescent monoclonal antibodies and analysed by flow cytometry. 
The uptake of antigen was assessed by AF660 fluorescence in all four DC subsets 
and we observed that CD11b+ DCs were the most efficient DC subset to take up 
labelled-SEA (Fig. 5-6 D). In fact, 40% of cMLNx lymph CD11b+ DCs were SEA-
AF660+, whereas only 8% of DP DCs and 4% of CD103+ and DN DCs carried 
SEA-AF660 in lymph after colonic injection (Fig. 5-6 E). When comparing total 
numbers of labelled DCs, CD11b+ DCs again carried the majority of antigen in 
cMLNx lymph, whereas only very few cells from the other subsets were SEA-
AF660+ (Fig. 5-6 F). Together with our observation that the frequency of CD11b+ 
DCs was increased after colonic egg injection, we suggest that CD11b+ DCs in the 
colon specifically respond to egg antigen. As DP DCs in the small intestine and 
CD11b+ DCs in the colon selectively respond to and transport S. mansoni egg 
antigen in lymph we hypothesize that they represent tissue-specific subsets 
specialized to induce Th2 responses in the respective draining lymph nodes. 
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5.1.4 Egg antigens only have limited effects on the expression of 
costimulatory markers by dendritic cells 
 
 
Figure 5-7. Egg injection does not induce the expression of CD40, CD80, CD86 or OX40L on 
lamina propria DCs 
The expression of CD40 (A), CD80 (B), CD86 (C) and OX40L (D) was assessed on small intestinal 
LP DC subsets from naive and egg injected animals. Median fluorescent intensity of isotype 
controls is represented as a dotted line. Data represent at least two independent experiments 
(mean ± SEM) with each point representing one animal. Mann-Whitney U tests were applied 
between naive and egg injected groups for statistical analysis.  
 
 
We have shown that egg antigen is taken up by specialized DC subsets in the 
small intestine and colon and transported to individual draining lymph nodes. 
There they interact with naive T cells and prime antigen specific immune 
responses. It has been reported that the uptake of antigen stimulates DCs and 
leads to the expression of costimulatory molecules that are required to efficiently 
communicate with naive T cells (Constant and Bottomly, 1997). We therefore 
addressed whether exposure to egg antigen also led to the upregulation of 
costimulatory molecules on DCs. We focused on CD40, CD80 and CD86, which 
represent costimulatory molecules that are upregulated during antigen-driven TLR 
activation, and OX40L which had been identified as a costimulatory molecule 
involved in Th2 priming (Jenkins et al., 2007). S. mansoni eggs were injected into 
the small intestinal lamina propria of C57BL/6 mice and the injected tissue was 
harvested after 24 hours. Tissues were digested with Collagenase VIII and cells 
stained for flow cytometry. The expression of costimulatory markers by DCs was 
assessed by measuring the median fluorescent intensity (MFI) for each antibody 
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compared to its fluorescent isotype control. Hereby a shift in fluorescent intensity 
signified increased expression. We observed that small intestinal DCs expressed 
low levels of CD40. Hereby, the CD11b+ and DP DC subsets expressed higher 
amounts of CD40 compared to CD103+ DCs but no increase in CD40 expression 
was observed in egg injected tissues (Fig. 5-7 A). The expression of CD80 and 
CD86 by small intestinal DCs was also low. Their MFI was around 3,000 for 
CD11b+, DP and CD103+ DCs and lower for DN DCs. As observed for CD40, egg 
injection did not have an effect on the expression of CD80 or CD86 by any of the 
DC subsets (Fig. 5-7 B&C). We hypothesized that the expression of these 
classical costimulatory markers, which are associated with proinflammatory 
conditions, were not induced by egg antigens. However, we assumed that egg 
antigens might induce the expression of OX40L, which had been associated with 
Th2 cell priming (Jenkins et al., 2007). We observed that OX40L was weakly 
expressed by small intestinal DCs and that CD103+ DCs expressed lower levels 
than CD11b+ and DP DCs and DN DCs did not express any OX40L. Furthermore, 
levels of OX40L did not increase in any of the small intestinal DC subsets upon 
egg injection (Fig. 5-7 D). Thus, we concluded that egg injection into the small 
intestine did not affect the overall expression of conventional or Th2 inducing 
costimulatory molecules on lamina propria DCs 24 hours after injection. However, 
we were unsure if the injection of eggs into the small intestine represented a 
suitable model to study costimulatory marker upregulation, as the distribution of 
antigen and cell migration away from the lamina propria could not be controlled. 
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Figure 5-8. In vitro incubation with SEA only has limited effects on the expression of 
costimulatory markers of FACS sorted LP and lymph DCs 
Survival of FACS sorted SI LP DC subsets after in vitro incubation with or without SEA (+/- SEA) 
for 18 hours (A). Representative expression of the costimulatory markers CD40, CD80, CD86 and 
OX40L is shown on SI LP DCs cultured with or without SEA for 18 hours (B). Viability of FACS 
sorted lymph DC subsets after in vitro incubation with or without SEA (+/- SEA) for 18 hours (C). 
Representative MFI histograms of lymph DCs incubated with or without SEA for 18 hours are 
shown for CD40, CD80, CD86 and OX40L (D). Data represent at least two independent 
experiments (mean ± SEM) with each point representing cells from an individual animal. 
 
 
We had observed that the expression of the costimulatory markers CD40, CD80, 
CD86 and OX40L by lamina propria DCs was not affected by intestinal egg 
injection. However, egg injections might not represent a suitable model to detect 
changes in costimulatory marker expression, as not all DCs might be exposed to 
the injected antigen. Indeed, we have shown that only 9% of total DCs take up 
fluorescent SEA in the small intestine. Thus, potential responses could be 
masked. Furthermore, DCs constantly migrate from the lamina propria to the 
draining lymph nodes and might not be present in the tissue at the time of harvest. 
We therefore incubated FACS-sorted DCs with SEA in vitro to establish a 
controlled environment and ensure antigen availability to all cells. Small intestines 
of C57BL/6 mice were harvested and digested with Collagenase VIII. Cells were 
stained with fluorescent monoclonal antibodies against B220, MHCII, CD11c, 
CD64, Ly6C, CD103 and CD11b and total DCs purified by FACS sorting. DCs 
were incubated with or without 15 µg/ml SEA for 18 hours at 37° C. Cells were 
then stained for the costimulatory markers CD40, CD80, CD86 and OX40L and 
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7AAD staining solution was added to assess viability. We observed that after in 
vitro incubation the viability of small intestinal DC subsets was greatly affected. 
When gating on the individual DC subsets and assessing their viability we 
observed that 35% of CD11b+ DCs were live, whereas 20% of DP and DN DCs 
and only 10% of CD103+ DCs were viable after the 18-hour incubation. No 
difference in survival was observed in SEA-containing cultures, suggesting that 
cell-intrinsic characteristics of the different subsets rather than the presence of 
antigen affected their survival in vitro (Fig. 5-8 A). The expression of costimulatory 
markers was assessed by comparing the MFIs between cells that were incubated 
with or without SEA. We observed that the expression of CD40 on total small 
intestinal DCs slightly decreased with SEA incubation whereas CD80 expression 
increased. However, these changes in MFI were not statistically significant and the 
expression of CD86 and OX40L by small intestinal DCs was unchanged after SEA 
incubation (Fig. 5-8 B). Supporting our previous observations, these data indicated 
that in vitro incubation with S. mansoni egg antigen only had minor effects on the 
expression of costimulatory markers by small intestinal DCs. However, in vitro 
incubation also severely affected cell viability, which could negatively influence cell 
stimulation and we suspected that the enzymatic digestion during DC isolation 
from the small intestine had a negative effect on cell survival.  
 
As DCs collected from the lymph do not require enzymatic digestion we tested 
whether incubation with SEA would increase their expression of costimulatory 
markers. Contrary to small intestinal DCs, lymph DCs do not represent immature 
peripheral DCs, but are of a semi-mature state and express higher levels of 
MHCII, costimulatory markers and CCR7. However, contrary to fully mature MLN 
DCs, they still respond to TLR ligands and can acquire the ability to drive T cell 
differentiation, supporting our approach to incubate them with SEA in vitro 
(Cerovic et al., 2013). Steady state lymph was collected from MLNx C57BL/6 mice 
and stained for flow cytometry. Total lymph DCs were sort purified and incubated 
with or without 15 µg/ml SEA for 18 hours. After incubation cells were stained for 
the costimulatory markers CD40, CD80, CD86 and OX40L and a viability dye was 
added. We observed that lymph DCs had a higher viability after the 18-hour 
incubation than their small intestinal LP DC counterparts, indicating that the 
enzymatic digestion of LP DCs negatively affected their survival. 35% of CD11b+ 
lymph DCs, 40% of DP DCs, 20% of CD103+ DC and 30% of DN DCs were viable 
after 18 hours and no statistical difference in cell survival was detected between 
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DCs incubated with or without SEA (Fig. 5-8 C). Compared to small intestinal LP 
DCs the expression of CD86 was higher in lymph DCs, indicating their semi-
mature state. Incubation with SEA decreased the expression of CD40 and CD86, 
whereas the MFIs of CD80 and OX40L were increased (Fig. 5-8 D). However, due 
to insufficient experimental replicates statistical analysis could not be performed, 
but MFI differences between lymph DCs incubated with or without SEA were 
greater compared to their small intestinal counterparts. Thus, lymph DCs 
expressed lower levels of CD40 and CD86, while expressing increased amounts 
of CD80 and OX40L after in vitro incubation with S. mansoni egg antigen. 
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5.1.5 CD301b+ CD11b-expressing dendritic cells preferentially 
carry egg antigens to the draining lymph nodes 
 
 
 
Figure 5-9. CD301b but not PDL2 expression matches the subset specific DC profile for 
intestinal Th2 induction 
Representative MFI histograms and percentage of PDL2 expression by small intestinal (A) and 
steady state sMLNx lymph (B) DC subsets. CD301b expression by small intestinal (C) and sMLNx 
lymph (D) DC subsets are shown in representative MFI histograms and the percentage of CD301b 
expression. Data represent two independent experiments (mean ± SEM) with each point 
representing one sample. 
 
 
We had observed that the incubation with egg antigen affected the expression of 
costimulatory molecules on DCs, and as such induced the expression of CD80 
and OX40L, whereas decreasing the expression of CD40 and CD86. We 
continued to characterize intestinal DCs by examining the expression of surface 
molecules that had previously been associated with Th2 priming. It had been 
reported that PDL2-expressing DCs were involved in the maintenance of Th2 
responses in the skin both in vitro and in vivo (Gao et al., 2013). We therefore 
investigated if PDL2 was also expressed by intestinal DCs and could serve as a 
marker to identify Th2-inducing DC subsets. We harvested small intestines from 
wild-type C57BL/6 mice and digested them with Collagenase VIII. Cells were 
stained for flow cytometry and PDL2 expression analysed on DC subsets. We 
observed that around 30% of CD11b+, DP and CD103+ DCs expressed PDL2 in 
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the small intestine, whereas only 15% of DN DCs were PDL2+ (Fig. 5-9 A). In 
previous experiments we had observed that CD11b+ and DP DCs carried small 
intestinal egg antigen in lymph and therefore tested if these lymph DC subsets 
also expressed PDL2. We cannulated MLNx C57BL/6 mice and collected lymph 
for 18 hours. Cells for stained with fluorescent monoclonal antibodies and 
analysed by flow cytometry. A high percentage of DCs expressed PDL2 in steady 
state lymph. In fact, 65% of CD11b+ DCs, 85% of DP DCs, 95% of CD103+ DCs 
and 40% of DN DCs were PDL2+ (Fig. 5-9 B). The expression of PDL2 on CD103+ 
and DN DCs however suggested that PDL2 was not a marker that could 
selectively identify Th2 priming DCs, as our experiments suggested that only 
CD11b+ and DP DCs were involved in carrying egg antigen to the draining lymph 
nodes. Rather, the increased level of PDL2 expression in lymph DCs suggested 
that PDL2 was a DC maturation marker. It had indeed been published that PLD2 
expression was upregulated upon in vitro stimulation of bone marrow derived DCs, 
suggesting its involvement in DC maturation (Gao et al., 2013).  
 
Another marker that had been associated with Th2 induction on DCs was CD301b. 
It had been shown that dermal CD301b+ DCs drove Th2 responses in the skin and 
that CD301b expression was under the control of IRF4 (Kumamoto et al., 2013). 
From our own experiments we knew that both CD11b+ and DP DCs expressed 
IRF4 and were important for the induction of intestinal Th2 responses. We 
therefore examined if these DC subsets also expressed CD301b. We harvested 
the small intestines of C57BL/6 mice and digested them with Collagenase VIII. 
Stained cells were analysed by flow cytometry and CD301b expression assessed 
on DC subsets. We observed that 30% of CD11b+ and DP DCs in the small 
intestine expressed CD301b, whereas CD103+ and DN DCs did not express 
CD301b, confirming published findings that CD301b was only expressed by IRF4+ 
CD11b+ cells  (Fig. 5-9 C). To investigate if CD301b expression was altered in 
migrating DCs we assessed its expression profile on lymph DC subsets. Steady 
state lymph was collected from cannulated MLNx mice for 18 hours and stained 
for flow cytometry. 40% of lymph CD11b+ DCs and 20% of DP DCs were 
CD301b+, whereas CD103+ and DN DC subsets did not express CD301b (Fig. 5-9 
D). As the expression of CD301b did not markedly change between small 
intestinal and lymph DCs, it suggested that a committed subset of CD11b+ and DP 
DCs expressed CD301b. Thus, CD301b was expressed on the same DC subsets 
that transported egg antigen to the MLNs, and could potentially help identify DCs 
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that were specialized for the uptake and presentation of parasite antigen and the 
induction of Th2 responses, as previously suggested in the skin (Kumamoto et al., 
2013).  
 
 
 
Figure 5-10. Subsets of CD11b+ and DP DCs express CD301b in lymph and preferentially 
carry SEA 
Expression of CD301b was assessed in sMLNx lymph DC subsets (A). Frequency of expression in 
each subset (B), uptake of SEA in CD301b- or CD301b+ CD11b+ and DP DCs and total number of 
SEA+ CD301b-expressing cells of each DC subset (C) are shown. Equally, CD301b expression 
was also assessed in lymph DC subsets from cMLNx mice (D). Frequency of CD301b expression 
in each DC subset (E), uptake of SEA in CD301b- or CD301b+ CD11b+ and DP DCs and total 
number of SEA+ CD301b-expressing cells of each DC subset (F) were evaluated. Data represent at 
least two independent experiments (mean ± SEM) with each point representing one animal (B&E) 
or with at least three animals per group (C&F). Mann-Whitney U tests between CD301b- and 
CD301b+ groups (C&F) were applied for statistical analysis (*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001).  
 
 
It has been reported that CD301b+ DCs are important to drive Th2 immunity in the 
skin (Kumamoto et al., 2013) and we had observed that that a committed subset of 
CD11b+ and DP DCs expressed CD301b. These subsets were also responsible in 
transporting intestinally injected egg antigen to the MLNs, where they likely prime 
antigen specific Th2 responses. To investigate whether CD301b-expressing 
CD11b+ and DP DCs were specifically involved in this process and would carry 
parasite antigen from the lamina propria to the draining lymph nodes we analysed 
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lymph DCs of SEA-AF660 injected mice. In previous experiments we had 
identified that antigen was carried by CD11b+ and DP DCs in lymph. More 
precisely, DP DCs carried the majority of antigen injected in the small intestinal, 
whereas CD11b+ DCs transported antigen from the colon. To address whether 
these organ specific differences could also be observed in the pattern of CD301b 
expression by DCs, we analysed small intestine and colon-draining lymph. sMLNx 
mice were cannulated and 20 µg SEA-AF660 injected in the small intestinal lamina 
propria. Lymph was collected for 18 hours and cells were stained for flow 
cytometry. When we assessed CD301b expression by DCs, we observed that it 
was expressed by 60% of CD11b+ sMLNx lymph DCs and 40% of DP DCs (Fig. 5-
10 A). CD103+ and DN DCs did not express CD301b, which was in agreement 
with our previous findings (Fig. 5-10 B). To assess whether CD301b+ DCs were 
specialized to take up egg antigen and prime Th2 responses we investigated 
whether they carried parasite antigen. The majority of SEA-AF660 staining was 
found in CD301b+ DCs. 80% of SEA, that had been injected in the small intestine, 
was carried by CD301b-expressing CD11b+ DCs and equal proportions of SEA 
were transported by CD301b- and CD301b+ DP DCs. When we compared total 
numbers of SEA+ CD301b+ DC subsets we noticed that the majority of SEA was 
carried by sMLNx lymph CD301b+ DP DCs and to a lower extend by CD11b+ DCs, 
whereas CD103+ and DN DCs did not carry egg antigen (Fig. 5-10 C). Our data 
therefore suggested that CD301b+ DC subsets preferentially carried parasite 
antigen in sMLNx lymph and, in accordance with our previous findings, more DP 
DCs carried small intestinally injected antigen than CD11b+ DCs.  
 
We compared these findings to cMLNx mice that were cannulated and injected 
with 20 µg SEA-AF660 into the colonic lamina propria. In cMLNx lymph DCs, 
collected after 18 hours, we observed a similar CD301b expression profile as in 
sMLNx lymph. CD301b was expressed by 60% of CD11b+ and 40% of DP DCs 
but not by CD103+ and DN DCs (Fig. 5-10 D&E). Within the CD11b+ DC subset, 
80% of injected antigen was carried by CD301b-expressing cells and 60% of SEA 
was carried by CD301b cells within DP DCs, again demonstrating that the majority 
of SEA was carried by CD301b-expressing cells. In accordance to our previous 
findings and contrary to the small intestine, analysis of total numbers of SEA+ 
CD301b+ DCs revealed that the majority of SEA+ cells in colon draining lymph 
were CD11b+ DCs (Fig. 5-10 F). We had therefore established that CD301b was 
expressed by the majority of lymph CD11b+ and DP DCs and that CD301b-
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expressing DCs preferentially carried parasite antigen. Total numbers of antigen 
carrying DCs revealed tissue specific differences that were in accordance with our 
previous findings and showed that SEA+ CD301b+ DP DCs were more abundant in 
sMLNx lymph whereas CD301b-expressing CD11b+ DCs carried nearly all SEA in 
cMLNx lymph. However, a significant proportion of CD301b- cells also carried 
SEA-AF660 in lymph suggesting that CD301b-expression by DCs is not sufficient 
to exclusively identify egg antigen presenting and Th2 priming DCs in our system. 
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5.2 Discussion 
 
We had observed that the role of migrating DCs was essential for the induction of 
Th2 responses against intestinally injected S. mansoni eggs and that these 
responses were impaired in IRF4f/f CD11c-cre-positive mice, which exhibited 
reduced numbers of CD11b+ and DP DCs in the MLNs. To focus directly on the 
cells that migrated from the lamina propria to the MLNs and monitor their migrating 
behaviour we collected thoracic duct lymph from mesenteric lymphadenectomized 
mice. In these mice the removal of the MLNs ensures the migration of DCs to the 
thoracic duct, which is cannulated by the surgical insertion of a cannula (Cerovic et 
al., 2013). By selectively removing the sMLNs or cMLNs we could further collect 
only small intestine or colon-draining DCs in lymph (Houston et al., 2016). We 
observed that four main immune cell populations could be identified in lymph: B 
cells, CD4 and CD8 T cells, and DCs. B cells represented the majority of cells, 
followed by CD4 T cells and CD8 T cells, whereas DCs only represented 1-2% of 
all lymph cells (Fig. 5-2). Many of these B and T cells were likely recirculating 
throughout the lymphatic system and the thoracic duct and did not directly 
originate from the intestine. The collected DCs however were directly migrating 
from the intestinal lamina propria, as the MLNs were the only lymph nodes 
removed in these mice.  
 
Thoracic duct cannulations have been used as a method to collect lymph from 
several animal species and similar observations have been made in 
lymphadenectomized mice and rats. It was demonstrated that mesenteric 
lymphadenectomy in rats was followed by the unification of the peripheral and 
central lymphatics, allowing the collection of intestine-derived peripheral lymph 
cells via the thoracic duct for several days. B and T cells comprised the majority of 
collected lymph cells, but nonlymphoid cells (NLC) that showed irregular and 
heterogeneous surface morphology, including long pseudopodia and veils, were 
also observed. These NLCs were present at very low frequencies in normal 
thoracic duct lymph at all times following cannulation and their expression of 
MHCII but lack of B or T cell markers suggested that they represent migrating DCs 
(Pugh et al., 1983). Similarly, thoracic duct cannulation of mesenteric 
lymphadenectomized mice allowed the collection of migrating DCs from the 
intestine, which represent 1-2% of all lymph cells and are absent in the lymph of 
non-lymphadenectomized mice (Cerovic et al., 2013). 
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Although steady-state migration of DCs occurs under homeostatic conditions it has 
also been reported that different TLR stimuli enhance the migration of DCs from 
the lamina propria to the draining lymph nodes. For example, oral administration of 
the TLR7/8 ligand resiquimod (R-848) induced a 20- to 30-fold increase in DC 
migration from the intestine within 10 hours, which was observed in the lymph of 
mesenteric lymphadenectomized rats and the mesenteric lymph nodes of mice. 
Hereby, R-848 induced the migration of nearly all lamina propria DCs resulting in 
cell accumulation in the MLNs (Yrlid et al., 2006). Similarly, intraluminal injection of 
Bacillus subtilis spores in MLNx rats induced a 5- to 10-fold increase in lymph 
migrating DCs, which selectively carried fluorescently labelled spores in lymph 
(Cerovic et al., 2009).  
 
To test whether S. mansoni eggs affected the migration of immune cells, eggs 
were injected into the lamina propria of cannulated MLNx mice and lymph 
collected for 18 hours. We observed that the injection of PBS or eggs did not 
significantly affect the proportion or total number of migrating immune cells, 
suggesting that the injection in itself and the injection of eggs specifically did not 
impair or enhance cell migration in this setup (Fig. 5-3). To investigate the 
migration of DCs in more detail we distinguished between DCs originating from the 
small intestine or the colon. As DCs cannot migrate past the MLNs, the selective 
removal of the sMLNs (“sMLNx”) allows the collection of small-intestine-derived 
DCs in thoracic duct lymph, whereas cMLN removal (“cMLNx”) only enables 
colonic DCs to migrate to the thoracic duct (Houston et al., 2016). We observed 
that lymph draining the small intestine of egg-injected animals contained a higher 
frequency of DP DCs and a lower frequency of CD103+ DCs compared to PBS 
injected controls. However, the volumes of lymph collected from each animal after 
cannulation of the thoracic duct were somewhat variable, as they are affected by 
surgical, physiological and micro-anatomical features of the individual cannulated 
animals. Therefore, changes in total numbers were less pronounced (Fig. 5-4). 
The finding that small intestinal DP DCs were found in increased frequency in the 
lymph of small intestinally egg-injected mice, suggested that this subset 
specifically responded to the injected antigen. This change in subset composition 
had likely been masked in previous experiments, where total DC frequencies and 
numbers were investigated, and demonstrated that S. mansoni egg antigen 
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stimulates DCs and specifically enhances the migration of the DP DC subset in the 
small intestine. 
 
When we assessed the frequency and total number of DCs in colon draining 
lymph we observed that 10 times fewer DCs were present compared to sMLNx 
lymph. This observation was consistent with our data from the colonic lamina 
propria and the cMLNs which also contain fewer DCs. Furthermore, as previously 
reported in the colon and the cMLNs (Denning et al., 2011; Houston et al., 2016), 
CD11b+ and CD103+ DCs were the most abundant DC subsets in lymph draining 
the colon, in contrast to small intestinal lymph where DP and CD103+ DCs are the 
most numerous subsets. Surprisingly, egg injection into the colon resulted in an 
increased frequency of migrating CD11b+ DCs in the lymph of cMLNx mice and 
not in DP DCs, as previously observed in small intestinal draining lymph (Fig. 5-5). 
Therefore, egg injections had an effect on the migration of tissue specific DC 
subsets, increasing the percentage of small intestinal DP DCs and colonic CD11b+ 
DCs in lymph of egg-injected animals.  
 
To investigate whether this increase in DC subset migration corresponded with the 
uptake of injected antigen, fluorescently labelled SEA was injected in the lamina 
propria of sMLNx or cMLNx mice and lymph collected for 18 hours. Among DCs 
carrying labelled SEA from the small intestine, lymph DP DCs were the most 
numerous, whereas CD11b+ DCs were the dominant subset that carried SEA 
injected in the colonic lamina propria (Fig. 5-6). Together with our previous 
observations that the same tissue specific subsets migrated in increased 
frequency after egg injection, we suggest that they are primarily involved in the 
uptake, transport and presentation of intestinal egg antigen to the MLNs. We 
therefore hypothesize that the priming of Th2 cells in the MLNs is likely to be 
carried out by distinct subsets of DCs; CD11b+CD103+ DP DCs in the small 
intestine and CD11b+CD103- single positive DCs in the colon. If this hypothesis is 
confirmed, it would demonstrate that specific DC subsets are specialized for the 
induction of Th2 responses, a concept that has already been shown for other 
types of immune responses, and furthermore suggest a tissue specific 
specialization. This would raise the question why these DC subsets have 
differentially developed but serve the same function and bring new complexity to 
our understanding of the tissue-specific cues that influence DC differentiation and 
function in the intestine. 
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Once DCs reach the lymph nodes they present antigen to naive T cells and prime 
them against the antigen. However, for the proper differentiation into T helper cells 
naive T cells also require cues from costimulatory markers expressed by DCs. As 
such, conventional costimulatory molecules such as CD40, CD80 and CD86 are 
upregulated in response to proinflammatory TLR stimuli of bacterial, fungal or viral 
origin and induce the differentiation of Th1 and Th17 cells (Chen and Flies, 2013). 
The costimulatory molecule OX40L has recently been identified to play a role in 
Th2 immunity and its expression can be induced by TSLP or parasite products 
(Jenkins et al., 2007). We therefore assessed whether egg antigens also induced 
the expression of conventional costimulatory molecules or OX40L 24 hours after 
small intestinal egg injection but could not observe any changes in their 
expression profile on intestinal DC subsets (Fig. 5-7). However, our previous 
experiments had shown that only 9% of total DCs take up fluorescent SEA in the 
small intestine suggesting that not all DCs within the lamina propria are exposed to 
intestinally injected antigen. As subserosal egg injections do not cover the entire 
area of the lamina propria nor the entire length of the small intestine certain areas 
remained unaffected. Furthermore, lamina propria DCs constantly migrate to the 
MLNs and exposed DCs might no longer be present in the tissue at the time of 
harvest. To ensure antigen availability to all cells we incubated FACS-sorted DCs 
with SEA in vitro. We observed that in vitro culturing had a negative impact on cell 
survival and that small intestinal DC subsets were stronger affected than lymph 
DCs. We suspect that the enzymatic digestion of the small intestine had a 
negative effect on cell survival. However, cell survival was not affected by the 
addition of SEA, suggesting that cell-intrinsic characteristics of the different 
subsets affected their survival in vitro. We observed that the expression of CD40 
on total small intestinal DCs slightly decreased with SEA incubation whereas 
CD80 expression increased. The expression of CD86 and OX40L by small 
intestinal DCs was unchanged.  
 
When we assessed the expression of these costimulatory markers in lymph DCs, 
we observed a generally higher expression of CD86. As previously published, 
lymph DCs do not represent immature peripheral DCs but are of a semi-mature 
state and express higher levels of MHCII, costimulatory markers and CCR7. 
However, contrary to fully mature MLN DCs, they still respond to TLR ligands and 
can acquire the ability to drive T cell differentiation (Cerovic et al., 2013), 
suggesting that they could still respond to egg antigens in vitro. Similar to our 
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observations in small intestinal DCs, SEA incubation of lymph DCs decreased the 
expression of CD40 and increased the expression of CD80. In addition, levels of 
CD86 were reduced and the MFIs of OX40L were increased after SEA incubation 
(Fig. 5-8). However, due to insufficient experimental replicates statistical analysis 
could not be performed, but MFI differences between lymph DCs incubated with or 
without SEA were greater compared to their small intestinal counterparts. We 
therefore concluded that SEA only had minor effects on the expression of 
costimulatory markers by small intestinal and lymph DC subsets after in vitro 
incubation.  
 
The observation that SEA does not increase the expression of conventional 
costimulatory markers has also been observed in the literature. In contrast to 
BMDCs incubated with Propionebacterium acnes, SEA-exposed BMDCs did not 
upregulate the costimulatory markers CD40, CD80 or CD86 (MacDonald et al., 
2002). Similarly, human monocyte-derived DCs did not upregulate CD80, CD83 or 
CD86 after SEA incubation and TLR-induced expression with poly-I:C or LPS was 
downregulated by SEA (van Liempt et al., 2007). In contrast, several studies have 
shown that OX40L expression by DCs is upregulated by TSLP or parasite 
products and is an important signal that drives Th2 immunity. Thus, blocking of 
OX40L using monoclonal antibodies led to impaired Th2 differentiation by TSLP-
activated human monocyte-derived DCs in vitro (Soumelis et al., 2002). 
Additionally, OX40L expression of human monocyte-derived DCs was increased 
after SEA or cholera toxin incubation (de Jong et al., 2002). Furthermore, murine 
SEA-pulsed OX40L-/- BMDCs could not induce antigen-specific Th2 responses 
when transferred into naive recipient animals, but responses were rescued by the 
injection of agonistic anti-OX40 antibodies, indicating that OX40L expression by 
DCs was important to drive appropriate Th2 responses (Jenkins et al., 2007). In 
our experiments we observed a minimal increase of OX40L expression after SEA 
incubation, but this increase was not as dramatic as some of the published 
responses. However, contrary to the culture systems used in the literature we 
assessed OX40L expression on tissue-derived DCs and not in in vitro generated 
cells, such as BMDCs or human monocyte-derived DCs. It needs to be taken into 
consideration that these in vitro generated cells represent a heterogeneous 
population of monocytes, DC-like and macrophage-like cells that may not 
accurately represent the behaviour of tissue-derived DCs (Helft et al., 2015). 
Although easy to generate, it is important to verify the observations in tissue-
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derived DCs. We could therefore demonstrate that the incubation with SEA in vitro 
did not induce the expression of conventional costimulatory markers in intestinal 
tissue-derived or lymph DCs and only slightly increased the expression of OX40L. 
 
Another DC marker that has recently been reported to be involved in Th2 immunity 
in the skin is PDL2. PDL2+ BMDCs induced Th2 responses in effector/memory 
CD4 T cells in vitro. Moreover, PDL2 was highly expressed in skin LN DCs and 
PDL2+ DCs induced the expression of IL-4 in naive and effector/memory CD4 T 
cells (Gao et al., 2013). We therefore assessed if PDL2 was also expressed in the 
intestine. We observed that around 30% of CD11b+, DP and CD103+ DCs and 
15% of DN DCs expressed PDL2 in the small intestine and 65% of CD11b+ DCs, 
85% of DP DCs, 95% of CD103+ DCs and 40% of DN DCs were PDL2+ in lymph 
(Fig. 5-9). The expression of PDL2 on CD103+ and DN DCs suggested that PDL2 
was not a marker that could selectively identify Th2-priming DCs in our system, as 
our experiments suggested that only CD11b+ and DP DCs were involved in 
carrying egg antigen to the draining lymph nodes. Rather, the increased level of 
PDL2 expression in lymph DCs suggested that PDL2 might be a DC maturation 
marker. It had indeed been published that PDL2 was upregulated upon in vitro 
stimulation of BMDCs and was highly expressed in skin draining lymph node DCs, 
suggesting its potential involvement in DC maturation (Gao et al., 2013). 
 
Another marker that has been associated with Th2 induction in the skin is 
CD301b/Mgl2. It had been shown that CD301b+ DCs carried OVA to the draining 
lymph nodes when the Th2-inducing adjuvant papain was administered, but not 
when PBS or the TLR-agonist CpG were injected. Furthermore, CD301b+ cell 
deficient Mgl2-DTR mice did not respond to papain or alum immunization in the 
skin nor mounted Th2 responses against N. brasiliensis, whereas proinflammatory 
responses against CpG/OVA were unaffected (Kumamoto et al., 2013). When we 
assessed CD301b expression by intestinal DCs, we observed that a committed 
subset of CD11b+ and DP DCs in the small intestine and lymph expressed 
CD301b (Fig. 5-9). CD301b was hereby expressed by CD11b+ and DP DCs in 
both small intestinal and colonic draining lymph. Furthermore, CD301b-expressing 
DCs preferentially carried fluorescently-labelled egg antigen in lymph, similar to 
the reported uptake of OVA during papain administration. When we compared 
total numbers of antigen carrying DCs, we observed tissue specific differences 
that were in accordance with our previous findings. SEA+ CD301b+ DP DCs were 
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more numerous in sMLNx lymph whereas CD301b-expressing CD11b+ DCs 
carried nearly all SEA in cMLNx lymph (Fig. 5-10). Thus, CD301b expression 
corresponded with the subset specific uptake of antigen we had previously 
observed. However, as the function of CD301b is currently unknown and a 
significant proportion of CD301b- cells also carried SEA-AF660 in lymph, CD301b-
expression by DCs was not sufficient to identify Th2 priming DCs in our system.  
Thus, our efforts to verify reported molecules that are important in the induction of 
Th2 responses have generated no clear result in our model of intestinal S. 
mansoni egg immunization. However, our experiments indicate that specific DC 
subsets are specialized to carry intestinal egg antigens to the draining lymph 
nodes. Interestingly, this is carried out by CD11b+CD103+ DP DCs in the small 
intestine and CD11b+CD103- single positive DCs in the colon, which suggests a 
tissue specific specialization.  
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5.3 Conclusions 
 
As previously published, we were able to identify B cells, T cells and DCs in the 
lymph of cannulated lymphadenectomized mice in steady state. The percentage 
and total number of these immune cells did not change upon intestinal egg 
injection suggesting that steady state migratory cells were sufficient to carry 
parasite antigen to the MLNs. Indeed, both migrating B cells and DCs carried 
fluorescent SEA injected into the small intestine in lymph. A closer look at the 
lymph migrating DC subsets revealed that DP and CD103+ DCs were the most 
numerous DC subsets in small intestine-draining sMLNx lymph, whereas CD11b+ 
and CD103+ DCs were the most numerous populations migrating from the colon. 
However, the frequency of DCs in cMLNx mice was 10-fold lower compared to 
sMLNx lymph.  
We observed that the frequency of the subset of DP DCs migrating from the small 
intestine increased after egg injection and that CD11b+ DCs were more frequent 
after egg injection in the colon. Small intestinal DP DCs and colonic CD11b+ DCs 
were also the most numerous subsets to carry fluorescent SEA in lymph, 
suggesting that the physiological differences between the small intestine and colon 
were reflected in distinct cellular responses upon S. mansoni egg injection. 
However, egg antigens did not induce the upregulation of conventional and Th2 
associated costimulatory molecules on DCs after small intestinal egg injection. 
However, after in vitro incubation of FACS sorted small intestinal and lymph DCs 
with SEA, minor effects on the expression of CD40, CD80, CD86 and a slight 
upregulation of OX40L were observed. PDL2 expression of intestinal DC subsets, 
which has been associated with Th2 responses in the skin, was identified in all 
four subsets and increased in lymph, suggesting that it is associated with DC 
maturation rather than Th2 induction. CD301b expression, another Th2 associated 
molecule, however was only expressed on committed CD11b+ and DP DCs in the 
small intestine and lymph, which correlated with our own findings that CD11b+ and 
DP DCs were involved in intestinal Th2 responses. Indeed, CD301b+ DCs in small 
intestinal and colonic draining lymph preferentially carried SEA and reflected 
tissue-specific differences in CD11b+ and DP DC composition. Taken together, our 
data suggest that DP DCs from the small intestine and CD11b+ DCs from the 
colon are specialized to carry intestinally injected egg antigen and are likely 
responsible for the induction of tissue specific Th2 responses in the respective 
MLNs.	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Chapter 6: Different subsets of small intestinal and 
colonic dendritic cells drive Th2 responses upon 
transfer into recipient mice  
  
6.1 Results 
 
In our previous experiments we had observed that B cells and DCs transported 
fluorescently-labelled SEA from the intestine to the draining lymph nodes. We had 
furthermore shown that distinct subsets of DCs transported parasite antigen from 
the small intestine and colon. To identify if these cell populations were also directly 
involved in priming naive T cells in the MLNs we FACS purified these populations 
from egg injected donor mice and transferred them into the MLNs of wild type 
recipient animals. Importantly, the purified donor cells were precisely injected 
under the capsule of a single MLN, using techniques we have recently developed 
(Cerovic et al., 2015). This allowed the controlled delivery into the subcapsular 
sinus of the draining lymph node, their natural route of entry (Braun et al., 2011), 
enabling us to directly assess the priming capabilities of the transferred cells in 
vivo.	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6.1.1 Dendritic cells but not B cells drive immune responses 
against S. mansoni egg antigens in the MLNs 
 
 
 
Figure 6-1.  DCs but not B cells are sufficient to prime Th2 responses upon transfer into 
recipient mice 
To assess whether lymph migrating immune cell populations could induce antigen specific immune 
responses once transferred into recipient mice, cells were collected from thoracic duct lymph of 
egg injected MLNx donor mice, FACS purified and transferred under the MLN capsule of recipient 
mice. 5 days after transfer immune responses were analysed by setting up 3 day in vitro MLN 
restimulation cultures. A schematic of the experiment is shown in A. Cytokines measured in 
restimulation cultures from transferred B cell and DC recipient mice (B). Immune responses 
induced by transferred MHCII-/- or C57BL/6 DCs from egg injected donors measured after 
restimulation of the recipient MLNs (B). Data represent at least three independent experiments 
(mean ± SEM) with at least three animals per group. Mann-Whitney U tests were applied for 
statistical analysis (**P ≤ 0.01).  
 
 
We had observed that both B cells and DCs, but not T cells, transported 
fluorescently labelled SEA in lymph, which had been injected into the subserosa of 
the small intestine of MLNx mice. Therefore, these cells were responsible for 
transporting the antigen from the intestine to the draining lymph nodes. To address 
if these cells were also sufficient to induce antigen specific immune responses 
within in the lymph node we transferred them into recipient mice. To collect these 
cells, eggs were injected into the intestines of donor MLNx mice and lymph was 
collected for 18 hours after cannulation. As we had observed that around 4% of B 
cells and 10% of DCs carried fluorescently labelled antigen, we equalized the 
amount of antigen-carrying cells by collecting twice as many B cells than DCs, and 
FACS purified 100,000 B cells and 50,000 total CD11c+ MHCII+ DCs from lymph. 
As these cells were collected from egg-injected donor mice, no exogenous antigen 
was provided but cells were directly resuspended in 5 µl PBS and injected under 
the MLN capsule of wild type recipient animals. The precise delivery into the MLN 
allowed us to investigate their physiological potential for priming T cells in vivo. We 
investigated if the transferred cells were sufficient to induce egg antigen specific 
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immune responses and 5 days after cell transfer the injected MLNs were 
harvested and cells were restimulated with SEA in vitro. After 3 days supernatants 
were collected and secreted cytokines measured by ELISA (Fig. 6-1 A). We 
detected the production of antigen specific cytokines in recipient mice after DC but 
not B cell transfer, suggesting that DCs but not B cells were sufficient to prime 
naive T cells in the recipient MLNs. IFN-γ as well as robust levels of IL-4, IL-5 and 
IL-13 were detected in restimulation cultures after DC transfer, indicating that egg 
antigen specific IFN-γ producing T cells as well as Th2 cells were primed by DCs 
but not B cells (Fig. 6-1 B). This observation corresponded to findings in the 
literature, which have shown in many experiments that antigen-presenting DCs are 
specialized to prime naive T cells and initiate immune responses, whereas 
antigen-presenting B cells communicate with effector/memory T helper cells to 
potentiate these responses. Furthermore, our own observations in IRF4f/f CD11c-
cre mice indicated that CD11c-expressing cells, which include DCs but not B cells, 
are necessary to drive Th2 responses against S. mansoni egg antigens in the 
intestine.  
 
As antigen presentation to CD4 T cells is mediated by MHCII molecules, we tested 
whether MHCII-deficient DCs could still induce immune responses upon transfer. It 
has been reported that uptake of antigen is not inhibited in MHCII-/- DCs, however 
antigen presentation to CD4 T cells does not occur (Villadangos et al., 2005). The 
transfer of MHCII-/- DCs from egg injected donors therefore allowed us to 
investigate if the transferred DCs directly primed naive CD4 T cells in the recipient 
animal or if they were just responsible for transporting the antigen to the draining 
lymph node. Again, eggs were subserosally injected into the small intestine of 
MLNx MHCII-/- or C57BL/6 mice and lymph collected via thoracic duct cannulations 
for 18 hours. Total CD11c+ DCs were selected from live B220- Ly6C- CD64- cells 
and FACS purified. 50,000 DCs from either MHCII-/- or C57BL/6 donor mice were 
transferred under the MLN capsule of each recipient animal and 5 days after 
transfer the injected MLNs were harvested and restimulated for 3 days with SEA in 
vitro. IFN-γ, IL-4, IL-5 and IL-13 were measured in the supernatants of these 
restimulation cultures and gave an indication of the induced immune response. We 
observed that the transfer of MHCII-/- DCs did not induce any antigen specific 
immune responses in recipient mice, whereas the transfer of C57BL/6 DCs from 
egg injected donors induced robust IFN-γ and Th2 responses (Fig. 6-1 C). 
Therefore, our findings clearly indicate that DCs and not B cells were sufficient to 
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induce egg antigen specific immune responses after transfer into wild type 
recipient mice and were responsible for inducing Th2 responses against egg 
antigen. T cell priming was mediated directly by the transferred DCs through 
MHCII and did not occur when MHCII-/- DCs were transferred.  
 
 
 
Figure 6-2. Small intestinal LP and lymph DCs, but not migratory MLN DCs, are able to 
present in vitro loaded SEA upon transfer 
To assess if DCs could present in vitro loaded SEA upon transfer, DCs were purified by FACS 
sorting, incubated with or without SEA for 6 hours and transferred under the capsule of recipient 
mice. Induced immune responses were analysed using restimulation cultures from MLNs 
harvested 5 days after transfer. A schematic illustrating the experimental protocol is shown in A. 
Cytokines measured in recipient MLNs of small intestinal LP DCs loaded with SEA (+ SEA) or 
without SEA (- SEA) from unstimulated (un) or restimulated (re) wells (B). Immune responses 
induced by transferred lymph DCs (C) or MLN DCs (D) loaded with or without SEA in vitro. Data 
represent at least three independent experiments (mean ± SEM) with at least three animals per 
group. Mann-Whitney U tests were applied for statistical analysis (**P ≤ 0.01; ***P ≤ 0.001).  
 
 
We had observed that lymph DCs from egg injected donor mice were sufficient to 
induce Th2 responses upon transfer into wild type recipient animals. In these 
experiments, antigen was acquired in the small intestinal lamina propria from 
subserosally injected eggs. To address whether in vitro antigen loaded DCs could 
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also be used to prime Th2 responses against SEA, we FACS sorted DCs from 
C57BL/6 mice, incubated them with our without SEA for 6 hours, and after 
thoroughly washing off any unbound antigen, transferred these cells under the 
MLN capsule of recipient mice. Antigen specific T cell responses were detected in 
the injected lymph nodes 5 days after DC transfer by in vitro restimulation and 
measurement of secreted cytokines (Fig. 6-2 A). We harvested total DCs from the 
small intestinal lamina propria, the lymph and the MLNs, which represent the 
tissues where migratory intestinal DCs are found (Cerovic et al., 2013). Small 
intestines of C57BL/6 mice were enzymatically digested with Collagenase VIII, 
cells stained with monoclonal fluorescent antibodies and total DCs purified by 
FACS. 50,000 total DCs were either incubated with or without 15 µg/ml SEA for 6 
hours at 37°C in vitro. Cells were washed twice with PBS to remove any antigen 
that had not been taken up, and resuspended in 5 µl PBS. DCs were transferred 
under the MLN capsule of individual wild type recipient animals and the induction 
of antigen specific immune responses by the transferred cells measured 5 days 
after transfer using SEA restimulation cultures. We observed that small intestinal 
DCs that were not incubated with SEA did not induce any antigen specific immune 
responses in recipient mice. SEA loaded small intestinal DCs did on the other 
hand induce immune responses, measured by the secretion of IFN-γ, IL-4, IL-5 
and IL-13 after restimulation. Low concentrations of IFN-γ (2 ng/ml) but no Th2 
cytokines were detected in unstimulated wells, indicating that some cells secreted 
IFN-γ without being stimulated. However, much higher amounts of cytokine were 
detected upon restimulation and 5 ng/ml of IFN-γ, 0.2 ng/ml of IL-4 and IL-5 and 5 
ng/ml of IL-13 were measured in these cultures (Fig. 6-2 B). Thus, small intestinal 
DCs that were loaded with SEA in vitro were sufficient to induce immune 
responses in recipient animals upon transfer. Similar to our previous experiments, 
these responses were antigen specific against SEA and required restimulation to 
be detected, indicating that antigen specific IFN-γ-producing cells and Th2 cells 
had been primed.  
 
Small intestinal DCs represent immature peripheral DCs that are responsible for 
taking up antigen in the lamina propria, which likely enabled them to also sample 
antigen in vitro. Upon stimulation by intestinal antigen and homeostatic signals 
within the intestine they enter a semi-mature state and upregulate MHCII, 
costimulatory markers and CCR7 (Randolph et al., 2005). They then migrate 
through the lymphatics to the MLNs, to present the acquired antigen. To test 
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whether semi-mature lymph DCs were also able to take up and present antigen 
acquired in vitro, we cannulated the thoracic lymph duct of MLNx animals and 
collected the lymph for 18 hours. Cells were then stained with fluorescent 
antibodies and total DCs purified by FACS sorting. Again, 50,000 DCs were either 
incubated with or without SEA for 6 hours in vitro. Unbound SEA was washed off 
with PBS and cells were injected into the MLNs of individual recipient animals. 5 
days after transfer the injected MLNs were harvested and MLN cells restimulated 
with SEA in vitro. To detect antigen specific immune responses, secreted 
cytokines were measured in the supernatants of these cultures. Similar to what we 
had observed after small intestinal DC transfers, lymph DCs that were not loaded 
with SEA did not induce any immune responses in the recipient MLNs. After being 
loaded with SEA, lymph DCs did induce antigen specific immune responses upon 
transfer, indicated by the secretion of IFN-γ, IL-4, IL-5 and IL-13 in restimulation 
cultures. In unstimulated conditions minimal amounts of cytokines were produced, 
whereas after restimulation 4 ng/ml of IFN-γ, 0.4 ng/ml of IL-4, 0.9 ng/ml of IL-5 
and 8 ng/ml of IL-13 were detected (Fig. 6-2 C). The concentrations of the 
released cytokines were comparable with small intestinal DC transfers for IFN-γ 
and IL-4 but increased for IL-5 and IL-13. We had previously observed that the 
enzymatic digestion during small intestinal DC isolation negatively affected cell 
survival in vitro, which could explain the reduced responses after small intestinal 
DC transfer compared to lymph DCs. As previously published with OVA protein 
(Cerovic et al., 2013) and corresponding with our own observations, lymph DCs 
retained the potential to take up SEA in vitro and present it to naive T cells upon 
transfer into wild type recipient animals.  
 
Once DCs reach the MLNs they fully mature and present intestinal antigens to 
naive T cells and can be distinguished from resident DCs by their higher 
expression of MHCII (Cerovic et al., 2013). To address whether migratory MLN 
DCs were still able to take up exogenous antigen in vitro and present it once 
transferred into recipient mice, MLNs of C57BL/6 animals were harvested. Tissues 
were digested with 8 U/ml Liberase and 10 µg/ml DNase, cells stained with 
fluorescent antibodies and total migratory MLN DCs purified by FACS sorting. 
50,000 cells were incubated with or without SEA for 6 hours in vitro, washed and 
transferred under the MLN capsule of recipient animals. The induction of antigen 
specific immune responses in these lymph nodes was assessed 5 days after 
transfer by restimulating harvested MLN cells with SEA in vitro. Cytokine 
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production during in vitro restimulation was measured in the supernatants by 
ELISA. As previously observed, DCs that were not loaded with SEA did not induce 
any immune responses in the recipient MLNs after transfer. In contrast to what we 
had observed from small intestinal and lymph DCs, SEA-loaded migratory DCs did 
not induce any antigen specific immune responses upon transfer, as we could not 
detect any cytokines after restimulation (Fig. 6-2 D). We were confident that viable 
MLN DCs had been transferred, as this was assessed by Trypan blue exclusion 
after the incubation period with SEA, and the cell viability was comparable to small 
intestinal and lymph DCs. Therefore, our results indicate that immature DCs from 
the small intestine and semi-mature DCs from lymph were able to present in vitro 
loaded SEA and could induce antigen-specific immune responses upon transfer, 
whereas fully mature migratory DCs from the MLNs were no longer able to present 
in vitro loaded antigen upon transfer.  
 
6.1.2 CD11b-expressing dendritic cells are uniquely able to 
induce Th2 responses against egg antigens 
 
 
Figure 6-3. Lymph CD11b+ and DP are specialized to induce Th2 responses upon transfer 
Lymph DC subsets were purified by FACS sorting, loaded with SEA in vitro and transferred under 
the capsule of recipient mice. 5 days after transfer MLN restimulation cultures were set up to 
quantify immune responses induced by the transferred cells. A schematic of the experimental 
protocol is shown in A. Cytokine responses measured from MLNs, from unstimulated (un) and 
restimulated (re) cultures, in which SEA-loaded CD11b+ (B), DP (C), DN (D) or CD103+ (E) lymph 
DCs had been transferred. Data represent at least three independent experiments (mean ± SEM) 
with at least three animals per group. Mann-Whitney U tests were applied for statistical analysis (*P 
≤ 0.05; **P ≤ 0.01).  
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As we had observed that total small intestinal and lymph migrating DCs were able 
to present in vitro loaded SEA when transferred into wild type recipient mice, we 
tested whether specific DC subsets were specialized to induce these responses. 
In our SEA uptake experiments we had discovered that CD11b+ and DP DC 
subsets transported intestinal egg antigen to the draining lymph nodes and 
therefore hypothesized that these subsets were also responsible for the induction 
of Th2 responses. Similarly, CD11b+ and DP DCs were greatly reduced in the 
MLNs of IRF4f/f CD11c-cre-positive mice, suggesting that they were essential for 
driving Th2 responses, which were impaired in these animals.  
 
As lymph DCs induced stronger responses after transfer compared to small 
intestinal DCs, which could be related to the enzymatic digestion necessary to 
isolate them from the intestine, we collected lymph from cannulated MLNx 
C57BL/6 mice and individually purified the four DC subsets by FACS sorting. To 
ensure that egg antigen was equally available to all DCs we incubated equal 
numbers of each DC subset with 15 µg/ml SEA in vitro. 30,000 cells of each 
subset were incubated with SEA for 6 hours, washed and transferred under the 
capsule of wild type recipient mice. After 5 days, the injected MLNs were 
harvested and restimulated with SEA in vitro and antigen specific immune 
responses were analysed by measuring secreted cytokines in the supernatants 
(Fig. 6-3 A). We did not observe any cytokine secretion in unstimulated wells, 
indicating that all primed T cell responses required restimulation. In restimulation 
cultures of MLNs that had received SEA-loaded CD11b+ lymph DCs we measured 
5 ng/ml of IFN-γ, 0.2 ng/ml of IL-4, 0.2 ng/ml of IL-5 and 7 ng/ml of IL-13 (Fig. 6-3 
B), indicating that SEA-loaded CD11b+ DCs were sufficient to prime Th2 
responses after transfer. These cytokines were also measured in MLNs from DP 
DC recipient animals. The amount of cytokines induced by DP DCs was higher 
compared to CD11b+ DC recipient mice, especially for the cytokines IL-4, IL-5 and 
IL-13 (Fig. 6-3 C), suggesting that DP DCs were more efficient in priming antigen-
specific Th2 cells. Transferred SEA-loaded DN and CD103+ DCs induced IFN-γ 
responses, but not Th2 cells, identified by the lack of IL-4, IL-5 and IL-13 in the 
supernatants of MLN restimulation cultures (Fig. 6-3 D&E). This indicated that DN 
and CD103+ DCs were viable, presented antigen and induced immune responses, 
but were not specialized to prime Th2 cells against egg antigens.  
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Our results therefore indicated that SEA-loaded lymph CD11b+ and DP DCs, but 
not DN and CD103+ DCs, were sufficient to induce Th2 responses upon transfer. 
As these same subsets also carried egg antigen in lymph, and were absent in the 
MLNs of IRF4f/f CD11c-cre-positive mice, we had thus clearly identified that 
CD11b+ and DP DCs are specialized to induce intestinal Th2 responses. 
 
 
 
Figure 6-4. The transfer of SEA-loaded CD11b+ and DP lymph DCs induced CD44hi CD4 T 
cell responses in the injected MLNs 
Lymph DC subsets were purified by FACS sorting, loaded with SEA in vitro and transferred under 
the capsule of recipient mice. 5 days after transfer injected MLNs were harvested and stimulated 
with (+) or without (-) PMA/ionomycin. After cell surface marker staining, cell fixation and 
permeabilization and intracellular staining, cells were analysed by flow cytometry and the 
percentage of IFN-γ, IL-4 and IL-13 expressing CD44hi CD4 T cells assessed. A representative 
gating strategy of stimulated DP DCs is shown in A. IFN-γ, IL-4 and IL-13 expressing CD44hi CD4 
T cells were compared between unstimulated and stimulated conditions from MLNs, in which SEA-
loaded CD11b+ (B), DP (C), DN (D) or CD103+ (E) lymph DCs had been transferred. Data 
represent at least two independent experiments (mean ± SEM) with each point representing one 
animal. Mann-Whitney U tests were applied for statistical analysis (**P ≤ 0.01; ***P ≤ 0.001).  
 
 
We had observed that specific subsets of SEA-loaded lymph DCs were sufficient 
to prime immune responses after being transferred into recipient MLNs. Using in 
vitro restimulation cultures we had determined that these responses were antigen 
specific and required restimulation with SEA to secrete cytokines, whereas 
unstimulated MLN cells did not secrete cytokines in vitro. During egg injection we 
had observed that CD4 T cells were responsible for secreting IFN-γ, IL-4 and IL-13 
in response to egg antigens. To confirm that the transfer of DCs induced the same 
cytokine production by CD4 T cells, we analysed cell specific cytokine secretion by 
flow cytometry. Lymph DCs were collected from cannulated MLNx C57BL/6 
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animals and individual DC subsets were purified by FACS sorting. 30,000 cells of 
each subset were incubated with SEA for 6 hours, washed and transferred under 
the MLN capsule of individual recipient mice. 5 days after transfer the injected 
MLNs were harvested and digested with 8 U/ml Liberase and 10 µg/ml DNase. 
Single cell suspensions were stimulated with or without PMA/ionomycin in the 
presence of Golgi stop for 4 hours, and cell surface markers stained with 
fluorescent antibodies. After cell fixation and permeabilization intracellular 
cytokines were stained and cells analysed by flow cytometry. Live CD4 T cells 
were selected and activated T cells were identified as CD44hi cells. The 
expression of IFN-γ, IL-4 and IL-13 was analysed and compared between 
unstimulated and PMA/ionomycin stimulated cells (Fig. 6-4 A). In general, less 
than 1% of CD44hi cells expressed IFN-γ, IL-4 and IL-13 in unstimulated 
conditions, indicating that PMA/ionomycin stimulation was needed to drive 
expression of these cytokines in vitro. In MLNs harvested from SEA-loaded 
CD11b+ DCs recipients, 8% of CD44hi CD4 T cells expressed IFN-γ and 2% 
expressed IL-4 and IL-13 after PMA/ionomycin stimulation (Fig. 6-4 B). As these 
percentages were significantly higher compared to the unstimulated conditions we 
could confirm that IFN-γ, IL-4 and IL-13 were indeed produced by activated CD4 T 
cells in MLNs harvested from SEA-loaded CD11b+ DC recipients. In fact, the 
majority of cytokines were produced by CD44hi and not by CD44low cells, indicating 
that CD4 T cells of an activated effector/memory phenotype responded to egg 
antigens. Furthermore, IFN-γ-producing cells did not co-express IL-4 or IL-13, 
whereas the populations of IL-4- and IL-13-producing cells overlapped, indicating 
that IFN-γ-producing cells and Th2 cells were primed against egg antigens.  
 
Expression of IFN-γ, IL-4 and IL-13 was even more pronounced in MLNs 
harvested from SEA-loaded DP DC recipients, with 9% of CD44hi CD4 T cells 
expressing IFN-γ, and 3.5% expressing IL-4 and IL-13 after PMA/ionomycin 
stimulation (Fig. 6-4 C). The stronger immune responses observed after the 
transfer of SEA-loaded DP DCs compared to CD11b+ DCs corresponded with our 
previous findings in in vitro restimulation cultures, which showed the same trend. 
Intracellular staining from MLNs of SEA-loaded DN and CD103+ DCs revealed that 
IFN-γ producing CD44hi CD4 T cells could be identified after PMA/ionomycin 
stimulation, but that the percentage of IL-4 and IL-13 expressing cells was similar 
to background levels measured without stimulation (Fig. 6-4 D&E). This matched 
our previous observations in restimulation cultures, which showed that the transfer 
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of SEA-loaded DN and CD103+ DCs induced antigen specific IFN-γ responses but 
no production of IL-4, IL-5 or IL-13. Therefore, our findings confirmed that the 
transfer of SEA-loaded lymph CD11b+ and DP DC subsets induced IFN-γ and Th2 
responses in the recipient MLNs, which were produced by individual populations of 
activated CD44hi CD4 T cells. 
 
6.1.3 IL-4 and IRF4 are not required by CD11b-expressing 
dendritic cells to induce Th2 responses 	  	  
 
Figure 6-5. IL-4 expression by DCs is not required for the induction of Th2 responses after 
DC transfer into recipient mice 
Lymph DC subsets from MLNx IL-4-/- mice were purified by FACS sorting, loaded with SEA in vitro 
and transferred under the capsule of recipient mice. The induced immune response was measured 
in restimulation cultures 5 days after transfer. The experimental protocol is illustrated in A. Immune 
responses after transfer of IL-4-/- SEA-loaded CD11b+ (B), DP (C), DN (D) or CD103+ (E) lymph 
DCs were analysed in unstimulated (un) and restimulated (re) conditions. Data represent at least 
three independent experiments (mean ± SEM) with at least three animals per group. Mann-
Whitney U tests were applied for statistical analysis (*P ≤ 0.05; **P ≤ 0.01).  
 
 
As we had observed that transferred SEA-loaded lymph DCs were sufficient to 
induce Th2 responses in the recipient MLNs, these DCs were directly able to 
prime Th2 cells. The priming of Th2 cells has been a controversial topic in the 
literature. Th2 cells require IL-4 for their differentiation in vitro and Th2 responses 
do not develop in the absence of IL-4 or IL-4 receptor signalling (Jankovic et al., 
2000), which we had also observed in IL-4-/- mice after egg injection. However, it 
has been demonstrated that IL-4-/- BMDCs induce similar Th2 responses as their 
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wild type counterparts (Maldonado-López et al., 2001; MacDonald and Pearce, 
2002) and other cells like basophils, eosinophils or ILC2s have therefore been 
suggested to produce initial IL-4, required for Th2 differentiation. However, it has 
also been shown that naive CD4 T cells produce IL-4 in low amounts upon TCR 
activation in vitro (Yamane et al., 2005), suggesting that Th2 differentiation does 
not require exogenous IL-4. 
 
As basophils, eosinophils and ILC2s mostly reside within the intestinal lamina 
propria and not within the lymph nodes, it was unclear which cells produced the 
initial IL-4 required for Th2 differentiation upon DC transfer. To address whether 
IL-4 was produced by the transferred DCs and required for the induction of Th2 
responses in the injected MLNs, we cannulated MLNx IL-4-/- mice. Thoracic duct 
lymph was collected for 18 hours and DC subsets purified by FACS sorting. 
30,000 cells of each subset were incubated with 15 µg/ml SEA in vitro. After 6 
hours any unbound SEA was washed off and cells were transferred under the 
MLN capsule of individual wild type recipient mice. 5 days after transfer the 
injected MLNs were harvested and restimulated with SEA for 3 days in vitro and 
the antigen-specific production of cytokines was measured in the supernatants 
(Fig. 6-5 A). We observed that the transfer of SEA-loaded IL-4-/- CD11b+ DCs 
induced both IFN-γ and Th2 cytokines, with 5 ng/ml of IFN-γ, 0.2 ng/ml of IL-4, 0.3 
ng/ml of IL-5 and 7 ng/ml of IL-13 being secreted after restimulation (Fig. 6-5 B). 
The transfer of SEA-loaded IL-4-/- DP DCs induced even stronger responses in the 
MLN, revealed by the increased amounts of IL-4, IL-5 and IL-13 detected after 
restimulation with SEA (Fig. 6-5 C). Similar to what we had observed from SEA-
loaded C57BL/6 DC subsets, the transfer of SEA-loaded IL-4-/- DN and CD103+ 
DCs only induced antigen specific IFN-γ responses, but no production of IL-4, IL-5 
or IL-13 (Fig. 6-5 D&E). Therefore, the transfer of SEA-loaded IL-4-/- DC subsets 
resulted in the induction of very similar immune responses compared to C57BL/6 
DCs, with CD11b+ and DP DCs being uniquely able to prime Th2 response upon 
transfer. Therefore, IL-4 expression by tissue-derived DCs was not required for the 
induction of Th2 responses in vivo, confirming similar findings using IL-4-/- BMDCs 
(Maldonado-López et al., 2001; MacDonald and Pearce, 2002). We therefore 
suggest that exogenous IL-4 is not required to induce Th2 responses in our 
system of DC transfer into the MLNs but that a small amount of naive T cells 
produce the initial IL-4 that is necessary for Th2 differentiation, as previously 
suggested by Yamane et al. (Yamane et al., 2005). 
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Figure 6-6. SEA-loaded IL-4-/- DCs are not deficient in inducing CD44hi CD4 T cell responses 
upon transfer into recipient mice 
Lymph DC subsets from MLNx IL-4-/- mice were purified by FACS sorting, loaded with SEA in vitro 
and transferred under the capsule of recipient mice. 5 days after transfer injected MLNs were 
harvested and stimulated with (+) or without (-) PMA/ionomycin. Cell surface markers were stained, 
cells fixed and permeabilized and cytokines stained intracellularly. The percentage of IFN-γ, IL-4 
and IL-13 expressing CD44hi CD4 T cells was then assessed by flow cytometry and compared 
between unstimulated and stimulated conditions. MLNs, in which SEA-loaded IL-4-/- CD11b+ (B), 
DP (C), DN (D) or CD103+ (E) lymph DCs had been transferred were analysed. Data represent at 
least two independent experiments (mean ± SEM) with each point representing one animal. Mann-
Whitney U tests were applied for statistical analysis (*P ≤ 0.05; **P ≤ 0.01).  
 
 
We had observed that IL-4-/- DCs, when loaded with SEA in vitro and transferred 
under the capsule of recipient mice, were as effective in inducing antigen specific 
cytokine responses as their C57BL/6 counterparts. To confirm that these cytokine 
responses were produced by activated T cells, we analysed the recipient MLNs of 
IL-4-/- DC transfers by flow cytometry. To obtain IL-4-/- lymph DCs, thoracic duct 
lymph was collected from cannulated MLNx IL-4-/- animals for 18 hours and cells 
stained for flow cytometry. DC subsets were purified by FACS sorting and 30,000 
cells of each subset incubated with SEA in vitro. Unbound SEA was then washed 
off and cells transferred into the MLNs of recipient animals. MLNs were harvested 
5 days after transfer and digested with DNase and Liberase. Cell suspensions 
were stimulated with or without PMA/ionomycin for 4 hours in the presence of 
Golgi Stop solution and then stained with fluorescent antibodies for cell surface 
markers. Cells were then fixed and permeabilized, after which intracellular 
cytokines were stained with fluorescent monoclonal antibodies. Then the 
expression of IFN-γ, IL-4, and IL-13 on live CD44hi CD4 T cells was assessed by 
flow cytometry. In general, the background expression of these cytokines was less 
than 1%, which we measured in unstimulated conditions. PMA/ionomycin 
stimulated MLNs from SEA-loaded IL-4-/- CD11b+ and DP DC recipient animals 
showed that IFN-γ, IL-4, and IL-13 producing CD4 T cells had been induced. 
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CD44hi and not CD44low CD4 T cells produced the majority of cytokines and 
around 10% of CD44hi CD4 T cells were IFN-γ+, and 2-3% were IL-4+ or IL-13+. 
We also noticed that the transfer of DP DCs induced stronger immune responses 
than CD11b+ DCs, a phenomenon that we had also observed in previous 
experiments (Fig. 6-6 A&B). The induction of immune responses in MLNs from 
SEA-loaded IL-4-/- DN and CD103+ DC recipient animals was relatively low. 5% of 
CD44hi CD4 T cells expressed IFN-γ, whereas only 1-2% expressed IL-4 or IL-13 
after PMA/ionomycin stimulation. Thus, only the expression of IFN-γ, but not the 
expression of IL-4 and IL-13, was significantly different from unstimulated 
conditions (Fig. 6-6 C&D). Therefore, these results corresponded with our in vitro 
restimulation data where IL-4-/- DN and CD103+ DCs only induced antigen specific 
IFN-γ responses. Taken together, intracellular staining for IFN-γ, IL-4 and IL-13 
confirmed that the transfer of SEA-loaded IL-4-/- CD11b+ and DP DCs induced the 
production of IFN-γ, IL-4 and IL-13 in activated CD44hi CD4 T cells, similar to what 
we had observed in our C57BL/6 DC transfer experiments. Together, these data 
conclusively showed that IL-4 deficiency in DCs did not affect their ability to prime 
egg antigen specific T cell responses, and had no affect on the induction of Th2 
cells by these cells. 
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Figure 6-7. SEA-loaded IRF4f/f CD11c-cre-positive DC subsets retain their potential to induce 
Th2 responses if transferred into the MLNs of recipient mice 
Small intestinal LP DC subsets were FACS purified from IRF4f/f CD11c-cre-positive bone marrow 
chimeras and loaded with SEA in vitro. 30,000 cells were transferred into individual recipient mice 
where the induced immune responses were measured in MLN restimulation cultures 5 days after 
transfer. A schematic of the experimental protocol is shown in A. Immune responses after transfer 
of IRF4f/f CD11c-cre-positive SEA-loaded CD11b+ (B), DP (C), DN (D) or CD103+ (E) SI LP DCs 
were analysed in unstimulated (un) and restimulated (re) conditions and the released cytokines 
measured by ELISA. Data represent at least three independent experiments (mean ± SEM) with at 
least three animals per group. Mann-Whitney U tests were applied for statistical analysis (**P ≤ 
0.01; ***P ≤ 0.001).  
 
 
Another important question that we intended to address by DC transfer was if IRF4 
deficiency in DCs affected their capacity to induce egg antigen specific T cell 
responses, in particular their ability to prime Th2 cells. 
The injection of S. mansoni eggs into the intestines of IRF4f/f CD11c-cre-positive 
bone marrow chimeras induced IFN-γ, but no Th2 responses, suggesting that the 
lack of IRF4 affected DC functionality in priming Th2 cells. We observed that IRF4 
deficiency in DCs led to differences in DC subsets compositions both in the lamina 
propria and the MLNs. DP DCs decreased in the intestinal lamina propria, 
whereas in the MLNs CD11b+ DCs were reduced by 50% and DP DCs almost 
completely absent. However, uptake of egg antigen was not impaired in the lamina 
propria of IRF4f/f CD11c-cre-positive mice but SEA-transporting DCs were greatly 
decreased in the MLNs. We therefore hypothesized that the ineffective Th2 
immune response upon injection of S. mansoni eggs into the intestine, was 
influenced by the lack of antigen carrying CD11b+ and DP DCs in the MLNs. 
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This hypothesis was supported by our finding that antigen presentation of OVA to 
OT-II CD4 T cells was not impaired in the remaining MLN DCs from IRF4f/f CD11c-
cre-positive animals, which suggested that IRF4-deficient DCs could present 
antigen and prime naive T cells. To furthermore show that IRF4-deficient DCs 
were functionally capable of inducing Th2 responses, intestinal DCs from IRF4f/f 
CD11c-cre-positive mice were loaded with SEA in vitro and transferred into wild 
type recipient mice. We had previously demonstrated that antigen uptake by 
intestinal DCs was not affected by the deletion of IRF4 and that intestinal SEA-
loaded C57BL/6 DCs were capable of inducing Th2 responses upon transfer. 
Thus, the transfer of SEA-loaded IRF4-deficient DCs would directly determine if 
their Th2 inducing potential was impaired or if their absence in the draining lymph 
nodes was responsible for the impaired Th2 responses observed in IRF4f/f CD11c-
cre-positive mice.  
 
Small intestines of IRF4f/f CD11c-cre-positive bone marrow chimeras were 
enzymatically digested with Collagenase VIII and single cell suspensions stained 
for flow cytometry. Individual intestinal DC subsets were purified by FACS sorting 
and 30,000 cells of each subset were incubated with SEA in vitro. After 6 hours 
unbound antigen was washed off and DCs were injected under the MLN capsule 
of wild type recipient animals. After 5 days the injected MLNs were harvested and 
restimulated with SEA in vitro for 3 days. To determine the induction of antigen-
specific immune responses induced by the transferred DCs, produced cytokines 
were measured in the supernatants by ELISA (Fig. 6-7 A). Upon transfer of SEA-
loaded CD11b+ DCs we detected IFN-γ, IL-4, IL-5 and IL-13 after restimulation. 15 
ng/ml of IFN-γ, 0.1 ng/ml of IL-4, 0.2 ng/ml of IL-5 and 7 ng/ml of IL-13 were 
measured, indicating that antigen specific IFN-γ and Th2 responses were induced 
by IRF4-deficient DCs (Fig. 6-7 B). Cytokine levels from DP DC transferred MLNs 
were higher, reaching 20 ng/ml for IFN-γ, 0.2 ng/ml for IL-4, 0.5 ng/ml for IL-5 and 
18 ng/ml for IL-13 (Fig. 6-7 C). This indicated that SEA- loaded DP DCs from 
IRF4f/f CD11c-cre-positive mice were able to induce stronger IFN-γ and Th2 
responses than CD11b+ DCs when transferred into recipient mice, with matched 
our previous observations from C57BL/6 mice. Similar to what we had observed 
with SEA-loaded C57BL/6 DCs, DN and CD103+ DC subsets from IRF4f/f CD11c-
cre-positive mice induced strong IFN-γ responses but only minor levels of Th2 
cytokines after being transferred into recipient MLNs (Fig. 6-7 D&E). Therefore, 
the deletion of IRF4 in DCs did not inhibit antigen presentation and T cell priming, 
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which was consistent with our findings that the presentation of OVA to OT-II cells 
was also not inhibited in these cells. Furthermore, IRF4 deletion did not affect the 
potential of DCs to prime Th2 responses after transfer. Similar to C57BL/6 DCs, 
IRF4f/f CD11c-cre-positive DP and CD11b+ DC subsets remained specialized for 
the induction of Th2 responses, with small intestinal DP DCs being the most 
potent Th2-inducing subset. Thus, in our model of intestinal S. mansoni egg 
immunization IRF4 deficiency did not alter DCs functionality but rather reduced 
CD11b+ and DP DC numbers and antigen availability in the draining lymph nodes, 
which likely impaired Th2 cell priming.	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6.1.4 Distinct subsets of CD11b-expressing dendritic cells drive 
Th2 responses in the small intestine and colon 
 
 
Figure 6-8. Lymph migrating DP DCs from the small intestine are uniquely specialized to 
present egg antigen to naive T cells and induce Th2 responses upon transfer 
DC subsets were FACS purified from the lymph of sMLNx C57BL/6 mice after small intestinal egg 
injection. Individual DC subsets were injected under the capsule of recipient mice and the induced 
immune responses assessed after 5 days in restimulation cultures. Secreted cytokine levels after 
restimulation are shown for MLNs where CD11b+ (A), DP (B), DN (C) and CD103+ DCs had been 
transferred. Immune responses induced by the transferred DC subsets were compared in E. Data 
represent at least three independent experiments (mean ± SEM) with at least three animals per 
group. Kruskal-Wallis tests were applied for statistical analysis in E (***P ≤ 0.001).  
 
 
Our previous data indicated that SEA-loaded CD11b+ and DP DCs from C57BL/6 
mice were specialized to induce antigen specific Th2 responses when transferred 
into wild type recipient animals. Hereby, equal numbers of cells were collected 
from the lymph of MLNx animals, loaded with SEA in vitro and transferred under 
the MLN capsule of recipient animals. We observed that lymph DP DCs induced 
the strongest immune responses, followed by CD11b+ DCs; whereas DN and 
CD103+ DCs only induced IFN-γ but no Th2 responses.  
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To investigate if in the physiological context of intestinal egg injection the same 
subsets were involved in Th2 priming in the MLNs, lymph DC subsets were 
directly collected from egg-injected donor mice and transferred into recipient 
animals. Lymph was collected from sMLNx donor mice after small intestinal egg 
injection, which allowed the selective collection of small intestinal migrating DCs. 
Lymph was collected for 18 hours, then cells were stained with fluorescent 
monoclonal antibodies and DC subsets were purified by FACS sorting. 30,000 
DCs of each subset were resuspended in 5 µl PBS and directly transferred under 
the MLN capsule of recipient animals. 5 days after transfer the injected MLNs were 
harvested and MLN cells were restimulated with SEA for 3 days in vitro and 
antigen specific immune responses induced by the transferred DCs were analysed 
by measuring the secreted cytokines. Contrary to our SEA-loading experiments, 
we observed that the transfer of lymph CD11b+ DCs from egg injected donor mice 
induced no antigen specific immune responses in the recipient animals (Fig. 6-8 
A). DP DCs however induced robust immune responses, measured by the 
secretion of IFN-γ, IL-4, IL-5 and IL-13 after restimulation (Fig. 6-8 B). 
Furthermore, no antigen specific immune responses were detected in the lymph 
nodes of DN and CD103+ DC injected animals (Fig. 6-8 C&D). This indicated that 
small intestinal DP DCs were solely responsible for priming egg antigen specific T 
cells when eggs were injected into the small intestine. As our previous data 
showed that lymph DP DCs were the most numerous subset to carry labelled SEA 
from the small intestine, it is likely that the other DC subsets did not carry sufficient 
amounts of antigen to induce T cell responses upon transfer and this could explain 
why the other lymph DC subsets did not induce any antigen specific immune 
responses. Thus, lymph migratory DP DCs were solely responsible to present 
small intestinal egg antigen to naive T cells under physiological conditions and 
induced antigen specific Th2 responses when transferred into wild type recipient 
animals (Fig. 6-8 E).  
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Figure 6-9. SEA-loaded small intestinal DP DCs induce strong Th2 responses when 
transferred into recipient mice 
CD11b and CD103 expressing DC subsets were FACS purified from enzymatically-digested small 
intestines and loaded with SEA in vitro. 30,000 cells of each subset were transferred under the 
MLN capsule of recipient mice and induced immune responses analysed in restimulation cultures 5 
days after transfer. Secreted cytokine levels after restimulation are shown for MLNs where SEA-
loaded CD11b+ (A), DP (B), DN (C) and CD103+ SI LP DCs had been transferred. Immune 
responses induced by the transferred DC subsets were compared in E. Data represent at least 
three independent experiments (mean ± SEM) with at least three animals per group. Kruskal-Wallis 
tests were applied for statistical analysis in E (***P ≤ 0.001).   
 
 
We had observed that lymph migrating DCs from egg-injected small intestines 
were uniquely able to induce Th2 responses upon transfer and under these 
conditions neither CD11b+, DN nor CD103+ DCs induced any antigen-specific 
immune responses. We had also observed that DP DCs were the most numerous 
subset to carry small intestinally-injected fluorescently labelled SEA in lymph and 
only small numbers of CD11b+, DN and CD103+ DCs were involved in this 
process. To clarify whether the physiological uptake of antigen or cell intrinsic 
properties of antigen processing and presentation predisposed DP DCs from the 
small intestine to be the only subset to induce antigen-specific immune responses 
after transfer we incubated all DC subsets with SEA in vitro. As we had observed 
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that DC specific differences existed between the small intestine and colon we 
isolated DCs from the lamina propria of the small intestine or colon, as not enough 
cells could be collected from cMLNx lymph or colon-draining cMLNs to allow a 
direct comparison. Thus, small intestines of C57BL/6 mice were enzymatically 
digested with Collagenase VIII and single cell suspensions stained for flow 
cytometry. DC subsets were purified by FACS sorting and incubated with 15 µg/ml 
SEA for 6 hours in vitro. Unbound SEA was washed off and 30,000 cells of each 
subset transferred under the MLN capsule of recipient mice. 5 days after transfer, 
MLNs were harvested and restimulated with SEA in vitro and the immune 
responses induced by the individual transferred DC subsets were assessed by the 
secretion of cytokines in response to SEA restimulation.  
 
The transfer of SEA-loaded small intestinal CD11b+ DCs induced weak IFN-γ and 
Th2 responses in the recipient mice, with 8 ng/ml of IFN-γ, 0.1 ng/ml IL-4, 0.2 
ng/ml IL-5 and 5 ng/ml IL-13 detected in restimulation cultures (Fig. 6-9 A). 
Antigen-specific immune responses induced by SEA-loaded DP DCs after transfer 
were higher and cytokine secretion reached 18 ng/ml for IFN-γ, 0.5 ng/ml for IL-4, 
1.2 ng/ml for IL-5 and 15 ng/ml for IL-13 (Fig. 6-9 B). Transferred SEA-loaded DN 
and CD103+ DCs induced IFN-γ responses of around 15 ng/ml but no significant 
amount of Th2 cytokines (Fig. 6-9 C&D). These findings corresponded with our 
data from SEA-loaded lymph DCs where DN and CD103+ subsets induced IFN-γ 
but no Th2 responses. When we compared the immune responses induced by the 
different transferred SEA-loaded DC subsets it became again apparent that small 
intestinal DP DCs were specialized to induce Th2 responses, whereas IFN-γ 
responses could be induced by all subsets (Fig. 6-9 E). This suggested that DP 
DCs from the small intestine were inherently better at either processing and 
presenting egg antigens or priming Th2 cells compared to the other subsets. This 
ability, together with our previous findings that they were the most numerous 
subset to transport egg antigen from the small intestine to the MLNs, could explain 
why they are the primary DC subset to induce Th2 responses in the small 
intestine.  
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Figure 6-10. SEA-loaded colon-derived CD11b+ DCs and not DP DCs are specialized to 
induce Th2 responses upon transfer 
DC subsets were FACS purified from enzymatically-digested colons of C57BL/6 mice and loaded 
with SEA in vitro. Individual subsets were transferred under the MLN capsule of recipient mice and 
5 days after transfer MLN restimulation cultures were set up. Secreted cytokine levels after 
restimulation are shown for MLNs where SEA-loaded CD11b+ (A), DP (B), DN (C) and CD103+ 
colon LP DCs had been transferred. Cytokine levels from all DC subset transfers were compared in 
E. Data represent at least three independent experiments (mean ± SEM) with at least three 
animals per group. Kruskal-Wallis tests were applied for statistical analysis in E (*P ≤ 0.05; **P ≤ 
0.01).  
 
 
In contrast to the small intestine, labelled SEA injected into the colonic lamina 
propria was transported to the cMLNs by CD11b+, which led us to hypothesize that 
this subset might be specialized to induce Th2 responses in the colonic draining 
lymph nodes. Unfortunately, due to the 10-fold lower numbers of DCs migrating 
from the colon compared to the small intestine, it was not possible to collect 
enough DCs from the lymph of colon-injected cMLNx mice to transfer into recipient 
animals. As an alternative approach, that would allow the direct comparison 
between small intestinal and colonic DCs, we isolated DCs from the lamina 
propria, incubated them with SEA in vitro and subcapsularly transferred these LP-
derived DCs into recipient animals. Thus, colons from C57BL/6 mice were 
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enzymatically digested and colonic DC subsets purified by FACS sorting. 
Equivalent to our experiments using small intestinal DCs, 30,000 cells of each 
subset were incubated with 15 µg/ml SEA for 6 hours, washed and transferred 
under the MLN capsule of recipient animals. 5 days after transfer MLNs were 
harvested and restimulated with SEA in vitro. After 3 days of restimulation, 
supernatants were assessed for secreted cytokines. Consistent with what we had 
observed in previous experiments, the immune responses induced by colonic DCs 
were generally lower compared to their small intestinal counterparts. In 
restimulation cultures of transferred SEA-loaded colonic CD11b+ DC MLNs we 
measured 8 ng/ml of IFN-γ, 0.15 ng/ml of IL-4, 0.2 ng/ml of IL-5 and 7 ng/ml of IL-
13 (Fig. 6-10 A). Immune responses in transferred DP, DN and CD103+ DC MLNs 
were lower, showing secretion of around 5 ng/ml IFN-γ and IL-13 but only minimal 
amounts of IL-4 and IL-5 (Fig. 6-10 B-D). Statistical comparison between the 
immune responses induced by the transferred SEA-loaded colonic DC subsets 
revealed that CD11b+ DCs induced the strongest Th2 responses, whereas IFN-γ 
responses could be induced by all subsets (Fig. 6-10 E). Together with our 
observation that colonic CD11b+ DCs were the only subset to transport egg 
antigen in lymph, these results demonstrated that in contrast to the small intestine, 
CD11b+ DCs and not DP DCs were specialized to induce Th2 responses in the 
colon. Thus, we have not only revealed that specific DC subsets are specialized to 
induce Th2 responses against S. mansoni eggs in the intestine but have also 
discovered that different cellular mechanisms exist between small intestinal and 
colonic DC subsets, which drive these responses. 
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6.2 Discussion 
 
When we injected fluorescently labelled SEA into the intestine we observed that 
both B cells and dendritic cells transported egg antigen in lymph. By transferring 
immune cells from egg-injected animals under the MLN capsule of recipient mice 
we were able to directly assess the priming capabilities of these cells in vivo. This 
method of cell delivery into the MLN has recently been developed in our laboratory 
and has major advantages over other cell transfer systems like intravenous or 
intraperitoneal transfer (Cerovic et al., 2015). As lymph migrating cells enter the 
MLN through the MLN capsule, subcapsular injections transfer cells to their 
biological point of entry, which allows their functional assessment in their 
physiological environment. Furthermore, the point of cell transfer and entry is 
exactly known, which allows us to monitor the responses in a precise manner by 
harvesting only the injected lymph node. Furthermore, subcapsular injections allow 
the transfer of much smaller cell numbers ranging from 30,000 to 200,000 cells 
compared to other techniques, which require millions of cells, and makes the 
transfer and study of tissue-derived cells feasible.  
 
Using subcapsular cell transfers we could directly monitor the T cell priming 
capabilities of B cells and DCs and observed that lymph DCs but not B cells from 
egg injected donors were sufficient to induce antigen specific immune responses 
in the recipient animals (Fig. 6-1). This observation supported many of our 
previous data, which indicated that IRF4+ CD11c-expressing cells, which includes 
DCs but not B cells, were required to drive Th2 responses against S. mansoni 
eggs and verified reports from the literature that have shown that the deletion of 
DCs in CD11c-DTR mice impaired Th2 responses in models of asthma and 
alum/OVA immunization, as well as during Schistosoma mansoni and 
Nippostrongylus  brasiliensis infection (van Rijt et al., 2005; Kool et al., 2008; 
Phythian-Adams et al., 2010; Smith et al., 2011). However, the deletion of DCs in 
these models did not allow the authors to determine, whether DCs were essential 
for the induction, maintenance or restimulation of the response. Using our cell 
transfer system we could clarify that DCs were essential for the induction of T cell 
responses against S. mansoni eggs. Furthermore, they were sufficient to induce 
these responses upon transfer, suggesting that DCs alone give all the required 
signals to prime Th2 responses. One of these required signals is the presentation 
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of antigen via MHCII and we showed that MHCII-deficient DCs were no longer 
capable of inducing T cell responses after transfer. 
 
Although B cells transported fluorescent antigen in lymph, they could not induce 
antigen-specific immune responses after transfer, which suggested that they did 
not directly play a role in T cell priming. However, as demonstrated in the 
literature, B cells can influence Th2 responses by magnifying the response 
through antibody secretion, such as IgE, or antigen-presentation to primed 
activated T cells (León et al., 2014). As our project focused on the identification of 
the cells responsible for inducing Th2 responses, we did not perform further 
experiments to assess the supportive role of B cells during the maintenance of the 
response. 
 
We had identified that flow-sorted DCs were sufficient to prime IFN-γ secreting 
cells and induce Th2 responses upon transfer. As these cells were sorted from 
egg injected donor mice, antigen was hereby acquired in the small intestine. 
However, antigen could also be provided in vitro and SEA-loaded FACS purified 
small intestinal and lymph dendritic cells could induce antigen-specific immune 
responses upon transfer (Fig. 6-2). As small intestinal DCs represent immature 
peripheral DCs they are responsible for taking up antigen in the lamina propria, 
which likely enabled them to also sample antigen in vitro. Semi-mature lymph DCs 
have also been reported to retain the potential to take up soluble antigen and drive 
T cell differentiation upon in vitro stimulation (Cerovic et al., 2013), which was in 
agreement with our own observations that they could present in vitro-loaded SEA. 
Fully mature DCs isolated from the MLN however could no longer present antigen 
acquired in vitro.  
 
Similar observations had been made early on in the Steinman laboratory. Freshly 
isolated immature Langerhans cells drove weak T cell responses in vitro 
immediately after isolation but after 3 days of maturation developed into potent T 
cell stimulators (Schuler and Steinman, 1985). They identified that during 
maturation antigen was processed and presented via MHCII (Romani et al., 1989). 
Other studies further demonstrated that MHCII-peptide complexes are present on 
the cell surface for several days and that mature DCs can acquire novel antigen 
but no longer process and present it on the cell surface (Villadangos et al., 2005). 
Thus, immature and semi-mature DCs readily acquire antigen and can process 
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and present it to naive T cells, which in our case happened during the 5 day 
immunization period after cell transfer, whereas mature DCs are specialized for 
the presentation of already acquired antigen over long periods of time and do no 
longer present novel antigen.  
 
Having identified that DCs primed T cells against egg antigens we furthermore 
addressed whether certain DC subsets were specialized to induce Th2 responses 
upon transfer. To exclude any possible bias of antigen uptake, which we had 
observed during fluorescent SEA injection, we FACS sorted individual DC subsets 
from lymph of MLNx C57BL/6 mice and incubated them with SEA in vitro. Transfer 
of SEA-loaded lymph DC subsets revealed that CD11b+ and DP DCs were able to 
induce IFN-γ and Th2 responses upon transfer, whereas DN and CD103+ DCs did 
induce IFN-γ but not Th2 responses. The induced immune responses from 
CD11b+ and DP DCs closely resembled those induced directly by injected eggs, 
which we assessed by cytokine secretion after in vitro restimulation with SEA and 
during PMA/ionomycin stimulation followed by intracellular staining (Fig. 6-3; 6-4). 
We had therefore demonstrated that CD11b-expressing DCs were specialized to 
drive Th2 responses against S. mansoni egg antigen in the MLNs and induced 
egg-equivalent immune responses, whereas antigen-specific IFN-γ responses 
could be induced by all DC subsets.  
 
We furthermore observed that the transfer of DP DCs induced more potent 
immune responses, compared to CD11b+ DCs, which could play an important role 
under the physiological conditions of egg injection. As we had observed that DP 
DCs transported the majority of egg antigen in lymph of small intestinally injected 
animals, they might therefore represent the most important subset to drive Th2 
responses in the small intestine. Conversely, CD11b+ DCs are the most abundant 
subset in the colon and transported fluorescent antigen in colon injected animals, 
which could predispose them to drive Th2 responses in the colon.  
Interestingly, the transfer of CD103+ and DN DCs induced antigen-specific IFN-γ 
but no Th2 responses. These results demonstrated that they were able to take up, 
process and present egg antigens to naive T cells and induce IFN-γ responses but 
were not able to prime Th2 cells. This observation supports the hypothesis that 
different DC subsets are specialized to drive distinct immune responses. For 
example, intestinal DP DCs have been shown to drive Th1, Th17 and Treg 
responses (Fujimoto et al., 2011; Persson et al., 2013b; Coombes et al., 2007), 
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whereas CD103+ DCs are specialized to induce Th1 responses and cross present 
antigen to CD8 T cells (Cerovic et al., 2013; 2015). Our own data also support 
these findings and show that all DC subsets can induce IFN-γ responses after in 
vitro incubation with SEA but we can now add that CD11b-expressing DCs are 
furthermore specialized to induce Th2 responses. 
 
The fact that the transfer of SEA-loaded DCs was sufficient to induce antigen-
specific Th2 responses raised the question of how DCs directly induce these 
responses. Many studies and our own findings have shown that Th2 responses 
require IL-4 to be established and maintained and IL-4 producing cells like 
basophils or type 2 innate lymphoid cells have been implicated in assisting Th2 
differentiation (Yoshimoto, 2010; Anyan et al., 2013; Oliphant et al., 2014). 
However, these cells mostly reside in intestinal tissues and not in the MLNs, and 
our data indicate that DC-intrinsic molecules produced by the transferred DCs 
were sufficient to drive effective Th2 responses after transfer in the MLN. We 
therefore addressed whether DCs themselves provided the initial IL-4 needed for 
Th2 differentiation. We observed that SEA-loaded DC subsets from IL-4-deficient 
mice induced similar Th2 responses compared to C57BL/6 DCs after transfer, 
which showed that IL-4 production by DCs was not required (Fig. 6-5; 6-6), which 
correlated with published findings using IL-4-/- BMDCs (MacDonald et al., 2002). 
 
However, it has been shown that a small number of T cells can differentiate into 
Th2 cells independently of IL-4 signalling, which then produce the necessary Th2 
cytokines to drive an efficient immune response (Noben-Trauth et al., 2000; 
Jankovic et al., 2000). This could represent a possible mechanism by which Th2 
responses are induced without requiring exogenous IL-4 for their initial 
differentiation, which could explain why the transfer of DCs in the MLN is sufficient 
to drive Th2 responses in our system. However, other factors, such as the 
production of IL-4 by other cells in the lymph node, delivery of IL-4 from the lamina 
propria via the lymph or the presence of memory Th2 cells, which become 
activated by the transferred DCs could also be involved. 
 
Another important question was addressed by the transfer of SEA-loaded IRF4f/f 
CD11c-cre-positive DC subsets (Fig. 6-7). We had observed that IRF4f/f CD11c-
cre-positive chimeras were impaired in inducing Th2 responses against intestinally 
injected S. mansoni eggs. Analysis of DC subsets revealed that despite the fact 
	   174 
that DP DCs were reduced in the small intestine, antigen uptake was not affected. 
In contrast, CD11b+ and DP DCs were greatly reduced in the MLNs resulting in 
limited antigen availability and we suggested that this affected efficient Th2 
priming. This corresponded with our observation that CD11b+ and DP DCs are 
specialized for the induction of Th2 responses and the absence of these cells 
would likely lead to an impaired Th2 induction. However, IRF4 may also affect cell 
intrinsic properties in DCs that are required to induce Th2 responses, as 
suggested by Williams et al. (Williams et al., 2013). Similar effects have been 
shown in other cell types such as T cells, that fail to develop into Th2 cells upon 
IRF4 deletion (Lohoff et al., 2002), or macrophages, which depend on IRF4 to 
develop into alternative activated macrophages during type 2 immune responses 
(Satoh et al., 2010; Negishi et al., 2005). We therefore transferred SEA-loaded 
IRF4f/f CD11c-cre-positive DC subsets from the small intestinal lamina propria into 
wild-type recipient mice and observed that they could efficiently induce Th2 
responses. DP DCs were again the most efficient DC subset to induce Th2 
responses, suggesting that the deletion of IRF4 in DCs, despite causing 
developmental defects in DP DCs in the small intestine, did not inhibit antigen 
presentation and Th2 priming of these cells. These findings corresponded with our 
previous experiments, which showed that the presentation of OVA to OT-II cells 
was not inhibited in IRF4-deficient DCs and indicated that IRF4f/f CD11c-cre-
positive DC subsets remained specialized to induce Th2 responses. This 
suggested that IRF4 deletion did not affect the priming capabilities of CD11b+ and 
DP DCs but rather their migration, which limited cell and antigen availability in the 
MLNs and led to inefficient Th2 responses.  
 
Having identified that SEA-loaded CD11b+ and DP lymph DCs are specialized to 
induce Th2 responses in the intestine we addressed if the same subsets were 
involved under physiological conditions of egg injections. We therefore sorted 
lymph DC subsets directly from egg-injected donor mice and transferred the 
individual subsets into recipient animals. We observed that under these conditions 
DP DCs were solely responsible to present small intestinal egg antigen to naive T 
cells and induce antigen specific Th2 responses after transfer (Fig. 6-8). We 
suggest that this is due to the fact that lymph DP DCs are the most numerous 
subset to carry egg antigen from the small intestine, which we had demonstrated 
by the injection of fluorescently labelled SEA. It is therefore likely that under these 
physiological conditions the other DC subsets did not carry sufficient amounts of 
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antigen to induce T cell responses upon transfer, in contrast to previous 
experiments where all subsets were loaded with SEA in vitro. To clarify whether 
the physiological uptake of antigen or cell intrinsic properties of antigen processing 
and presentation predisposed DP DCs from the small intestine to be the only 
subset to induce antigen-specific immune responses after transfer, we incubated 
all DC subsets with SEA in vitro. As we had observed that DP DCs from the small 
intestine but CD11b+ DCs from the colon transported the majority of egg antigen to 
the draining lymph nodes we aimed to directly compare these tissue-specific DCs 
and their capacity to induce Th2 responses. Unfortunately, we could not collect 
enough cells from the lymph of cMLNx animals to perform direct cell transfer 
experiments from colon injected donor mice. Instead, DCs were isolated from the 
intestinal lamina propria. Similar to our observations from SEA-loaded lymph DCs, 
SEA-loaded DP DCs from the small intestine were again the most efficient subset 
to induce Th2 responses in recipient animals. SEA-loaded CD11b+ DCs from the 
small intestine induced could induce very low levels of Th2 responses in the MLNs 
of recipient mice after restimulation, whereas SEA-loaded DN and CD103+ DCs 
could induce IFN-γ, but no Th2, responses upon transfer (Fig. 6-9). These data 
suggested that DP DCs from the small intestine were inherently better at either 
processing and presenting egg antigens or priming Th2 cells than the other DC 
subsets found in the small intestine. Together with our previous findings that they 
were the most numerous subset to transport egg antigen from the small intestine 
to the draining lymph nodes, and that they are the sole DC subset to induce egg 
antigen specific immune responses under physiological conditions, we argue that 
DP DCs are the primary DC subset to induce Th2 responses in the small intestine. 
 
In contrast to small intestinal DC subsets, SEA-loaded CD11b+ DCs from the colon 
induced the strongest Th2 responses in the recipient MLNs compared to the other 
DC subsets. But IFN-γ responses, similar to our previous observations, could be 
induced by all colonic DC subsets (Fig. 6-10). We had observed similar tissue-
specific differences in previous experiments, where we observed that CD11b+ 
DCs, and not DP DCs as for the small intestine, exclusively transported parasite 
antigen from the colon to the cMLNs. Furthermore, CD11b+ DCs were present in 
increased frequency in lymph from colon injected animals, whereas DP DCs were 
more frequent after small intestinal injections. We therefore suggest that CD11b+ 
DCs are the main subset to induce Th2 responses in the colon.  
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This is a surprising and important finding that raises many questions and could 
also have implications for other antigens and immune responses in these tissues, 
which will be discussed in more detail in chapter 7. Importantly, it remains to be 
determined whether both tissue-specific subsets process and present egg antigen 
to the same extend. It has been suggested by other studies that despite fulfilling 
similar functions such as oral/colonic tolerance the molecular mechanisms of 
these DCs are unique (Veenbergen et al., 2016), which would be interesting to 
address in the context of Th2 responses. Thus, this work is, to our knowledge, the 
first identification of the DC subsets that promote Th2 responses in the intestine, 
as well as the first demonstration that different DC populations from the small 
intestine and colon are specialized to induce these responses.  
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6.3 Conclusions 
 
By transferring immune cells under the capsule of recipient mice, we were able to 
assess the Th2-priming potential of lymph migrating cells in vivo. We showed that 
dendritic cells, but not B cells, were responsible for priming egg antigen specific T 
cell responses in the MLNs, despite our findings that both cell populations carried 
egg antigen in lymph. T cell priming was directly mediated by the injected DCs in a 
MHCII-dependent manner. Dendritic cells were also able to present in vitro loaded 
SEA after transfer. Hereby, dendritic cells harvested from the small intestinal 
lamina propria and the lymph were able to induce IFN-γ, IL-4, IL-5 and IL-13 
secreting immune responses, whereas fully mature migratory DCs from the MLNs 
could no longer present in vitro loaded SEA after transfer. We further discovered 
that CD11b+ and DP DCs were specialized to induce Th2 responses after transfer, 
whereas DN and CD103+ DCs only induced antigen-specific IFN-γ responses. 
Intracellular staining revealed that the transferred DCs induced IFN-γ expression 
and IL-4 and IL-13 production by separate populations of activated CD44hi CD4 T 
cells.  
Immune responses could also be initiated by transferred DCs, which were unable 
to produce IL-4, suggesting that exogenous IL-4 was not required for the induction 
of Th2 responses during DC transfer into the MLNs. Furthermore, SEA-loaded 
DCs from in IRF4f/f CD11c-cre-positive mice retained their potential to prime Th2 
responses when transferred into the MLNs, suggesting that limited migration of 
IRF4-deficient DCs, and not functional defects, impaired Th2 responses in these 
mice. Importantly, detailed comparisons between small intestinal and colonic DC 
subsets revealed that DP DCs from the small intestine were specialized and 
responsible to induce Th2 responses after transfer, whereas CD11b+ DCs from the 
colon were the most efficient subset to induce Th2 responses after transfer. Thus, 
we have not only identified that DCs are responsible for priming Th2 cells against 
intestinal S. mansoni eggs, but that specialized intestinal DC subsets are involved. 
We also discovered that different cellular mechanisms exist in the small intestine 
and colon, revealing a hitherto unappreciated functional heterogeneity among 
intestinal DCs.  
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Chapter 7: Final Discussion 
 
In this thesis we have identified that conventional dendritic cells are sufficient for 
driving Th2 responses in the intestine. As a Th2 inducing stimuli, we have used 
Schistosoma mansoni eggs, which drive potent type 2 immune responses and 
cause damage and induce granuloma formation, which lead to organ fibrosis and 
morbidity during chronic infection. We have furthermore revealed the mechanisms 
by which the induction of these Th2 responses is dependent on the transcription 
factor IRF4, and that different tissue-specific subsets of dendritic cells are 
specialized to drive Th2 responses in the small intestine and colon. In this final 
chapter an overview of the novel insights into DC functionality regarding Th2 
responses will be described and the immunological relevance of these findings will 
be discussed. 
 
We have developed an experimental immunization protocol that for the first time 
allows the detailed assessment of the induction of Th2 responses in the intestine. 
The delivery of eggs into the intestinal subserosa allowed us to control parameters 
such as the amount and location of deposited eggs and the timing of the induction 
period, which are impossible to define during live infection. The definition of these 
parameters is crucial to investigate Th2 cell induction in vivo and separate it from 
other immunological events like Th2 cell maintenance or restimulation. 
Furthermore, the importance of understanding the induction of Th2 responses in 
the intestine is highlighted by the fact that the intestine is heavily affected by 
penetrating and trapped eggs during live S. mansoni infection and is the target of 
numerous helminths parasite infections (Grencis, 2015). During live infections, S. 
mansoni eggs normally penetrate through the intestinal wall to be shed in the 
faeces to continue the parasite’s life cycle. However, not all eggs succeed in 
penetrating the intestine and many remain trapped within the tissue, where they 
are encased by granulomas and lead to tissue fibrosis (Pearce and MacDonald, 
2002). Our egg injection technique is specifically designed to enable the delivery 
of eggs into their physiological location and represent trapped eggs within the 
tissue in vivo, which is a distinct refinement over previously used approaches. We 
detected strong antigen specific immune responses in the draining mesenteric 
lymph nodes that were comprised of IFN-γ and Th2 responses, which are typically 
mounted against S. mansoni eggs (MacDonald and Pearce, 2002; MacDonald and 
Maizels, 2008; Cook et al., 2015). Thus, the experimental immunization of S. 
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mansoni eggs enabled us to focus on and precisely examine the physiologically 
relevant mechanisms of Th2 induction in the intestine with unprecedented clarity in 
vivo.  
 
It has been demonstrated that the transcription factor IRF4 is an important 
regulator of type 2 immunity and controls the development of Th2 cells, post-
germinal center plasma cells, alternatively activated macrophages and CD11b-
expressing dendritic cells. We focused on the effects of IRF4 deficiency on 
dendritic cells and discovered that Th2 responses against S. mansoni eggs were 
impaired in IRF4f/f CD11c-cre mice, which was accompanied by an increased IFN-
γ response. It had been previously observed that type 2 immune responses are 
abrogated during allergen challenge in the lung (Williams et al., 2013), but this is 
the first demonstration that IRF4 is also required by DCs to drive Th2 responses 
against parasite antigens. IRF4 is not only involved in the development of DCs but 
has also been shown to play a role in dendritic cell migration and directly 
regulating BMDC-driven Th2 differentiation via peptide-MHC class II complex 
formation (Vander Lugt et al., 2014) and the expression of IL-10, IL-33 and OX40L 
(Williams et al., 2013). In the intestine we verified that IRF4 affected intestinal DC 
subset development and diminished the number of CD11b-expressing DCs in the 
MLNs, as previously described (Persson et al., 2013b). Importantly, we were able 
to reveal a direct functional importance, as this dramatic decrease of CD11b-
expressing DCs in the MLNs led to insufficient transport of parasite antigen to the 
lymph nodes. We suggest that the decrease of CD11b-expressing DCs and limited 
amounts of antigen are key factors that impair the induction of Th2 responses in 
IRF4f/f CD11c-cre mice. In contrast to published findings, we found that IRF4 
deficient DCs from the intestine could prime naive T cells and induce Th2 
responses when transferred into recipient mice, suggesting that defective 
migration, rather than molecular changes that impaired T cell priming and 
differentiation were involved. Further experiments, like the assessment of lymph 
migrating DC subsets from IRF4f/f CD11c-cre mice could clarify if defects in cell 
migration or cell survival lead to the diminished number of CD11b-expressing DCs 
in the MLNs. 
 
As determined by our experiments in IRF4f/f CD11c-cre mice and shown in 
previous studies using CD11c-DTR mice (Phythian-Adams et al., 2010), CD11c+ 
cells are necessary for the establishment of Th2 responses against S. mansoni 
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egg antigens. However, it was unknown whether DCs are also sufficient to drive 
effective Th2 responses. We have used innovative approaches to isolate DCs 
from the exact tissues involved in Th2 responses to S. mansoni eggs, be it the 
intestinal lamina propria, lymph or individual small intestinal or colonic draining 
mesenteric lymph nodes (MLNs). To identify DCs populations sufficient to prime 
intestinal Th2 responses we developed techniques for transferring purified DCs 
into recipient animals. DCs were delivered under the capsule of the MLN, precisely 
where they would enter the lymph node under normal physiological conditions. By 
efficiently delivering the appropriate DCs into the correct location, we could directly 
and precisely examine their Th2-inducing functions. This painstaking approach to 
the use of precise tissue-derived DCs was critical, as we were thus able to 
discover that immature intestinal DCs, as well as semi-mature lymph migrating 
DCs were sufficient to drive Th2 responses against S. mansoni egg antigens, 
whereas fully mature MLN DCs no longer presented exogenously provided egg 
antigens. This evidence demonstrates for the first time that intestinal DCs are 
sufficient to drive Th2 responses (Fig. 7-1).   
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Figure 7-1. Induction of Th2 responses against Schistosoma mansoni eggs in the intestine 
In our experimental immunization model S. mansoni eggs are injected into the intestinal subserosa. 
Egg antigen is taken up by DCs, which migrate to the draining mesenteric lymph nodes (MLNs). 
We have identified that these DCs express CD11b, CD301b and IRF4 and in the small intestine the 
subset of CD11b+CD103+ DP DCs and in the colon CD11b+CD103- DCs are predominantly 
involved in this process. Within the MLN these DCs present egg antigen to naive T cells via MHCII 
and drive their differentiation into antigen specific Th2 cells. CD11b+CD103+ DP DCs from the 
small intestine and CD11b+CD103- DCs from the colon are specialized to drive this differentiation 
and are necessary and sufficient to prime Th2 cells against S. mansoni egg antigens in the 
intestine. 
 
 
Other models have suggested that apart from DCs other cells, like basophils or 
ILC2s, are required to provide signals necessary for the full differentiation of Th2 
cells. However, in our transfer system DCs were sufficient to drive competent 
immune responses that were comparable to the injections of eggs into the 
intestine. Thus, conventional intestinal DCs are fully capable of inducing Th2 
responses against S. mansoni egg antigens upon transfer, without the explicit 
requirement for other accessory cells that also required transfer. In an attempt to 
define the molecular mechanisms that could be involved, we determined that the 
incubation with soluble egg antigens (SEA) had limited effects on the expression 
of costimulatory molecules and that the secretion of IL-4 by DCs was not required 
to drive Th2 responses, which was in accordance to published findings 
(MacDonald et al., 2002). However, we were not able to find a distinctive 
molecular signature, and the molecular mechanisms by which intestinal DCs 
induce Th2 differentiation remain elusive. Technologies, like RNA sequencing, 
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could reveal changes in gene expression after incubation with S. mansoni and 
may thus suggest novel targets and pathways that might be involved. 
 
Recent work in DC biology has demonstrated that specific DC subsets are 
specialized to perform different roles in T helper cell differentiation. This has been 
demonstrated for Th1, Th17 and Treg cells in the intestines but it is unclear if it 
also applies to the induction of Th2 cells. Using our state of the art techniques of 
intestinal DC transfers we were not only able to determine that intestinal DCs were 
sufficient to drive Th2 responses against S. mansoni egg antigens, but also 
investigate if specific DC subsets were required. Our findings from IRF4f/f CD11c-
cre mice suggested that CD11b-expressing DCs are involved; as these are greatly 
reduced in these animals, whereas CD103+ DCs were not affected. In the intestine 
two DC subsets exist that express CD11b: CD11b+CD103- (CD11b+) DCs, and 
CD11b+CD103+ double positive (DP) DCs. The composition of these subsets 
differs between the small intestine and the colon and DP DCs are the predominant 
subset in the small intestine, whereas CD11b+ DCs are more abundant in the 
colon (Denning et al., 2011). To selectively observe if the tissue specific 
composition of DC subsets also translated into functional differences we took 
special care to selectively isolating them. The separate collection of the small 
intestine and the colon, the selective removal of the sMLNs or cMLNs in 
lymphadenectomized mice, which allowed the collection of small intestinal or colon 
migrating DCs in lymph, and the individual harvesting of sMLNs and cMLNs 
ensured that tissue-specific DCs were collected.  
 
We observed that after egg injection in the small intestine, DP DCs migrated in 
increased frequency in lymph, whereas after colonic egg injection CD11b+ DCs 
were increased in lymph. Furthermore, these specific subsets were also 
responsible for carrying fluorescently-labelled SEA from the lamina propria of the 
small intestine or colon to the draining lymph nodes. This suggested that DP DCs 
in the small intestine and CD11b+ DCs in the colon respond to egg antigens and 
are specialized to carry them to the draining lymph nodes. Using our cell transfer 
system we were able to demonstrate that these tissue-specific DC subsets were 
furthermore responsible for priming Th2 cells (Fig. 7-1). We have thus 
demonstrated that specific subsets of intestinal DCs are specialized to prime Th2 
cells. We speculate that this capacity extends beyond antigens from S. mansoni 
eggs but might also be relevant for other parasitic antigens or allergens. Many 
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different food allergies exist and specific food allergens could be used to 
determine if the same DC subsets are involved in the induction of allergic Th2 
responses in the intestine. Identifying and targeting these specific subsets could 
be beneficial for the modulation of pathological Th2 responses, including chronic 
schistosomiasis, and an array of allergic diseases affecting the intestine. 
 
We believe that our discovery that distinct subsets of DCs prime Th2 responses in 
the small intestine and colon represents a paradigm-shifting finding and is also 
relevant for intestinal immunology beyond type 2 immunity. 
We demonstrate that distinct DC subsets within different tissues can carry out the 
same functions. Thus, tissue-specific factors acting on DC precursors can drive 
independent patterning of phenotypic and functional DC characteristics. This not 
only highlights the need for accurate markers of DCs’ functional properties, but 
also brings new complexity to our understanding of the tissue-specific cues that 
influence DC differentiation, in the intestine and elsewhere. Thus, tissue-specific 
factors that induce the expression of particular subset-specific surface markers 
can no longer be assumed to generate the same functional characteristics. The 
differences in the functions of DC subsets between the small intestine and colon 
also provide clear evidence that the induction of immune responses in these 
tissues is distinct. This idea is supported by recent findings that have 
demonstrated that oral tolerance in the small intestine and colonic tolerance are 
driven by distinct subsets of tissue-specific DCs (Veenbergen et al., 2016). 
Beyond advancing our understanding of the immunological differences between 
these tissues this raises the possibility that diseases in the small intestine and 
colon could also be influenced by distinct subsets of DCs. Many important 
infections and diseases of the intestine, (e.g. parasite infections, Crohn’s disease, 
ulcerative colitis and celiac disease), selectively affect the small intestine or colon 
and dendritic cells have been shown to contribute to disease induction or 
progression. Identifying the role of specific DC subsets could reveal novel 
approaches that could be precisely and independently targeted to interfere with 
these diseases. Thus, our identification of the tissue-specific DC subsets that 
induce Th2 responses against Schistosoma mansoni eggs in the intestine reveals 
novel details for intestinal type 2 immune responses, and also impacts our 
understanding of intestinal immune responses in general, by demonstrating that 
different tissue-specific subsets are involved.	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7.1 Conclusions 
 
Here we have developed an immunization protocol that allows for the physiological 
delivery of Schistosoma mansoni eggs into the intestine to study the induction of 
Th2 responses induced by egg antigens. We have revealed that conventional DCs 
are responsible for carrying egg antigen to the draining mesenteric lymph nodes, 
where they prime naive T cells and induce antigen specific IFN-γ and Th2 
responses. In fact, intestinal IRF4 and CD11b-expressing DCs are specialized to 
drive Th2 responses and distinct populations play a role in the small intestine and 
colon, whereas antigen specific IFN-γ can be induced by all DC populations. Thus, 
we have identified the specific DC subsets that drive intestinal Th2 responses and 
revealed a hitherto unappreciated functional heterogeneity among intestinal DCs 
between the small intestine and colon. These findings not only advance our 
knowledge of intestinal Th2 responses against parasite antigens but also impact 
our immunological understanding of the small intestine and colon. Future 
experiments will demonstrate if these DC subsets also drive Th2 responses 
against other intestinal parasites or allergic conditions and if distinct subsets of 
CD11b-expressing DCs from the small intestine or colon are involved in driving 
other immunological conditions like Crohn’s disease, ulcerative colitis and celiac 
disease. 
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